id	sid	tid	token	lemma	pos
dpc-5264	1	1	dermatology	dermatology	NOUN
dpc-5264	1	2	:	:	PUNCT
dpc-5264	1	3	practical	practical	ADJ
dpc-5264	1	4	and	and	CCONJ
dpc-5264	1	5	conceptual	conceptual	ADJ
dpc-5264	1	6	original	original	ADJ
dpc-5264	1	7	article	article	NOUN
dpc-5264	1	8	|	|	ADV
dpc-5264	1	9	dermatol	dermatol	ADJ
dpc-5264	1	10	pract	pract	NOUN
dpc-5264	1	11	concept	concept	NOUN
dpc-5264	1	12	.	.	PUNCT
dpc-5264	2	1	2025;15(3):5264	2025;15(3):5264	NUM
dpc-5264	2	2	1	1	NUM
dpc-5264	2	3	impact	impact	NOUN
dpc-5264	2	4	of	of	ADP
dpc-5264	2	5	rosacea	rosacea	NOUN
dpc-5264	2	6	on	on	ADP
dpc-5264	2	7	keratinocyte	keratinocyte	NOUN
dpc-5264	2	8	skin	skin	NOUN
dpc-5264	2	9	cancers	cancer	NOUN
dpc-5264	2	10	:	:	PUNCT
dpc-5264	2	11	a	a	DET
dpc-5264	2	12	prospective	prospective	ADJ
dpc-5264	2	13	case	case	NOUN
dpc-5264	2	14	-	-	PUNCT
dpc-5264	2	15	control	control	NOUN
dpc-5264	2	16	study	study	NOUN
dpc-5264	2	17	of	of	ADP
dpc-5264	2	18	basal	basal	ADJ
dpc-5264	2	19	and	and	CCONJ
dpc-5264	2	20	squamous	squamous	ADJ
dpc-5264	2	21	cell	cell	NOUN
dpc-5264	2	22	carcinoma	carcinoma	NOUN
dpc-5264	2	23	risk	risk	NOUN
dpc-5264	2	24	aslı	aslı	VERB
dpc-5264	2	25	aksu1	aksu1	PROPN
dpc-5264	2	26	,	,	PUNCT
dpc-5264	2	27	ayşenur	ayşenur	VERB
dpc-5264	2	28	demir1	demir1	PROPN
dpc-5264	2	29	,	,	PUNCT
dpc-5264	2	30	hatice	hatice	NOUN
dpc-5264	2	31	günay1	günay1	PROPN
dpc-5264	2	32	,	,	PUNCT
dpc-5264	2	33	pinar	pinar	PROPN
dpc-5264	2	34	ozdemir	ozdemir	PROPN
dpc-5264	2	35	cetinkaya1	cetinkaya1	PROPN
dpc-5264	2	36	,	,	PUNCT
dpc-5264	2	37	birgul	birgul	VERB
dpc-5264	2	38	ozkesici	ozkesici	PROPN
dpc-5264	2	39	kurt1	kurt1	PROPN
dpc-5264	2	40	,	,	PUNCT
dpc-5264	2	41	hazel	hazel	ADJ
dpc-5264	2	42	ezgi	ezgi	ADJ
dpc-5264	2	43	kaya1	kaya1	NOUN
dpc-5264	2	44	,	,	PUNCT
dpc-5264	2	45	i̇lknur	i̇lknur	VERB
dpc-5264	2	46	kıvanç	kıvanç	PROPN
dpc-5264	2	47	altunay1	altunay1	PROPN
dpc-5264	2	48	,	,	PUNCT
dpc-5264	2	49	deniz	deniz	PROPN
dpc-5264	2	50	altınel2	altınel2	PROPN
dpc-5264	2	51	1	1	NUM
dpc-5264	2	52	university	university	NOUN
dpc-5264	2	53	of	of	ADP
dpc-5264	2	54	health	health	PROPN
dpc-5264	2	55	sciences	sciences	PROPN
dpc-5264	2	56	,	,	PUNCT
dpc-5264	2	57	şişli	şişli	NOUN
dpc-5264	2	58	hamidiye	hamidiye	NOUN
dpc-5264	2	59	etfal	etfal	NOUN
dpc-5264	2	60	training	training	NOUN
dpc-5264	2	61	and	and	CCONJ
dpc-5264	2	62	research	research	NOUN
dpc-5264	2	63	hospital	hospital	NOUN
dpc-5264	2	64	,	,	PUNCT
dpc-5264	2	65	department	department	NOUN
dpc-5264	2	66	of	of	ADP
dpc-5264	2	67	dermatology	dermatology	NOUN
dpc-5264	2	68	,	,	PUNCT
dpc-5264	2	69	i̇stanbul	i̇stanbul	ADV
dpc-5264	2	70	,	,	PUNCT
dpc-5264	2	71	turkey	turkey	PROPN
dpc-5264	2	72	2	2	NUM
dpc-5264	2	73	university	university	NOUN
dpc-5264	2	74	of	of	ADP
dpc-5264	2	75	health	health	PROPN
dpc-5264	2	76	sciences	sciences	PROPN
dpc-5264	2	77	,	,	PUNCT
dpc-5264	2	78	şişli	şişli	NOUN
dpc-5264	2	79	hamidiye	hamidiye	NOUN
dpc-5264	2	80	etfal	etfal	NOUN
dpc-5264	2	81	training	training	NOUN
dpc-5264	2	82	and	and	CCONJ
dpc-5264	2	83	research	research	NOUN
dpc-5264	2	84	hospital	hospital	NOUN
dpc-5264	2	85	,	,	PUNCT
dpc-5264	2	86	department	department	NOUN
dpc-5264	2	87	of	of	ADP
dpc-5264	2	88	pathology	pathology	PROPN
dpc-5264	2	89	,	,	PUNCT
dpc-5264	2	90	i̇stanbul	i̇stanbul	ADV
dpc-5264	2	91	,	,	PUNCT
dpc-5264	2	92	turkey	turkey	PROPN
dpc-5264	2	93	key	key	ADJ
dpc-5264	2	94	words	word	NOUN
dpc-5264	2	95	:	:	PUNCT
dpc-5264	2	96	rosacea	rosacea	NOUN
dpc-5264	2	97	and	and	CCONJ
dpc-5264	2	98	skin	skin	NOUN
dpc-5264	2	99	cancer	cancer	NOUN
dpc-5264	2	100	,	,	PUNCT
dpc-5264	2	101	basal	basal	ADJ
dpc-5264	2	102	cell	cell	NOUN
dpc-5264	2	103	carcinoma	carcinoma	NOUN
dpc-5264	2	104	,	,	PUNCT
dpc-5264	2	105	squamous	squamous	ADJ
dpc-5264	2	106	cell	cell	NOUN
dpc-5264	2	107	carcinoma	carcinoma	NOUN
dpc-5264	2	108	risk	risk	NOUN
dpc-5264	2	109	,	,	PUNCT
dpc-5264	2	110	keratinocyte	keratinocyte	NOUN
dpc-5264	2	111	carcinoma	carcinoma	NOUN
dpc-5264	2	112	,	,	PUNCT
dpc-5264	2	113	dermatological	dermatological	ADJ
dpc-5264	2	114	diseases	disease	NOUN
dpc-5264	2	115	citation	citation	NOUN
dpc-5264	2	116	:	:	PUNCT
dpc-5264	2	117	aksu	aksu	PROPN
dpc-5264	2	118	a	a	PROPN
dpc-5264	2	119	,	,	PUNCT
dpc-5264	2	120	demir	demir	PROPN
dpc-5264	2	121	a	a	PROPN
dpc-5264	2	122	,	,	PUNCT
dpc-5264	2	123	günay	günay	PROPN
dpc-5264	2	124	h	h	PROPN
dpc-5264	2	125	,	,	PUNCT
dpc-5264	2	126	et	et	PROPN
dpc-5264	2	127	al	al	PROPN
dpc-5264	2	128	.	.	PROPN
dpc-5264	2	129	impact	impact	NOUN
dpc-5264	2	130	of	of	ADP
dpc-5264	2	131	rosacea	rosacea	NOUN
dpc-5264	2	132	on	on	ADP
dpc-5264	2	133	keratinocyte	keratinocyte	NOUN
dpc-5264	2	134	skin	skin	NOUN
dpc-5264	2	135	cancers	cancer	NOUN
dpc-5264	2	136	:	:	PUNCT
dpc-5264	2	137	a	a	DET
dpc-5264	2	138	prospective	prospective	ADJ
dpc-5264	2	139	case	case	NOUN
dpc-5264	2	140	-	-	PUNCT
dpc-5264	2	141	control	control	NOUN
dpc-5264	2	142	study	study	NOUN
dpc-5264	2	143	of	of	ADP
dpc-5264	2	144	basal	basal	ADJ
dpc-5264	2	145	and	and	CCONJ
dpc-5264	2	146	squamous	squamous	ADJ
dpc-5264	2	147	cell	cell	NOUN
dpc-5264	2	148	carcinoma	carcinoma	NOUN
dpc-5264	2	149	risk	risk	NOUN
dpc-5264	2	150	.	.	PUNCT
dpc-5264	3	1	dermatol	dermatol	NOUN
dpc-5264	3	2	pract	pract	PROPN
dpc-5264	3	3	concept	concept	NOUN
dpc-5264	3	4	.	.	PUNCT
dpc-5264	4	1	2025;15(3):5264	2025;15(3):5264	NUM
dpc-5264	4	2	.	.	PUNCT
dpc-5264	5	1	doi	doi	NOUN
dpc-5264	5	2	:	:	PUNCT
dpc-5264	5	3	https://doi.org/10.5826/dpc.1503a5264	https://doi.org/10.5826/dpc.1503a5264	PROPN
dpc-5264	5	4	accepted	accept	VERB
dpc-5264	5	5	:	:	PUNCT
dpc-5264	5	6	may	may	AUX
dpc-5264	5	7	19	19	NUM
dpc-5264	5	8	,	,	PUNCT
dpc-5264	5	9	2025	2025	NUM
dpc-5264	5	10	;	;	PUNCT
dpc-5264	5	11	published	publish	VERB
dpc-5264	5	12	:	:	PUNCT
dpc-5264	5	13	july	july	PROPN
dpc-5264	5	14	2025	2025	NUM
dpc-5264	5	15	copyright	copyright	NOUN
dpc-5264	5	16	:	:	PUNCT
dpc-5264	6	1	©	©	PROPN
dpc-5264	6	2	2025	2025	NUM
dpc-5264	6	3	aksu	aksu	PROPN
dpc-5264	6	4	et	et	PROPN
dpc-5264	6	5	al	al	PROPN
dpc-5264	6	6	.	.	PUNCT
dpc-5264	7	1	this	this	PRON
dpc-5264	7	2	is	be	AUX
dpc-5264	7	3	an	an	DET
dpc-5264	7	4	open	open	ADJ
dpc-5264	7	5	-	-	PUNCT
dpc-5264	7	6	access	access	NOUN
dpc-5264	7	7	article	article	NOUN
dpc-5264	7	8	distributed	distribute	VERB
dpc-5264	7	9	under	under	ADP
dpc-5264	7	10	the	the	DET
dpc-5264	7	11	terms	term	NOUN
dpc-5264	7	12	of	of	ADP
dpc-5264	7	13	the	the	DET
dpc-5264	7	14	creative	creative	ADJ
dpc-5264	7	15	commons	common	NOUN
dpc-5264	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5264	7	17	license	license	NOUN
dpc-5264	7	18	(	(	PUNCT
dpc-5264	7	19	by	by	ADP
dpc-5264	7	20	-	-	PUNCT
dpc-5264	7	21	nc-4.0	nc-4.0	NOUN
dpc-5264	7	22	)	)	PUNCT
dpc-5264	7	23	,	,	PUNCT
dpc-5264	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5264	7	25	,	,	PUNCT
dpc-5264	7	26	which	which	PRON
dpc-5264	7	27	permits	permit	VERB
dpc-5264	7	28	unrestricted	unrestricted	ADJ
dpc-5264	7	29	noncommercial	noncommercial	ADJ
dpc-5264	7	30	use	use	NOUN
dpc-5264	7	31	,	,	PUNCT
dpc-5264	7	32	distribution	distribution	NOUN
dpc-5264	7	33	,	,	PUNCT
dpc-5264	7	34	and	and	CCONJ
dpc-5264	7	35	reproduction	reproduction	NOUN
dpc-5264	7	36	in	in	ADP
dpc-5264	7	37	any	any	DET
dpc-5264	7	38	medium	medium	NOUN
dpc-5264	7	39	,	,	PUNCT
dpc-5264	7	40	provided	provide	VERB
dpc-5264	7	41	the	the	DET
dpc-5264	7	42	original	original	ADJ
dpc-5264	7	43	authors	author	NOUN
dpc-5264	7	44	and	and	CCONJ
dpc-5264	7	45	source	source	NOUN
dpc-5264	7	46	are	be	AUX
dpc-5264	7	47	credited	credit	VERB
dpc-5264	7	48	.	.	PUNCT
dpc-5264	8	1	funding	funding	NOUN
dpc-5264	8	2	:	:	PUNCT
dpc-5264	8	3	none	none	NOUN
dpc-5264	8	4	.	.	PUNCT
dpc-5264	9	1	competing	compete	VERB
dpc-5264	9	2	interests	interest	NOUN
dpc-5264	9	3	:	:	PUNCT
dpc-5264	9	4	none	none	NOUN
dpc-5264	9	5	.	.	PUNCT
dpc-5264	10	1	authorship	authorship	NOUN
dpc-5264	10	2	:	:	PUNCT
dpc-5264	10	3	all	all	DET
dpc-5264	10	4	authors	author	NOUN
dpc-5264	10	5	have	have	AUX
dpc-5264	10	6	contributed	contribute	VERB
dpc-5264	10	7	significantly	significantly	ADV
dpc-5264	10	8	to	to	ADP
dpc-5264	10	9	this	this	DET
dpc-5264	10	10	publication	publication	NOUN
dpc-5264	10	11	.	.	PUNCT
dpc-5264	11	1	corresponding	correspond	VERB
dpc-5264	11	2	author	author	NOUN
dpc-5264	11	3	:	:	PUNCT
dpc-5264	11	4	aslı	aslı	VERB
dpc-5264	11	5	aksu	aksu	PROPN
dpc-5264	11	6	,	,	PUNCT
dpc-5264	11	7	assoc	assoc	PROPN
dpc-5264	11	8	.	.	PUNCT
dpc-5264	12	1	prof	prof	PROPN
dpc-5264	12	2	,	,	PUNCT
dpc-5264	12	3	university	university	PROPN
dpc-5264	12	4	of	of	ADP
dpc-5264	12	5	health	health	PROPN
dpc-5264	12	6	sciences	sciences	PROPN
dpc-5264	12	7	,	,	PUNCT
dpc-5264	12	8	şişli	şişli	NOUN
dpc-5264	12	9	hamidiye	hamidiye	NOUN
dpc-5264	12	10	etfal	etfal	NOUN
dpc-5264	12	11	training	training	NOUN
dpc-5264	12	12	and	and	CCONJ
dpc-5264	12	13	research	research	NOUN
dpc-5264	12	14	hospital	hospital	NOUN
dpc-5264	12	15	,	,	PUNCT
dpc-5264	12	16	department	department	NOUN
dpc-5264	12	17	of	of	ADP
dpc-5264	12	18	dermatology	dermatology	NOUN
dpc-5264	12	19	,	,	PUNCT
dpc-5264	12	20	seyrantepe	seyrantepe	NOUN
dpc-5264	12	21	,	,	PUNCT
dpc-5264	12	22	huzur	huzur	PROPN
dpc-5264	12	23	mah	mah	PROPN
dpc-5264	12	24	.	.	PROPN
dpc-5264	12	25	,	,	PUNCT
dpc-5264	12	26	cumhuriyet	cumhuriyet	ADV
dpc-5264	12	27	ve	ve	VERB
dpc-5264	12	28	demokrasi	demokrasi	PROPN
dpc-5264	12	29	cad	cad	PROPN
dpc-5264	12	30	.	.	PROPN
dpc-5264	12	31	,	,	PUNCT
dpc-5264	12	32	no	no	INTJ
dpc-5264	12	33	:	:	SYM
dpc-5264	12	34	1	1	NUM
dpc-5264	12	35	,	,	PUNCT
dpc-5264	12	36	sarıyer	sarıyer	NOUN
dpc-5264	12	37	,	,	PUNCT
dpc-5264	12	38	i̇stanbul	i̇stanbul	ADV
dpc-5264	12	39	,	,	PUNCT
dpc-5264	12	40	turkey	turkey	NOUN
dpc-5264	12	41	.	.	PUNCT
dpc-5264	13	1	orcid	orcid	NOUN
dpc-5264	13	2	number	number	NOUN
dpc-5264	13	3	:	:	PUNCT
dpc-5264	13	4	0000	0000	NUM
dpc-5264	13	5	-	-	PUNCT
dpc-5264	13	6	00033979	00033979	NUM
dpc-5264	13	7	-	-	SYM
dpc-5264	13	8	7486	7486	NUM
dpc-5264	13	9	.	.	PUNCT
dpc-5264	14	1	e	e	X
dpc-5264	14	2	-	-	NOUN
dpc-5264	14	3	mail	mail	NOUN
dpc-5264	14	4	:	:	PUNCT
dpc-5264	15	1	aksuasli@hotmail.com	aksuasli@hotmail.com	X
dpc-5264	15	2	introduction	introduction	NOUN
dpc-5264	15	3	:	:	PUNCT
dpc-5264	15	4	the	the	DET
dpc-5264	15	5	full	full	ADJ
dpc-5264	15	6	range	range	NOUN
dpc-5264	15	7	of	of	ADP
dpc-5264	15	8	cutaneous	cutaneous	ADJ
dpc-5264	15	9	comorbidities	comorbiditie	NOUN
dpc-5264	15	10	associated	associate	VERB
dpc-5264	15	11	with	with	ADP
dpc-5264	15	12	keratinocyte	keratinocyte	NOUN
dpc-5264	15	13	skin	skin	NOUN
dpc-5264	15	14	cancers	cancer	NOUN
dpc-5264	15	15	remains	remain	VERB
dpc-5264	15	16	to	to	PART
dpc-5264	15	17	be	be	AUX
dpc-5264	15	18	elucidated	elucidate	VERB
dpc-5264	15	19	.	.	PUNCT
dpc-5264	16	1	objectives	objective	NOUN
dpc-5264	16	2	:	:	PUNCT
dpc-5264	16	3	we	we	PRON
dpc-5264	16	4	aimed	aim	VERB
dpc-5264	16	5	to	to	PART
dpc-5264	16	6	examine	examine	VERB
dpc-5264	16	7	other	other	ADJ
dpc-5264	16	8	skin	skin	NOUN
dpc-5264	16	9	diseases	disease	NOUN
dpc-5264	16	10	in	in	ADP
dpc-5264	16	11	patients	patient	NOUN
dpc-5264	16	12	with	with	ADP
dpc-5264	16	13	keratinocyte	keratinocyte	NOUN
dpc-5264	16	14	cancer	cancer	NOUN
dpc-5264	16	15	(	(	PUNCT
dpc-5264	16	16	kc	kc	PROPN
dpc-5264	16	17	)	)	PUNCT
dpc-5264	16	18	and	and	CCONJ
dpc-5264	16	19	to	to	PART
dpc-5264	16	20	reveal	reveal	VERB
dpc-5264	16	21	potential	potential	ADJ
dpc-5264	16	22	associations	association	NOUN
dpc-5264	16	23	between	between	ADP
dpc-5264	16	24	them	they	PRON
dpc-5264	16	25	.	.	PUNCT
dpc-5264	17	1	methods	method	NOUN
dpc-5264	17	2	:	:	PUNCT
dpc-5264	17	3	included	include	VERB
dpc-5264	17	4	in	in	ADP
dpc-5264	17	5	the	the	DET
dpc-5264	17	6	study	study	NOUN
dpc-5264	17	7	were	be	AUX
dpc-5264	17	8	200	200	NUM
dpc-5264	17	9	patients	patient	NOUN
dpc-5264	17	10	with	with	ADP
dpc-5264	17	11	kc	kc	PROPN
dpc-5264	17	12	and	and	CCONJ
dpc-5264	17	13	200	200	NUM
dpc-5264	17	14	disease	disease	NOUN
dpc-5264	17	15	-	-	PUNCT
dpc-5264	17	16	free	free	ADJ
dpc-5264	17	17	controls	control	NOUN
dpc-5264	17	18	.	.	PUNCT
dpc-5264	18	1	to	to	PART
dpc-5264	18	2	identify	identify	VERB
dpc-5264	18	3	any	any	DET
dpc-5264	18	4	additional	additional	ADJ
dpc-5264	18	5	concomitant	concomitant	ADJ
dpc-5264	18	6	dermatological	dermatological	ADJ
dpc-5264	18	7	conditions	condition	NOUN
dpc-5264	18	8	,	,	PUNCT
dpc-5264	18	9	all	all	DET
dpc-5264	18	10	study	study	NOUN
dpc-5264	18	11	groups	group	NOUN
dpc-5264	18	12	underwent	underwent	ADJ
dpc-5264	18	13	examination	examination	NOUN
dpc-5264	18	14	by	by	ADP
dpc-5264	18	15	two	two	NUM
dpc-5264	18	16	dermatologists	dermatologist	NOUN
dpc-5264	18	17	.	.	PUNCT
dpc-5264	19	1	results	result	NOUN
dpc-5264	19	2	:	:	PUNCT
dpc-5264	19	3	in	in	ADP
dpc-5264	19	4	patients	patient	NOUN
dpc-5264	19	5	with	with	ADP
dpc-5264	19	6	kc	kc	PROPN
dpc-5264	19	7	,	,	PUNCT
dpc-5264	19	8	87.5	87.5	NUM
dpc-5264	19	9	%	%	NOUN
dpc-5264	19	10	were	be	AUX
dpc-5264	19	11	diagnosed	diagnose	VERB
dpc-5264	19	12	with	with	ADP
dpc-5264	19	13	basal	basal	ADJ
dpc-5264	19	14	cell	cell	NOUN
dpc-5264	19	15	carcinoma	carcinoma	NOUN
dpc-5264	19	16	and	and	CCONJ
dpc-5264	19	17	13.5	13.5	NUM
dpc-5264	19	18	%	%	NOUN
dpc-5264	19	19	were	be	AUX
dpc-5264	19	20	diagnosed	diagnose	VERB
dpc-5264	19	21	with	with	ADP
dpc-5264	19	22	squamous	squamous	ADJ
dpc-5264	19	23	cell	cell	NOUN
dpc-5264	19	24	carcinoma	carcinoma	NOUN
dpc-5264	19	25	.	.	PUNCT
dpc-5264	20	1	there	there	PRON
dpc-5264	20	2	was	be	VERB
dpc-5264	20	3	no	no	DET
dpc-5264	20	4	statistically	statistically	ADV
dpc-5264	20	5	significant	significant	ADJ
dpc-5264	20	6	difference	difference	NOUN
dpc-5264	20	7	between	between	ADP
dpc-5264	20	8	the	the	DET
dpc-5264	20	9	two	two	NUM
dpc-5264	20	10	groups	group	NOUN
dpc-5264	20	11	regarding	regard	VERB
dpc-5264	20	12	sunscreen	sunscreen	NOUN
dpc-5264	20	13	use	use	NOUN
dpc-5264	20	14	habits	habit	NOUN
dpc-5264	20	15	(	(	PUNCT
dpc-5264	20	16	p	p	NOUN
dpc-5264	20	17	=	=	NOUN
dpc-5264	20	18	0.284	0.284	NUM
dpc-5264	20	19	)	)	PUNCT
dpc-5264	20	20	.	.	PUNCT
dpc-5264	21	1	patients	patient	NOUN
dpc-5264	21	2	with	with	ADP
dpc-5264	21	3	kc	kc	PROPN
dpc-5264	21	4	exhibited	exhibit	VERB
dpc-5264	21	5	a	a	DET
dpc-5264	21	6	significantly	significantly	ADV
dpc-5264	21	7	elevated	elevate	VERB
dpc-5264	21	8	odds	odd	NOUN
dpc-5264	21	9	ratio	ratio	NOUN
dpc-5264	21	10	(	(	PUNCT
dpc-5264	21	11	or	or	CCONJ
dpc-5264	21	12	)	)	PUNCT
dpc-5264	21	13	for	for	ADP
dpc-5264	21	14	the	the	DET
dpc-5264	21	15	presence	presence	NOUN
dpc-5264	21	16	of	of	ADP
dpc-5264	21	17	rosacea	rosacea	NOUN
dpc-5264	21	18	(	(	PUNCT
dpc-5264	21	19	or	or	CCONJ
dpc-5264	21	20	5.13	5.13	NUM
dpc-5264	21	21	,	,	PUNCT
dpc-5264	21	22	95	95	NUM
dpc-5264	21	23	%	%	NOUN
dpc-5264	21	24	ci	ci	NOUN
dpc-5264	21	25	:	:	PUNCT
dpc-5264	21	26	3.2–8.3	3.2–8.3	NUM
dpc-5264	21	27	,	,	PUNCT
dpc-5264	21	28	p=0.000	p=0.000	NUM
dpc-5264	21	29	)	)	PUNCT
dpc-5264	21	30	and	and	CCONJ
dpc-5264	21	31	especially	especially	ADV
dpc-5264	21	32	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5264	21	33	rosacea	rosacea	NOUN
dpc-5264	21	34	(	(	PUNCT
dpc-5264	21	35	etr	etr	PROPN
dpc-5264	21	36	)	)	PUNCT
dpc-5264	21	37	subtype	subtype	NOUN
dpc-5264	21	38	(	(	PUNCT
dpc-5264	21	39	or	or	CCONJ
dpc-5264	21	40	5.03	5.03	NUM
dpc-5264	21	41	,	,	PUNCT
dpc-5264	21	42	95	95	NUM
dpc-5264	21	43	%	%	NOUN
dpc-5264	21	44	ci	ci	NOUN
dpc-5264	21	45	:	:	PUNCT
dpc-5264	21	46	3.1–8.2	3.1–8.2	NUM
dpc-5264	21	47	,	,	PUNCT
dpc-5264	21	48	p=0.000	p=0.000	NUM
dpc-5264	21	49	)	)	PUNCT
dpc-5264	21	50	.	.	PUNCT
dpc-5264	22	1	an	an	DET
dpc-5264	22	2	receiver	receiver	NOUN
dpc-5264	22	3	operating	operate	VERB
dpc-5264	22	4	characteristic	characteristic	NOUN
dpc-5264	22	5	(	(	PUNCT
dpc-5264	22	6	roc	roc	PROPN
dpc-5264	22	7	)	)	PUNCT
dpc-5264	22	8	curve	curve	NOUN
dpc-5264	22	9	analysis	analysis	NOUN
dpc-5264	22	10	was	be	AUX
dpc-5264	22	11	conducted	conduct	VERB
dpc-5264	22	12	to	to	PART
dpc-5264	22	13	assess	assess	VERB
dpc-5264	22	14	the	the	DET
dpc-5264	22	15	efficacy	efficacy	NOUN
dpc-5264	22	16	of	of	ADP
dpc-5264	22	17	rosacea	rosacea	NOUN
dpc-5264	22	18	in	in	ADP
dpc-5264	22	19	differentiating	differentiate	VERB
dpc-5264	22	20	between	between	ADP
dpc-5264	22	21	the	the	DET
dpc-5264	22	22	control	control	NOUN
dpc-5264	22	23	group	group	NOUN
dpc-5264	22	24	and	and	CCONJ
dpc-5264	22	25	patients	patient	NOUN
dpc-5264	22	26	with	with	ADP
dpc-5264	22	27	kc	kc	PROPN
dpc-5264	22	28	.	.	PUNCT
dpc-5264	23	1	the	the	DET
dpc-5264	23	2	sensitivity	sensitivity	NOUN
dpc-5264	23	3	,	,	PUNCT
dpc-5264	23	4	specificity	specificity	NOUN
dpc-5264	23	5	,	,	PUNCT
dpc-5264	23	6	negative	negative	ADJ
dpc-5264	23	7	predictive	predictive	ADJ
dpc-5264	23	8	value	value	NOUN
dpc-5264	23	9	,	,	PUNCT
dpc-5264	23	10	and	and	CCONJ
dpc-5264	23	11	positive	positive	ADJ
dpc-5264	23	12	predictive	predictive	ADJ
dpc-5264	23	13	value	value	NOUN
dpc-5264	23	14	for	for	ADP
dpc-5264	23	15	rosacea	rosacea	NOUN
dpc-5264	23	16	were	be	AUX
dpc-5264	23	17	45.5	45.5	NUM
dpc-5264	23	18	%	%	NOUN
dpc-5264	23	19	,	,	PUNCT
dpc-5264	23	20	86	86	NUM
dpc-5264	23	21	%	%	NOUN
dpc-5264	23	22	,	,	PUNCT
dpc-5264	23	23	61.2	61.2	NUM
dpc-5264	23	24	%	%	NOUN
dpc-5264	23	25	,	,	PUNCT
dpc-5264	23	26	and	and	CCONJ
dpc-5264	23	27	76.5	76.5	NUM
dpc-5264	23	28	%	%	NOUN
dpc-5264	23	29	,	,	PUNCT
dpc-5264	23	30	respectively	respectively	ADV
dpc-5264	23	31	(	(	PUNCT
dpc-5264	23	32	auc	auc	NOUN
dpc-5264	23	33	0.658	0.658	NUM
dpc-5264	23	34	,	,	PUNCT
dpc-5264	23	35	95	95	NUM
dpc-5264	23	36	%	%	NOUN
dpc-5264	23	37	ci	ci	NOUN
dpc-5264	23	38	:	:	PUNCT
dpc-5264	23	39	0.604–0.711	0.604–0.711	NOUN
dpc-5264	23	40	,	,	PUNCT
dpc-5264	23	41	p=0.000	p=0.000	NOUN
dpc-5264	23	42	)	)	PUNCT
dpc-5264	23	43	,	,	PUNCT
dpc-5264	23	44	while	while	SCONJ
dpc-5264	23	45	for	for	ADP
dpc-5264	23	46	etr	etr	PROPN
dpc-5264	23	47	it	it	PRON
dpc-5264	23	48	was	be	AUX
dpc-5264	23	49	44	44	NUM
dpc-5264	23	50	%	%	NOUN
dpc-5264	23	51	,	,	PUNCT
dpc-5264	23	52	86.5	86.5	NUM
dpc-5264	23	53	%	%	NOUN
dpc-5264	23	54	,	,	PUNCT
dpc-5264	23	55	abstract	abstract	ADJ
dpc-5264	23	56	2	2	NUM
dpc-5264	23	57	original	original	ADJ
dpc-5264	23	58	article	article	NOUN
dpc-5264	23	59	|	|	ADV
dpc-5264	23	60	dermatol	dermatol	ADJ
dpc-5264	23	61	pract	pract	NOUN
dpc-5264	23	62	concept	concept	NOUN
dpc-5264	23	63	.	.	PUNCT
dpc-5264	24	1	2025;15(3):5264	2025;15(3):5264	NUM
dpc-5264	24	2	introduction	introduction	NOUN
dpc-5264	24	3	keratinocyte	keratinocyte	NOUN
dpc-5264	24	4	skin	skin	NOUN
dpc-5264	24	5	cancers	cancer	NOUN
dpc-5264	24	6	represent	represent	VERB
dpc-5264	24	7	the	the	DET
dpc-5264	24	8	most	most	ADV
dpc-5264	24	9	prevalent	prevalent	ADJ
dpc-5264	24	10	form	form	NOUN
dpc-5264	24	11	of	of	ADP
dpc-5264	24	12	cancer	cancer	NOUN
dpc-5264	24	13	globally	globally	ADV
dpc-5264	24	14	.	.	PUNCT
dpc-5264	25	1	basal	basal	PROPN
dpc-5264	25	2	cell	cell	NOUN
dpc-5264	25	3	carcinoma	carcinoma	NOUN
dpc-5264	25	4	(	(	PUNCT
dpc-5264	25	5	bcc	bcc	PROPN
dpc-5264	25	6	)	)	PUNCT
dpc-5264	25	7	and	and	CCONJ
dpc-5264	25	8	squamous	squamous	ADJ
dpc-5264	25	9	cell	cell	NOUN
dpc-5264	25	10	carcinoma	carcinoma	NOUN
dpc-5264	25	11	(	(	PUNCT
dpc-5264	25	12	scc	scc	NOUN
dpc-5264	25	13	)	)	PUNCT
dpc-5264	25	14	collectively	collectively	ADV
dpc-5264	25	15	account	account	VERB
dpc-5264	25	16	for	for	ADP
dpc-5264	25	17	99	99	NUM
dpc-5264	25	18	%	%	NOUN
dpc-5264	25	19	of	of	ADP
dpc-5264	25	20	all	all	DET
dpc-5264	25	21	keratinocyte	keratinocyte	NOUN
dpc-5264	25	22	cancers	cancer	NOUN
dpc-5264	25	23	(	(	PUNCT
dpc-5264	25	24	kcs	kcs	NOUN
dpc-5264	25	25	)	)	PUNCT
dpc-5264	26	1	[	[	X
dpc-5264	26	2	1	1	NUM
dpc-5264	26	3	]	]	PUNCT
dpc-5264	26	4	.	.	PUNCT
dpc-5264	27	1	the	the	DET
dpc-5264	27	2	prevalence	prevalence	NOUN
dpc-5264	27	3	of	of	ADP
dpc-5264	27	4	kcs	kcs	PROPN
dpc-5264	27	5	is	be	AUX
dpc-5264	27	6	higher	high	ADJ
dpc-5264	27	7	among	among	ADP
dpc-5264	27	8	the	the	DET
dpc-5264	27	9	elderly	elderly	ADJ
dpc-5264	27	10	,	,	PUNCT
dpc-5264	27	11	and	and	CCONJ
dpc-5264	27	12	as	as	SCONJ
dpc-5264	27	13	the	the	DET
dpc-5264	27	14	proportion	proportion	NOUN
dpc-5264	27	15	of	of	ADP
dpc-5264	27	16	the	the	DET
dpc-5264	27	17	global	global	ADJ
dpc-5264	27	18	population	population	NOUN
dpc-5264	27	19	aged	age	VERB
dpc-5264	27	20	60	60	NUM
dpc-5264	27	21	and	and	CCONJ
dpc-5264	27	22	above	above	ADV
dpc-5264	27	23	continues	continue	VERB
dpc-5264	27	24	to	to	PART
dpc-5264	27	25	grow	grow	VERB
dpc-5264	27	26	,	,	PUNCT
dpc-5264	27	27	these	these	DET
dpc-5264	27	28	cancers	cancer	NOUN
dpc-5264	27	29	are	be	AUX
dpc-5264	27	30	becoming	become	VERB
dpc-5264	27	31	a	a	DET
dpc-5264	27	32	significant	significant	ADJ
dpc-5264	27	33	burden	burden	NOUN
dpc-5264	27	34	on	on	ADP
dpc-5264	27	35	healthcare	healthcare	NOUN
dpc-5264	27	36	systems	system	NOUN
dpc-5264	27	37	worldwide	worldwide	ADV
dpc-5264	28	1	[	[	X
dpc-5264	28	2	2	2	NUM
dpc-5264	28	3	]	]	PUNCT
dpc-5264	28	4	.	.	PUNCT
dpc-5264	29	1	a	a	DET
dpc-5264	29	2	more	more	ADV
dpc-5264	29	3	comprehensive	comprehensive	ADJ
dpc-5264	29	4	understanding	understanding	NOUN
dpc-5264	29	5	of	of	ADP
dpc-5264	29	6	the	the	DET
dpc-5264	29	7	etiology	etiology	NOUN
dpc-5264	29	8	of	of	ADP
dpc-5264	29	9	kcs	kcs	PROPN
dpc-5264	29	10	may	may	AUX
dpc-5264	29	11	facilitate	facilitate	VERB
dpc-5264	29	12	more	more	ADV
dpc-5264	29	13	effective	effective	ADJ
dpc-5264	29	14	treatment	treatment	NOUN
dpc-5264	29	15	and	and	CCONJ
dpc-5264	29	16	prevention	prevention	NOUN
dpc-5264	29	17	strategies	strategy	NOUN
dpc-5264	29	18	.	.	PUNCT
dpc-5264	30	1	predisposing	predispose	VERB
dpc-5264	30	2	factors	factor	NOUN
dpc-5264	30	3	include	include	VERB
dpc-5264	30	4	fair	fair	ADJ
dpc-5264	30	5	skin	skin	NOUN
dpc-5264	30	6	type	type	NOUN
dpc-5264	30	7	,	,	PUNCT
dpc-5264	30	8	ultraviolet	ultraviolet	ADJ
dpc-5264	30	9	radiation	radiation	NOUN
dpc-5264	30	10	(	(	PUNCT
dpc-5264	30	11	uvr	uvr	NOUN
dpc-5264	30	12	)	)	PUNCT
dpc-5264	30	13	,	,	PUNCT
dpc-5264	30	14	immunosuppression	immunosuppression	NOUN
dpc-5264	30	15	,	,	PUNCT
dpc-5264	30	16	and	and	CCONJ
dpc-5264	30	17	certain	certain	ADJ
dpc-5264	30	18	genetic	genetic	ADJ
dpc-5264	30	19	syndromes	syndrome	NOUN
dpc-5264	30	20	as	as	ADV
dpc-5264	30	21	well	well	ADV
dpc-5264	30	22	as	as	ADP
dpc-5264	30	23	the	the	DET
dpc-5264	30	24	human	human	ADJ
dpc-5264	30	25	papilloma	papilloma	PROPN
dpc-5264	30	26	virus	virus	NOUN
dpc-5264	30	27	,	,	PUNCT
dpc-5264	30	28	particularly	particularly	ADV
dpc-5264	30	29	in	in	ADP
dpc-5264	30	30	the	the	DET
dpc-5264	30	31	case	case	NOUN
dpc-5264	30	32	of	of	ADP
dpc-5264	30	33	scc	scc	PROPN
dpc-5264	30	34	.	.	PUNCT
dpc-5264	31	1	additionally	additionally	ADV
dpc-5264	31	2	,	,	PUNCT
dpc-5264	31	3	exposure	exposure	NOUN
dpc-5264	31	4	to	to	ADP
dpc-5264	31	5	chemicals	chemical	NOUN
dpc-5264	31	6	such	such	ADJ
dpc-5264	31	7	as	as	ADP
dpc-5264	31	8	arsenic	arsenic	NOUN
dpc-5264	31	9	,	,	PUNCT
dpc-5264	31	10	chronic	chronic	ADJ
dpc-5264	31	11	ulcers	ulcer	NOUN
dpc-5264	31	12	,	,	PUNCT
dpc-5264	31	13	and	and	CCONJ
dpc-5264	31	14	burn	burn	VERB
dpc-5264	31	15	scars	scar	NOUN
dpc-5264	31	16	may	may	AUX
dpc-5264	31	17	contribute	contribute	VERB
dpc-5264	31	18	to	to	ADP
dpc-5264	31	19	the	the	DET
dpc-5264	31	20	development	development	NOUN
dpc-5264	31	21	of	of	ADP
dpc-5264	31	22	these	these	DET
dpc-5264	31	23	cancers	cancer	NOUN
dpc-5264	31	24	[	[	X
dpc-5264	31	25	1	1	NUM
dpc-5264	31	26	]	]	PUNCT
dpc-5264	31	27	.	.	PUNCT
dpc-5264	32	1	however	however	ADV
dpc-5264	32	2	,	,	PUNCT
dpc-5264	32	3	the	the	DET
dpc-5264	32	4	available	available	ADJ
dpc-5264	32	5	data	datum	NOUN
dpc-5264	32	6	on	on	ADP
dpc-5264	32	7	the	the	DET
dpc-5264	32	8	relationship	relationship	NOUN
dpc-5264	32	9	between	between	ADP
dpc-5264	32	10	kcs	kcs	PROPN
dpc-5264	32	11	and	and	CCONJ
dpc-5264	32	12	other	other	ADJ
dpc-5264	32	13	cutaneous	cutaneous	ADJ
dpc-5264	32	14	diseases	disease	NOUN
dpc-5264	32	15	are	be	AUX
dpc-5264	32	16	limited	limited	ADJ
dpc-5264	32	17	.	.	PUNCT
dpc-5264	33	1	in	in	ADP
dpc-5264	33	2	recent	recent	ADJ
dpc-5264	33	3	years	year	NOUN
dpc-5264	33	4	,	,	PUNCT
dpc-5264	33	5	studies	study	NOUN
dpc-5264	33	6	have	have	AUX
dpc-5264	33	7	investigated	investigate	VERB
dpc-5264	33	8	the	the	DET
dpc-5264	33	9	relationship	relationship	NOUN
dpc-5264	33	10	between	between	ADP
dpc-5264	33	11	kcs	kcs	PROPN
dpc-5264	33	12	and	and	CCONJ
dpc-5264	33	13	rosacea	rosacea	NOUN
dpc-5264	33	14	.	.	PUNCT
dpc-5264	34	1	however	however	ADV
dpc-5264	34	2	,	,	PUNCT
dpc-5264	34	3	the	the	DET
dpc-5264	34	4	results	result	NOUN
dpc-5264	34	5	of	of	ADP
dpc-5264	34	6	these	these	DET
dpc-5264	34	7	studies	study	NOUN
dpc-5264	34	8	were	be	AUX
dpc-5264	34	9	inconsistent	inconsistent	ADJ
dpc-5264	34	10	.	.	PUNCT
dpc-5264	35	1	egeberg	egeberg	PROPN
dpc-5264	35	2	et	et	PROPN
dpc-5264	35	3	al	al	PROPN
dpc-5264	35	4	.	.	PROPN
dpc-5264	35	5	conducted	conduct	VERB
dpc-5264	35	6	an	an	DET
dpc-5264	35	7	epidemiological	epidemiological	ADJ
dpc-5264	35	8	study	study	NOUN
dpc-5264	35	9	to	to	PART
dpc-5264	35	10	investigate	investigate	VERB
dpc-5264	35	11	the	the	DET
dpc-5264	35	12	incidence	incidence	NOUN
dpc-5264	35	13	of	of	ADP
dpc-5264	35	14	cancer	cancer	NOUN
dpc-5264	35	15	in	in	ADP
dpc-5264	35	16	patients	patient	NOUN
dpc-5264	35	17	with	with	ADP
dpc-5264	35	18	previously	previously	ADV
dpc-5264	35	19	diagnosed	diagnose	VERB
dpc-5264	35	20	rosacea	rosacea	NOUN
dpc-5264	35	21	compared	compare	VERB
dpc-5264	35	22	with	with	ADP
dpc-5264	35	23	the	the	DET
dpc-5264	35	24	general	general	ADJ
dpc-5264	35	25	population	population	NOUN
dpc-5264	36	1	[	[	X
dpc-5264	36	2	3	3	NUM
dpc-5264	36	3	]	]	PUNCT
dpc-5264	36	4	.	.	PUNCT
dpc-5264	37	1	their	their	PRON
dpc-5264	37	2	4	4	NUM
dpc-5264	37	3	-	-	PUNCT
dpc-5264	37	4	year	year	NOUN
dpc-5264	37	5	follow	follow	NOUN
dpc-5264	37	6	-	-	PUNCT
dpc-5264	37	7	up	up	NOUN
dpc-5264	37	8	revealed	reveal	VERB
dpc-5264	37	9	an	an	DET
dpc-5264	37	10	increased	increased	ADJ
dpc-5264	37	11	risk	risk	NOUN
dpc-5264	37	12	of	of	ADP
dpc-5264	37	13	non	non	ADJ
dpc-5264	37	14	-	-	ADJ
dpc-5264	37	15	melanoma	melanoma	ADJ
dpc-5264	37	16	skin	skin	NOUN
dpc-5264	37	17	cancer	cancer	NOUN
dpc-5264	37	18	(	(	PUNCT
dpc-5264	37	19	nmsc	nmsc	NOUN
dpc-5264	37	20	)	)	PUNCT
dpc-5264	37	21	,	,	PUNCT
dpc-5264	37	22	breast	breast	NOUN
dpc-5264	37	23	cancer	cancer	NOUN
dpc-5264	37	24	,	,	PUNCT
dpc-5264	37	25	and	and	CCONJ
dpc-5264	37	26	liver	liver	NOUN
dpc-5264	37	27	cancer	cancer	NOUN
dpc-5264	37	28	in	in	ADP
dpc-5264	37	29	rosacea	rosacea	NOUN
dpc-5264	37	30	patients	patient	NOUN
dpc-5264	37	31	.	.	PUNCT
dpc-5264	38	1	in	in	ADP
dpc-5264	38	2	a	a	DET
dpc-5264	38	3	systematic	systematic	ADJ
dpc-5264	38	4	analysis	analysis	NOUN
dpc-5264	38	5	of	of	ADP
dpc-5264	38	6	the	the	DET
dpc-5264	38	7	association	association	NOUN
dpc-5264	38	8	between	between	ADP
dpc-5264	38	9	rosacea	rosacea	NOUN
dpc-5264	38	10	and	and	CCONJ
dpc-5264	38	11	cancer	cancer	NOUN
dpc-5264	38	12	in	in	ADP
dpc-5264	38	13	us	us	PROPN
dpc-5264	38	14	women	woman	NOUN
dpc-5264	38	15	,	,	PUNCT
dpc-5264	38	16	li	li	PROPN
dpc-5264	38	17	et	et	PROPN
dpc-5264	38	18	al	al	PROPN
dpc-5264	38	19	.	.	PROPN
dpc-5264	38	20	found	find	VERB
dpc-5264	38	21	that	that	SCONJ
dpc-5264	38	22	patients	patient	NOUN
dpc-5264	38	23	with	with	ADP
dpc-5264	38	24	a	a	DET
dpc-5264	38	25	history	history	NOUN
dpc-5264	38	26	of	of	ADP
dpc-5264	38	27	rosacea	rosacea	NOUN
dpc-5264	38	28	exhibited	exhibit	VERB
dpc-5264	38	29	an	an	DET
dpc-5264	38	30	elevated	elevated	ADJ
dpc-5264	38	31	risk	risk	NOUN
dpc-5264	38	32	of	of	ADP
dpc-5264	38	33	thyroid	thyroid	NOUN
dpc-5264	38	34	cancer	cancer	NOUN
dpc-5264	38	35	and	and	CCONJ
dpc-5264	38	36	bcc	bcc	PROPN
dpc-5264	39	1	[	[	X
dpc-5264	39	2	4	4	NUM
dpc-5264	39	3	]	]	PUNCT
dpc-5264	39	4	.	.	PUNCT
dpc-5264	40	1	however	however	ADV
dpc-5264	40	2	,	,	PUNCT
dpc-5264	40	3	dupont	dupont	PROPN
dpc-5264	40	4	et	et	PROPN
dpc-5264	40	5	al	al	PROPN
dpc-5264	40	6	.	.	PROPN
dpc-5264	40	7	identified	identify	VERB
dpc-5264	40	8	no	no	DET
dpc-5264	40	9	significant	significant	ADJ
dpc-5264	40	10	correlation	correlation	NOUN
dpc-5264	40	11	between	between	ADP
dpc-5264	40	12	rosacea	rosacea	NOUN
dpc-5264	40	13	and	and	CCONJ
dpc-5264	40	14	the	the	DET
dpc-5264	40	15	occurrence	occurrence	NOUN
dpc-5264	40	16	of	of	ADP
dpc-5264	40	17	skin	skin	NOUN
dpc-5264	40	18	cancers	cancer	NOUN
dpc-5264	40	19	[	[	X
dpc-5264	40	20	5	5	NUM
dpc-5264	40	21	]	]	PUNCT
dpc-5264	40	22	.	.	PUNCT
dpc-5264	41	1	furthermore	furthermore	ADV
dpc-5264	41	2	,	,	PUNCT
dpc-5264	41	3	lin	lin	PROPN
dpc-5264	41	4	et	et	PROPN
dpc-5264	41	5	al	al	PROPN
dpc-5264	41	6	.	.	PROPN
dpc-5264	41	7	proposed	propose	VERB
dpc-5264	41	8	that	that	SCONJ
dpc-5264	41	9	a	a	DET
dpc-5264	41	10	history	history	NOUN
dpc-5264	41	11	of	of	ADP
dpc-5264	41	12	rosacea	rosacea	NOUN
dpc-5264	41	13	may	may	AUX
dpc-5264	41	14	act	act	VERB
dpc-5264	41	15	as	as	ADP
dpc-5264	41	16	a	a	DET
dpc-5264	41	17	protective	protective	ADJ
dpc-5264	41	18	factor	factor	NOUN
dpc-5264	41	19	against	against	ADP
dpc-5264	41	20	the	the	DET
dpc-5264	41	21	development	development	NOUN
dpc-5264	41	22	of	of	ADP
dpc-5264	41	23	facial	facial	ADJ
dpc-5264	41	24	bcc	bcc	NOUN
dpc-5264	42	1	[	[	X
dpc-5264	42	2	6	6	NUM
dpc-5264	42	3	]	]	PUNCT
dpc-5264	42	4	.	.	PUNCT
dpc-5264	43	1	objectives	objective	NOUN
dpc-5264	43	2	in	in	ADP
dpc-5264	43	3	light	light	NOUN
dpc-5264	43	4	of	of	ADP
dpc-5264	43	5	the	the	DET
dpc-5264	43	6	inconclusive	inconclusive	ADJ
dpc-5264	43	7	nature	nature	NOUN
dpc-5264	43	8	of	of	ADP
dpc-5264	43	9	these	these	DET
dpc-5264	43	10	findings	finding	NOUN
dpc-5264	43	11	,	,	PUNCT
dpc-5264	43	12	our	our	PRON
dpc-5264	43	13	objective	objective	NOUN
dpc-5264	43	14	was	be	AUX
dpc-5264	43	15	to	to	PART
dpc-5264	43	16	examine	examine	VERB
dpc-5264	43	17	the	the	DET
dpc-5264	43	18	presence	presence	NOUN
dpc-5264	43	19	of	of	ADP
dpc-5264	43	20	cutaneous	cutaneous	ADJ
dpc-5264	43	21	comorbidities	comorbiditie	NOUN
dpc-5264	43	22	in	in	ADP
dpc-5264	43	23	patients	patient	NOUN
dpc-5264	43	24	with	with	ADP
dpc-5264	43	25	kc	kc	PROPN
dpc-5264	43	26	and	and	CCONJ
dpc-5264	43	27	ascertain	ascertain	VERB
dpc-5264	43	28	whether	whether	SCONJ
dpc-5264	43	29	they	they	PRON
dpc-5264	43	30	are	be	AUX
dpc-5264	43	31	associated	associate	VERB
dpc-5264	43	32	.	.	PUNCT
dpc-5264	44	1	methods	method	NOUN
dpc-5264	44	2	participants	participant	NOUN
dpc-5264	44	3	and	and	CCONJ
dpc-5264	44	4	protocol	protocol	VERB
dpc-5264	44	5	this	this	DET
dpc-5264	44	6	prospective	prospective	ADJ
dpc-5264	44	7	case	case	NOUN
dpc-5264	44	8	-	-	PUNCT
dpc-5264	44	9	control	control	NOUN
dpc-5264	44	10	study	study	NOUN
dpc-5264	44	11	was	be	AUX
dpc-5264	44	12	conducted	conduct	VERB
dpc-5264	44	13	in	in	ADP
dpc-5264	44	14	a	a	DET
dpc-5264	44	15	single	single	ADJ
dpc-5264	44	16	center	center	NOUN
dpc-5264	44	17	from	from	ADP
dpc-5264	44	18	september	september	PROPN
dpc-5264	44	19	2023	2023	NUM
dpc-5264	44	20	to	to	ADP
dpc-5264	44	21	may	may	PROPN
dpc-5264	44	22	2024	2024	NUM
dpc-5264	44	23	,	,	PUNCT
dpc-5264	44	24	at	at	ADP
dpc-5264	44	25	the	the	DET
dpc-5264	44	26	department	department	NOUN
dpc-5264	44	27	of	of	ADP
dpc-5264	44	28	dermatology	dermatology	NOUN
dpc-5264	44	29	.	.	PUNCT
dpc-5264	45	1	the	the	DET
dpc-5264	45	2	study	study	NOUN
dpc-5264	45	3	was	be	AUX
dpc-5264	45	4	approved	approve	VERB
dpc-5264	45	5	by	by	ADP
dpc-5264	45	6	the	the	DET
dpc-5264	45	7	institutional	institutional	ADJ
dpc-5264	45	8	ethics	ethic	NOUN
dpc-5264	45	9	committee	committee	PROPN
dpc-5264	45	10	(	(	PUNCT
dpc-5264	45	11	approval	approval	NOUN
dpc-5264	45	12	number	number	NOUN
dpc-5264	45	13	:	:	PUNCT
dpc-5264	45	14	4493	4493	NUM
dpc-5264	45	15	)	)	PUNCT
dpc-5264	45	16	.	.	PUNCT
dpc-5264	46	1	all	all	DET
dpc-5264	46	2	aspects	aspect	NOUN
dpc-5264	46	3	of	of	ADP
dpc-5264	46	4	the	the	DET
dpc-5264	46	5	study	study	NOUN
dpc-5264	46	6	were	be	AUX
dpc-5264	46	7	conducted	conduct	VERB
dpc-5264	46	8	in	in	ADP
dpc-5264	46	9	accordance	accordance	NOUN
dpc-5264	46	10	with	with	ADP
dpc-5264	46	11	the	the	DET
dpc-5264	46	12	latest	late	ADJ
dpc-5264	46	13	version	version	NOUN
dpc-5264	46	14	of	of	ADP
dpc-5264	46	15	the	the	DET
dpc-5264	46	16	helsinki	helsinki	PROPN
dpc-5264	46	17	declaration	declaration	PROPN
dpc-5264	46	18	and	and	CCONJ
dpc-5264	46	19	the	the	DET
dpc-5264	46	20	guidelines	guideline	NOUN
dpc-5264	46	21	for	for	ADP
dpc-5264	46	22	good	good	ADJ
dpc-5264	46	23	clinical	clinical	ADJ
dpc-5264	46	24	practice	practice	NOUN
dpc-5264	46	25	.	.	PUNCT
dpc-5264	47	1	the	the	DET
dpc-5264	47	2	study	study	NOUN
dpc-5264	47	3	population	population	NOUN
dpc-5264	47	4	comprised	comprise	VERB
dpc-5264	47	5	the	the	DET
dpc-5264	47	6	kcs	kcs	PROPN
dpc-5264	47	7	group	group	NOUN
dpc-5264	47	8	,	,	PUNCT
dpc-5264	47	9	which	which	PRON
dpc-5264	47	10	was	be	AUX
dpc-5264	47	11	recruited	recruit	VERB
dpc-5264	47	12	from	from	ADP
dpc-5264	47	13	patients	patient	NOUN
dpc-5264	47	14	admitted	admit	VERB
dpc-5264	47	15	to	to	ADP
dpc-5264	47	16	the	the	DET
dpc-5264	47	17	dermatology	dermatology	NOUN
dpc-5264	47	18	outpatient	outpatient	NOUN
dpc-5264	47	19	clinic	clinic	NOUN
dpc-5264	47	20	.	.	PUNCT
dpc-5264	48	1	the	the	DET
dpc-5264	48	2	control	control	PROPN
dpc-5264	48	3	group	group	NOUN
dpc-5264	48	4	consisted	consist	VERB
dpc-5264	48	5	of	of	ADP
dpc-5264	48	6	ageand	ageand	NOUN
dpc-5264	48	7	sex	sex	NOUN
dpc-5264	48	8	-	-	PUNCT
dpc-5264	48	9	matched	match	VERB
dpc-5264	48	10	volunteers	volunteer	NOUN
dpc-5264	48	11	consisting	consist	VERB
dpc-5264	48	12	of	of	ADP
dpc-5264	48	13	patients	patient	NOUN
dpc-5264	48	14	’	'	PUNCT
dpc-5264	48	15	relatives	relative	NOUN
dpc-5264	48	16	.	.	PUNCT
dpc-5264	49	1	the	the	DET
dpc-5264	49	2	diagnosis	diagnosis	NOUN
dpc-5264	49	3	of	of	ADP
dpc-5264	49	4	the	the	DET
dpc-5264	49	5	kc	kc	PROPN
dpc-5264	49	6	in	in	ADP
dpc-5264	49	7	patients	patient	NOUN
dpc-5264	49	8	was	be	AUX
dpc-5264	49	9	made	make	VERB
dpc-5264	49	10	based	base	VERB
dpc-5264	49	11	on	on	ADP
dpc-5264	49	12	clinicopathological	clinicopathological	ADJ
dpc-5264	49	13	criteria	criterion	NOUN
dpc-5264	49	14	.	.	PUNCT
dpc-5264	50	1	the	the	DET
dpc-5264	50	2	following	follow	VERB
dpc-5264	50	3	details	detail	NOUN
dpc-5264	50	4	were	be	AUX
dpc-5264	50	5	recorded	record	VERB
dpc-5264	50	6	:	:	PUNCT
dpc-5264	50	7	the	the	DET
dpc-5264	50	8	histological	histological	ADJ
dpc-5264	50	9	type	type	NOUN
dpc-5264	50	10	of	of	ADP
dpc-5264	50	11	bcc	bcc	PROPN
dpc-5264	50	12	,	,	PUNCT
dpc-5264	50	13	the	the	DET
dpc-5264	50	14	site	site	NOUN
dpc-5264	50	15	of	of	ADP
dpc-5264	50	16	localization	localization	NOUN
dpc-5264	50	17	,	,	PUNCT
dpc-5264	50	18	the	the	DET
dpc-5264	50	19	number	number	NOUN
dpc-5264	50	20	of	of	ADP
dpc-5264	50	21	lesions	lesion	NOUN
dpc-5264	50	22	,	,	PUNCT
dpc-5264	50	23	the	the	DET
dpc-5264	50	24	patient	patient	NOUN
dpc-5264	50	25	’s	’s	PART
dpc-5264	50	26	skin	skin	NOUN
dpc-5264	50	27	type	type	NOUN
dpc-5264	50	28	,	,	PUNCT
dpc-5264	50	29	their	their	PRON
dpc-5264	50	30	family	family	NOUN
dpc-5264	50	31	history	history	NOUN
dpc-5264	50	32	,	,	PUNCT
dpc-5264	50	33	and	and	CCONJ
dpc-5264	50	34	their	their	PRON
dpc-5264	50	35	habits	habit	NOUN
dpc-5264	50	36	concerning	concern	VERB
dpc-5264	50	37	using	use	VERB
dpc-5264	50	38	sunscreen	sunscreen	NOUN
dpc-5264	50	39	.	.	PUNCT
dpc-5264	51	1	both	both	CCONJ
dpc-5264	51	2	the	the	DET
dpc-5264	51	3	patient	patient	ADJ
dpc-5264	51	4	group	group	NOUN
dpc-5264	51	5	with	with	ADP
dpc-5264	51	6	kc	kc	PROPN
dpc-5264	51	7	and	and	CCONJ
dpc-5264	51	8	the	the	DET
dpc-5264	51	9	control	control	NOUN
dpc-5264	51	10	group	group	NOUN
dpc-5264	51	11	underwent	underwent	NOUN
dpc-5264	51	12	examination	examination	NOUN
dpc-5264	51	13	by	by	ADP
dpc-5264	51	14	two	two	NUM
dpc-5264	51	15	dermatologists	dermatologist	NOUN
dpc-5264	51	16	to	to	PART
dpc-5264	51	17	identify	identify	VERB
dpc-5264	51	18	any	any	DET
dpc-5264	51	19	additional	additional	ADJ
dpc-5264	51	20	concomitant	concomitant	ADJ
dpc-5264	51	21	dermatological	dermatological	ADJ
dpc-5264	51	22	conditions	condition	NOUN
dpc-5264	51	23	.	.	PUNCT
dpc-5264	52	1	the	the	DET
dpc-5264	52	2	study	study	NOUN
dpc-5264	52	3	included	include	VERB
dpc-5264	52	4	participants	participant	NOUN
dpc-5264	52	5	aged	age	VERB
dpc-5264	52	6	18	18	NUM
dpc-5264	52	7	years	year	NOUN
dpc-5264	52	8	and	and	CCONJ
dpc-5264	52	9	above	above	ADV
dpc-5264	52	10	.	.	PUNCT
dpc-5264	53	1	participants	participant	NOUN
dpc-5264	53	2	with	with	ADP
dpc-5264	53	3	a	a	DET
dpc-5264	53	4	syndrome	syndrome	NOUN
dpc-5264	53	5	known	know	VERB
dpc-5264	53	6	to	to	PART
dpc-5264	53	7	cause	cause	VERB
dpc-5264	53	8	kc	kc	PROPN
dpc-5264	53	9	,	,	PUNCT
dpc-5264	53	10	a	a	DET
dpc-5264	53	11	history	history	NOUN
dpc-5264	53	12	of	of	ADP
dpc-5264	53	13	organ	organ	NOUN
dpc-5264	53	14	transplantation	transplantation	NOUN
dpc-5264	53	15	,	,	PUNCT
dpc-5264	53	16	a	a	DET
dpc-5264	53	17	confirmed	confirm	VERB
dpc-5264	53	18	hiv	hiv	PROPN
dpc-5264	53	19	diagnosis	diagnosis	NOUN
dpc-5264	53	20	,	,	PUNCT
dpc-5264	53	21	a	a	DET
dpc-5264	53	22	history	history	NOUN
dpc-5264	53	23	of	of	ADP
dpc-5264	53	24	arsenic	arsenic	ADJ
dpc-5264	53	25	and	and	CCONJ
dpc-5264	53	26	chemical	chemical	NOUN
dpc-5264	53	27	exposure	exposure	NOUN
dpc-5264	53	28	,	,	PUNCT
dpc-5264	53	29	users	user	NOUN
dpc-5264	53	30	of	of	ADP
dpc-5264	53	31	photosensitizing	photosensitize	VERB
dpc-5264	53	32	drugs	drug	NOUN
dpc-5264	53	33	,	,	PUNCT
dpc-5264	53	34	patients	patient	NOUN
dpc-5264	53	35	with	with	ADP
dpc-5264	53	36	a	a	DET
dpc-5264	53	37	history	history	NOUN
dpc-5264	53	38	of	of	ADP
dpc-5264	53	39	phototherapy	phototherapy	NOUN
dpc-5264	53	40	,	,	PUNCT
dpc-5264	53	41	and	and	CCONJ
dpc-5264	53	42	patients	patient	NOUN
dpc-5264	53	43	receiving	receive	VERB
dpc-5264	53	44	immunosuppressive	immunosuppressive	ADJ
dpc-5264	53	45	therapy	therapy	NOUN
dpc-5264	53	46	were	be	AUX
dpc-5264	53	47	excluded	exclude	VERB
dpc-5264	53	48	from	from	ADP
dpc-5264	53	49	the	the	DET
dpc-5264	53	50	study	study	NOUN
dpc-5264	53	51	.	.	PUNCT
dpc-5264	54	1	statistical	statistical	ADJ
dpc-5264	54	2	analysis	analysis	NOUN
dpc-5264	54	3	the	the	DET
dpc-5264	54	4	statistical	statistical	ADJ
dpc-5264	54	5	analyses	analysis	NOUN
dpc-5264	54	6	were	be	AUX
dpc-5264	54	7	conducted	conduct	VERB
dpc-5264	54	8	using	use	VERB
dpc-5264	54	9	the	the	DET
dpc-5264	54	10	spss	spss	PROPN
dpc-5264	54	11	28.0	28.0	NUM
dpc-5264	54	12	software	software	NOUN
dpc-5264	54	13	.	.	PUNCT
dpc-5264	55	1	descriptive	descriptive	ADJ
dpc-5264	55	2	statistics	statistic	NOUN
dpc-5264	55	3	were	be	AUX
dpc-5264	55	4	performed	perform	VERB
dpc-5264	55	5	on	on	ADP
dpc-5264	55	6	the	the	DET
dpc-5264	55	7	data	datum	NOUN
dpc-5264	55	8	using	use	VERB
dpc-5264	55	9	mean	mean	NOUN
dpc-5264	55	10	,	,	PUNCT
dpc-5264	55	11	standard	standard	ADJ
dpc-5264	55	12	deviation	deviation	NOUN
dpc-5264	55	13	,	,	PUNCT
dpc-5264	55	14	median	median	NOUN
dpc-5264	55	15	,	,	PUNCT
dpc-5264	55	16	minimum	minimum	ADJ
dpc-5264	55	17	,	,	PUNCT
dpc-5264	55	18	maximum	maximum	ADJ
dpc-5264	55	19	,	,	PUNCT
dpc-5264	55	20	frequency	frequency	NOUN
dpc-5264	55	21	,	,	PUNCT
dpc-5264	55	22	and	and	CCONJ
dpc-5264	55	23	ratio	ratio	NOUN
dpc-5264	55	24	values	value	NOUN
dpc-5264	55	25	.	.	PUNCT
dpc-5264	56	1	the	the	DET
dpc-5264	56	2	distribution	distribution	NOUN
dpc-5264	56	3	of	of	ADP
dpc-5264	56	4	the	the	DET
dpc-5264	56	5	variables	variable	NOUN
dpc-5264	56	6	was	be	AUX
dpc-5264	56	7	evaluated	evaluate	VERB
dpc-5264	56	8	using	use	VERB
dpc-5264	56	9	the	the	DET
dpc-5264	56	10	kolmogorov	kolmogorov	ADJ
dpc-5264	56	11	-	-	PUNCT
dpc-5264	56	12	smirnov	smirnov	PROPN
dpc-5264	56	13	and	and	CCONJ
dpc-5264	56	14	shapiro	shapiro	NOUN
dpc-5264	56	15	-	-	PUNCT
dpc-5264	56	16	wilk	wilk	NOUN
dpc-5264	56	17	tests	test	NOUN
dpc-5264	56	18	.	.	PUNCT
dpc-5264	57	1	the	the	DET
dpc-5264	57	2	mann	mann	PROPN
dpc-5264	57	3	-	-	PUNCT
dpc-5264	57	4	whitney	whitney	PROPN
dpc-5264	57	5	u	u	PROPN
dpc-5264	57	6	test	test	NOUN
dpc-5264	57	7	was	be	AUX
dpc-5264	57	8	employed	employ	VERB
dpc-5264	57	9	to	to	PART
dpc-5264	57	10	analyze	analyze	VERB
dpc-5264	57	11	quantitative	quantitative	ADJ
dpc-5264	57	12	independent	independent	ADJ
dpc-5264	57	13	data	datum	NOUN
dpc-5264	57	14	exhibiting	exhibit	VERB
dpc-5264	57	15	a	a	DET
dpc-5264	57	16	non	non	ADJ
dpc-5264	57	17	-	-	ADJ
dpc-5264	57	18	normal	normal	ADJ
dpc-5264	57	19	distribution	distribution	NOUN
dpc-5264	57	20	.	.	PUNCT
dpc-5264	58	1	the	the	DET
dpc-5264	58	2	chi	chi	NOUN
dpc-5264	58	3	-	-	PUNCT
dpc-5264	58	4	squared	square	VERB
dpc-5264	58	5	test	test	NOUN
dpc-5264	58	6	was	be	AUX
dpc-5264	58	7	employed	employ	VERB
dpc-5264	58	8	to	to	PART
dpc-5264	58	9	analyze	analyze	VERB
dpc-5264	58	10	qualitative	qualitative	ADJ
dpc-5264	58	11	independent	independent	ADJ
dpc-5264	58	12	data	datum	NOUN
dpc-5264	58	13	,	,	PUNCT
dpc-5264	58	14	while	while	SCONJ
dpc-5264	58	15	the	the	DET
dpc-5264	58	16	fischer	fischer	PROPN
dpc-5264	58	17	test	test	NOUN
dpc-5264	58	18	was	be	AUX
dpc-5264	58	19	utilized	utilize	VERB
dpc-5264	58	20	in	in	ADP
dpc-5264	58	21	instances	instance	NOUN
dpc-5264	58	22	where	where	SCONJ
dpc-5264	58	23	the	the	DET
dpc-5264	58	24	conditions	condition	NOUN
dpc-5264	58	25	for	for	ADP
dpc-5264	58	26	the	the	DET
dpc-5264	58	27	chisquared	chisquared	ADJ
dpc-5264	58	28	test	test	NOUN
dpc-5264	58	29	were	be	AUX
dpc-5264	58	30	not	not	PART
dpc-5264	58	31	met	meet	VERB
dpc-5264	58	32	.	.	PUNCT
dpc-5264	59	1	the	the	DET
dpc-5264	59	2	effect	effect	NOUN
dpc-5264	59	3	level	level	NOUN
dpc-5264	59	4	and	and	CCONJ
dpc-5264	59	5	cutoff	cutoff	NOUN
dpc-5264	59	6	value	value	NOUN
dpc-5264	59	7	were	be	AUX
dpc-5264	59	8	subjected	subject	VERB
dpc-5264	59	9	to	to	ADP
dpc-5264	59	10	analysis	analysis	NOUN
dpc-5264	59	11	via	via	ADP
dpc-5264	59	12	the	the	DET
dpc-5264	59	13	roc	roc	PROPN
dpc-5264	59	14	curve	curve	NOUN
dpc-5264	59	15	.	.	PUNCT
dpc-5264	60	1	the	the	DET
dpc-5264	60	2	effect	effect	NOUN
dpc-5264	60	3	level	level	NOUN
dpc-5264	60	4	60.7	60.7	NUM
dpc-5264	60	5	%	%	NOUN
dpc-5264	60	6	,	,	PUNCT
dpc-5264	60	7	and	and	CCONJ
dpc-5264	60	8	76.5	76.5	NUM
dpc-5264	60	9	%	%	NOUN
dpc-5264	60	10	,	,	PUNCT
dpc-5264	60	11	respectively	respectively	ADV
dpc-5264	60	12	(	(	PUNCT
dpc-5264	60	13	auc	auc	NOUN
dpc-5264	60	14	0.653	0.653	NUM
dpc-5264	60	15	,	,	PUNCT
dpc-5264	60	16	95	95	NUM
dpc-5264	60	17	%	%	NOUN
dpc-5264	60	18	ci	ci	NOUN
dpc-5264	60	19	:	:	PUNCT
dpc-5264	60	20	0.599–0.706	0.599–0.706	NOUN
dpc-5264	60	21	,	,	PUNCT
dpc-5264	60	22	p=0.000	p=0.000	NUM
dpc-5264	60	23	)	)	PUNCT
dpc-5264	60	24	.	.	PUNCT
dpc-5264	61	1	the	the	DET
dpc-5264	61	2	presence	presence	NOUN
dpc-5264	61	3	of	of	ADP
dpc-5264	61	4	rosacea	rosacea	NOUN
dpc-5264	61	5	demonstrated	demonstrate	VERB
dpc-5264	61	6	a	a	DET
dpc-5264	61	7	significant	significant	ADJ
dpc-5264	61	8	efficacy	efficacy	NOUN
dpc-5264	61	9	in	in	ADP
dpc-5264	61	10	differentiating	differentiate	VERB
dpc-5264	61	11	patients	patient	NOUN
dpc-5264	61	12	with	with	ADP
dpc-5264	61	13	kc	kc	PROPN
dpc-5264	61	14	from	from	ADP
dpc-5264	61	15	the	the	DET
dpc-5264	61	16	control	control	NOUN
dpc-5264	61	17	group	group	NOUN
dpc-5264	61	18	in	in	ADP
dpc-5264	61	19	all	all	DET
dpc-5264	61	20	localizations	localization	NOUN
dpc-5264	61	21	(	(	PUNCT
dpc-5264	61	22	p	p	X
dpc-5264	61	23	<	<	X
dpc-5264	61	24	0.05	0.05	NUM
dpc-5264	61	25	)	)	PUNCT
dpc-5264	61	26	.	.	PUNCT
dpc-5264	62	1	conclusion	conclusion	NOUN
dpc-5264	62	2	:	:	PUNCT
dpc-5264	62	3	the	the	DET
dpc-5264	62	4	risk	risk	NOUN
dpc-5264	62	5	of	of	ADP
dpc-5264	62	6	rosacea	rosacea	NOUN
dpc-5264	62	7	in	in	ADP
dpc-5264	62	8	patients	patient	NOUN
dpc-5264	62	9	with	with	ADP
dpc-5264	62	10	kc	kc	PROPN
dpc-5264	62	11	,	,	PUNCT
dpc-5264	62	12	particularly	particularly	ADV
dpc-5264	62	13	those	those	PRON
dpc-5264	62	14	with	with	ADP
dpc-5264	62	15	the	the	DET
dpc-5264	62	16	etr	etr	PROPN
dpc-5264	62	17	subtype	subtype	NOUN
dpc-5264	62	18	,	,	PUNCT
dpc-5264	62	19	was	be	AUX
dpc-5264	62	20	found	find	VERB
dpc-5264	62	21	to	to	PART
dpc-5264	62	22	be	be	AUX
dpc-5264	62	23	significantly	significantly	ADV
dpc-5264	62	24	elevated	elevate	VERB
dpc-5264	62	25	,	,	PUNCT
dpc-5264	62	26	irrespective	irrespective	ADV
dpc-5264	62	27	of	of	ADP
dpc-5264	62	28	age	age	NOUN
dpc-5264	62	29	,	,	PUNCT
dpc-5264	62	30	sex	sex	NOUN
dpc-5264	62	31	,	,	PUNCT
dpc-5264	62	32	or	or	CCONJ
dpc-5264	62	33	localization	localization	NOUN
dpc-5264	62	34	.	.	PUNCT
dpc-5264	63	1	original	original	ADJ
dpc-5264	63	2	article	article	NOUN
dpc-5264	63	3	|	|	ADV
dpc-5264	63	4	dermatol	dermatol	ADJ
dpc-5264	63	5	pract	pract	NOUN
dpc-5264	63	6	concept	concept	NOUN
dpc-5264	63	7	.	.	PUNCT
dpc-5264	64	1	2025;15(3):5264	2025;15(3):5264	NUM
dpc-5264	64	2	3	3	NUM
dpc-5264	64	3	was	be	AUX
dpc-5264	64	4	analyzed	analyze	VERB
dpc-5264	64	5	using	use	VERB
dpc-5264	64	6	univariate	univariate	ADJ
dpc-5264	64	7	and	and	CCONJ
dpc-5264	64	8	multivariate	multivariate	VERB
dpc-5264	64	9	logistic	logistic	ADJ
dpc-5264	64	10	regression	regression	NOUN
dpc-5264	64	11	.	.	PUNCT
dpc-5264	65	1	statistically	statistically	ADV
dpc-5264	65	2	significant	significant	ADJ
dpc-5264	65	3	was	be	AUX
dpc-5264	65	4	defined	define	VERB
dpc-5264	65	5	as	as	ADP
dpc-5264	65	6	p<0.05	p<0.05	NOUN
dpc-5264	65	7	.	.	PUNCT
dpc-5264	66	1	results	result	VERB
dpc-5264	66	2	a	a	DET
dpc-5264	66	3	total	total	NOUN
dpc-5264	66	4	of	of	ADP
dpc-5264	66	5	200	200	NUM
dpc-5264	66	6	patients	patient	NOUN
dpc-5264	66	7	and	and	CCONJ
dpc-5264	66	8	200	200	NUM
dpc-5264	66	9	controls	control	NOUN
dpc-5264	66	10	were	be	AUX
dpc-5264	66	11	included	include	VERB
dpc-5264	66	12	in	in	ADP
dpc-5264	66	13	the	the	DET
dpc-5264	66	14	study	study	NOUN
dpc-5264	66	15	.	.	PUNCT
dpc-5264	67	1	there	there	PRON
dpc-5264	67	2	were	be	VERB
dpc-5264	67	3	no	no	DET
dpc-5264	67	4	significant	significant	ADJ
dpc-5264	67	5	differences	difference	NOUN
dpc-5264	67	6	between	between	ADP
dpc-5264	67	7	cases	case	NOUN
dpc-5264	67	8	and	and	CCONJ
dpc-5264	67	9	controls	control	NOUN
dpc-5264	67	10	regarding	regard	VERB
dpc-5264	67	11	age	age	NOUN
dpc-5264	67	12	,	,	PUNCT
dpc-5264	67	13	sex	sex	NOUN
dpc-5264	67	14	,	,	PUNCT
dpc-5264	67	15	skin	skin	NOUN
dpc-5264	67	16	type	type	NOUN
dpc-5264	67	17	,	,	PUNCT
dpc-5264	67	18	or	or	CCONJ
dpc-5264	67	19	race	race	NOUN
dpc-5264	67	20	/	/	SYM
dpc-5264	67	21	ethnicity	ethnicity	NOUN
dpc-5264	67	22	(	(	PUNCT
dpc-5264	67	23	all	all	DET
dpc-5264	67	24	p>0.05	p>0.05	PROPN
dpc-5264	67	25	)	)	PUNCT
dpc-5264	67	26	.	.	PUNCT
dpc-5264	68	1	in	in	ADP
dpc-5264	68	2	patients	patient	NOUN
dpc-5264	68	3	with	with	ADP
dpc-5264	68	4	kc	kc	PROPN
dpc-5264	68	5	,	,	PUNCT
dpc-5264	68	6	175	175	NUM
dpc-5264	68	7	patients	patient	NOUN
dpc-5264	68	8	(	(	PUNCT
dpc-5264	68	9	87.5	87.5	NUM
dpc-5264	68	10	%	%	NOUN
dpc-5264	68	11	)	)	PUNCT
dpc-5264	68	12	were	be	AUX
dpc-5264	68	13	diagnosed	diagnose	VERB
dpc-5264	68	14	with	with	ADP
dpc-5264	68	15	bcc	bcc	PROPN
dpc-5264	68	16	and	and	CCONJ
dpc-5264	68	17	27	27	NUM
dpc-5264	68	18	patients	patient	NOUN
dpc-5264	68	19	(	(	PUNCT
dpc-5264	68	20	13.5	13.5	NUM
dpc-5264	68	21	%	%	NOUN
dpc-5264	68	22	)	)	PUNCT
dpc-5264	68	23	were	be	AUX
dpc-5264	68	24	diagnosed	diagnose	VERB
dpc-5264	68	25	with	with	ADP
dpc-5264	68	26	scc	scc	PROPN
dpc-5264	68	27	.	.	PUNCT
dpc-5264	69	1	subtype	subtype	NOUN
dpc-5264	69	2	analysis	analysis	NOUN
dpc-5264	69	3	revealed	reveal	VERB
dpc-5264	69	4	that	that	SCONJ
dpc-5264	69	5	132	132	NUM
dpc-5264	69	6	(	(	PUNCT
dpc-5264	69	7	66.0	66.0	NUM
dpc-5264	69	8	%	%	NOUN
dpc-5264	69	9	)	)	PUNCT
dpc-5264	69	10	of	of	ADP
dpc-5264	69	11	patients	patient	NOUN
dpc-5264	69	12	with	with	ADP
dpc-5264	69	13	bcc	bcc	PROPN
dpc-5264	69	14	had	have	VERB
dpc-5264	69	15	nodular	nodular	ADJ
dpc-5264	69	16	bcc	bcc	PROPN
dpc-5264	69	17	,	,	PUNCT
dpc-5264	69	18	34	34	NUM
dpc-5264	69	19	(	(	PUNCT
dpc-5264	69	20	17.0	17.0	NUM
dpc-5264	69	21	%	%	NOUN
dpc-5264	69	22	)	)	PUNCT
dpc-5264	69	23	had	have	VERB
dpc-5264	69	24	infiltrative	infiltrative	ADJ
dpc-5264	69	25	bcc	bcc	PROPN
dpc-5264	69	26	,	,	PUNCT
dpc-5264	69	27	19	19	NUM
dpc-5264	69	28	(	(	PUNCT
dpc-5264	69	29	9.5	9.5	NUM
dpc-5264	69	30	%	%	NOUN
dpc-5264	69	31	)	)	PUNCT
dpc-5264	69	32	had	have	VERB
dpc-5264	69	33	superficial	superficial	ADJ
dpc-5264	69	34	bcc	bcc	PROPN
dpc-5264	69	35	,	,	PUNCT
dpc-5264	69	36	five	five	NUM
dpc-5264	69	37	(	(	PUNCT
dpc-5264	69	38	2.5	2.5	NUM
dpc-5264	69	39	%	%	NOUN
dpc-5264	69	40	)	)	PUNCT
dpc-5264	69	41	had	have	AUX
dpc-5264	69	42	adenoid	adenoid	PROPN
dpc-5264	69	43	bcc	bcc	PROPN
dpc-5264	69	44	,	,	PUNCT
dpc-5264	69	45	one	one	NUM
dpc-5264	69	46	(	(	PUNCT
dpc-5264	69	47	0.5	0.5	NUM
dpc-5264	69	48	%	%	NOUN
dpc-5264	69	49	)	)	PUNCT
dpc-5264	69	50	had	have	VERB
dpc-5264	69	51	morpheaform	morpheaform	PROPN
dpc-5264	69	52	bcc	bcc	PROPN
dpc-5264	69	53	,	,	PUNCT
dpc-5264	69	54	one	one	NUM
dpc-5264	69	55	(	(	PUNCT
dpc-5264	69	56	0.5	0.5	NUM
dpc-5264	69	57	%	%	NOUN
dpc-5264	69	58	)	)	PUNCT
dpc-5264	69	59	had	have	AUX
dpc-5264	69	60	pigmented	pigment	VERB
dpc-5264	69	61	bcc	bcc	PROPN
dpc-5264	69	62	,	,	PUNCT
dpc-5264	69	63	and	and	CCONJ
dpc-5264	69	64	four	four	NUM
dpc-5264	69	65	(	(	PUNCT
dpc-5264	69	66	2.0	2.0	NUM
dpc-5264	69	67	%	%	NOUN
dpc-5264	69	68	)	)	PUNCT
dpc-5264	69	69	had	have	VERB
dpc-5264	69	70	basosquamous	basosquamous	ADJ
dpc-5264	69	71	carcinoma	carcinoma	NOUN
dpc-5264	69	72	.	.	PUNCT
dpc-5264	70	1	eighteen	eighteen	NUM
dpc-5264	70	2	of	of	ADP
dpc-5264	70	3	these	these	DET
dpc-5264	70	4	patients	patient	NOUN
dpc-5264	70	5	(	(	PUNCT
dpc-5264	70	6	9.0	9.0	NUM
dpc-5264	70	7	%	%	NOUN
dpc-5264	70	8	)	)	PUNCT
dpc-5264	70	9	had	have	VERB
dpc-5264	70	10	multiple	multiple	ADJ
dpc-5264	70	11	bcc	bcc	PROPN
dpc-5264	70	12	with	with	ADP
dpc-5264	70	13	different	different	ADJ
dpc-5264	70	14	histological	histological	ADJ
dpc-5264	70	15	types	type	NOUN
dpc-5264	70	16	.	.	PUNCT
dpc-5264	71	1	three	three	NUM
dpc-5264	71	2	(	(	PUNCT
dpc-5264	71	3	1.5	1.5	NUM
dpc-5264	71	4	%	%	NOUN
dpc-5264	71	5	)	)	PUNCT
dpc-5264	71	6	patients	patient	NOUN
dpc-5264	71	7	also	also	ADV
dpc-5264	71	8	had	have	VERB
dpc-5264	71	9	both	both	CCONJ
dpc-5264	71	10	bcc	bcc	PROPN
dpc-5264	71	11	and	and	CCONJ
dpc-5264	71	12	scc	scc	PROPN
dpc-5264	71	13	.	.	PUNCT
dpc-5264	72	1	the	the	DET
dpc-5264	72	2	majority	majority	NOUN
dpc-5264	72	3	of	of	ADP
dpc-5264	72	4	kcs	kcs	PROPN
dpc-5264	72	5	were	be	AUX
dpc-5264	72	6	localized	localize	VERB
dpc-5264	72	7	on	on	ADP
dpc-5264	72	8	the	the	DET
dpc-5264	72	9	face	face	NOUN
dpc-5264	72	10	(	(	PUNCT
dpc-5264	72	11	n=153	n=153	PROPN
dpc-5264	72	12	,	,	PUNCT
dpc-5264	72	13	76.5	76.5	NUM
dpc-5264	72	14	%	%	NOUN
dpc-5264	72	15	)	)	PUNCT
dpc-5264	72	16	,	,	PUNCT
dpc-5264	72	17	followed	follow	VERB
dpc-5264	72	18	by	by	ADP
dpc-5264	72	19	the	the	DET
dpc-5264	72	20	trunk	trunk	NOUN
dpc-5264	72	21	(	(	PUNCT
dpc-5264	72	22	n=22	n=22	PROPN
dpc-5264	72	23	,	,	PUNCT
dpc-5264	72	24	11.0	11.0	NUM
dpc-5264	72	25	%	%	NOUN
dpc-5264	72	26	)	)	PUNCT
dpc-5264	72	27	,	,	PUNCT
dpc-5264	72	28	scalp	scalp	NOUN
dpc-5264	72	29	(	(	PUNCT
dpc-5264	72	30	n=15	n=15	PROPN
dpc-5264	72	31	,	,	PUNCT
dpc-5264	72	32	7.5	7.5	NUM
dpc-5264	72	33	%	%	NOUN
dpc-5264	72	34	)	)	PUNCT
dpc-5264	72	35	,	,	PUNCT
dpc-5264	72	36	ear	ear	X
dpc-5264	72	37	(	(	PUNCT
dpc-5264	72	38	n=6	n=6	NOUN
dpc-5264	72	39	,	,	PUNCT
dpc-5264	72	40	3.0	3.0	NUM
dpc-5264	72	41	%	%	NOUN
dpc-5264	72	42	)	)	PUNCT
dpc-5264	72	43	,	,	PUNCT
dpc-5264	72	44	neck	neck	NOUN
dpc-5264	72	45	(	(	PUNCT
dpc-5264	72	46	n=6	n=6	NOUN
dpc-5264	72	47	,	,	PUNCT
dpc-5264	72	48	3.0	3.0	NUM
dpc-5264	72	49	%	%	NOUN
dpc-5264	72	50	)	)	PUNCT
dpc-5264	72	51	,	,	PUNCT
dpc-5264	72	52	lower	low	ADJ
dpc-5264	72	53	extremity	extremity	NOUN
dpc-5264	72	54	(	(	PUNCT
dpc-5264	72	55	n=6	n=6	NOUN
dpc-5264	72	56	,	,	PUNCT
dpc-5264	72	57	3.0	3.0	NUM
dpc-5264	72	58	%	%	NOUN
dpc-5264	72	59	)	)	PUNCT
dpc-5264	72	60	,	,	PUNCT
dpc-5264	72	61	and	and	CCONJ
dpc-5264	72	62	upper	upper	ADJ
dpc-5264	72	63	extremity	extremity	NOUN
dpc-5264	72	64	(	(	PUNCT
dpc-5264	72	65	n=5	n=5	PROPN
dpc-5264	72	66	,	,	PUNCT
dpc-5264	72	67	2.5	2.5	NUM
dpc-5264	72	68	%	%	NOUN
dpc-5264	72	69	)	)	PUNCT
dpc-5264	72	70	.	.	PUNCT
dpc-5264	73	1	the	the	DET
dpc-5264	73	2	majority	majority	NOUN
dpc-5264	73	3	of	of	ADP
dpc-5264	73	4	the	the	DET
dpc-5264	73	5	patients	patient	NOUN
dpc-5264	73	6	presented	present	VERB
dpc-5264	73	7	with	with	ADP
dpc-5264	73	8	a	a	DET
dpc-5264	73	9	single	single	ADJ
dpc-5264	73	10	lesion	lesion	NOUN
dpc-5264	73	11	(	(	PUNCT
dpc-5264	73	12	n=165	n=165	PROPN
dpc-5264	73	13	,	,	PUNCT
dpc-5264	73	14	82.5	82.5	NUM
dpc-5264	73	15	%	%	NOUN
dpc-5264	73	16	)	)	PUNCT
dpc-5264	73	17	,	,	PUNCT
dpc-5264	73	18	while	while	SCONJ
dpc-5264	73	19	23	23	NUM
dpc-5264	73	20	(	(	PUNCT
dpc-5264	73	21	11.5	11.5	NUM
dpc-5264	73	22	%	%	NOUN
dpc-5264	73	23	)	)	PUNCT
dpc-5264	73	24	had	have	VERB
dpc-5264	73	25	two	two	NUM
dpc-5264	73	26	lesions	lesion	NOUN
dpc-5264	73	27	,	,	PUNCT
dpc-5264	73	28	10	10	NUM
dpc-5264	73	29	(	(	PUNCT
dpc-5264	73	30	5.0	5.0	NUM
dpc-5264	73	31	%	%	NOUN
dpc-5264	73	32	)	)	PUNCT
dpc-5264	73	33	had	have	VERB
dpc-5264	73	34	three	three	NUM
dpc-5264	73	35	lesions	lesion	NOUN
dpc-5264	73	36	,	,	PUNCT
dpc-5264	73	37	one	one	NUM
dpc-5264	73	38	(	(	PUNCT
dpc-5264	73	39	0.5	0.5	NUM
dpc-5264	73	40	%	%	NOUN
dpc-5264	73	41	)	)	PUNCT
dpc-5264	73	42	had	have	VERB
dpc-5264	73	43	four	four	NUM
dpc-5264	73	44	lesions	lesion	NOUN
dpc-5264	73	45	,	,	PUNCT
dpc-5264	73	46	and	and	CCONJ
dpc-5264	73	47	one	one	NUM
dpc-5264	73	48	(	(	PUNCT
dpc-5264	73	49	0.5	0.5	NUM
dpc-5264	73	50	%	%	NOUN
dpc-5264	73	51	)	)	PUNCT
dpc-5264	73	52	had	have	VERB
dpc-5264	73	53	five	five	NUM
dpc-5264	73	54	lesions	lesion	NOUN
dpc-5264	73	55	.	.	PUNCT
dpc-5264	74	1	while	while	SCONJ
dpc-5264	74	2	188	188	NUM
dpc-5264	74	3	(	(	PUNCT
dpc-5264	74	4	94.0	94.0	NUM
dpc-5264	74	5	%	%	NOUN
dpc-5264	74	6	)	)	PUNCT
dpc-5264	74	7	of	of	ADP
dpc-5264	74	8	the	the	DET
dpc-5264	74	9	patients	patient	NOUN
dpc-5264	74	10	had	have	VERB
dpc-5264	74	11	no	no	DET
dpc-5264	74	12	family	family	NOUN
dpc-5264	74	13	history	history	NOUN
dpc-5264	74	14	,	,	PUNCT
dpc-5264	74	15	12	12	NUM
dpc-5264	74	16	(	(	PUNCT
dpc-5264	74	17	6.0	6.0	NUM
dpc-5264	74	18	%	%	NOUN
dpc-5264	74	19	)	)	PUNCT
dpc-5264	74	20	of	of	ADP
dpc-5264	74	21	the	the	DET
dpc-5264	74	22	patients	patient	NOUN
dpc-5264	74	23	had	have	VERB
dpc-5264	74	24	a	a	DET
dpc-5264	74	25	family	family	NOUN
dpc-5264	74	26	history	history	NOUN
dpc-5264	74	27	of	of	ADP
dpc-5264	74	28	kc	kc	PROPN
dpc-5264	74	29	.	.	PUNCT
dpc-5264	75	1	there	there	PRON
dpc-5264	75	2	was	be	VERB
dpc-5264	75	3	no	no	DET
dpc-5264	75	4	statistically	statistically	ADV
dpc-5264	75	5	significant	significant	ADJ
dpc-5264	75	6	difference	difference	NOUN
dpc-5264	75	7	between	between	ADP
dpc-5264	75	8	the	the	DET
dpc-5264	75	9	two	two	NUM
dpc-5264	75	10	groups	group	NOUN
dpc-5264	75	11	regarding	regard	VERB
dpc-5264	75	12	sunscreen	sunscreen	NOUN
dpc-5264	75	13	use	use	NOUN
dpc-5264	75	14	habits	habit	NOUN
dpc-5264	75	15	(	(	PUNCT
dpc-5264	75	16	p=0.284	p=0.284	NOUN
dpc-5264	75	17	)	)	PUNCT
dpc-5264	75	18	(	(	PUNCT
dpc-5264	75	19	table	table	NOUN
dpc-5264	75	20	1	1	NUM
dpc-5264	75	21	)	)	PUNCT
dpc-5264	75	22	.	.	PUNCT
dpc-5264	76	1	table	table	NOUN
dpc-5264	76	2	2	2	NUM
dpc-5264	76	3	illustrates	illustrate	VERB
dpc-5264	76	4	the	the	DET
dpc-5264	76	5	prevalence	prevalence	NOUN
dpc-5264	76	6	of	of	ADP
dpc-5264	76	7	other	other	ADJ
dpc-5264	76	8	dermatological	dermatological	ADJ
dpc-5264	76	9	conditions	condition	NOUN
dpc-5264	76	10	observed	observe	VERB
dpc-5264	76	11	in	in	ADP
dpc-5264	76	12	patients	patient	NOUN
dpc-5264	76	13	with	with	ADP
dpc-5264	76	14	kc	kc	PROPN
dpc-5264	76	15	and	and	CCONJ
dpc-5264	76	16	control	control	NOUN
dpc-5264	76	17	subjects	subject	NOUN
dpc-5264	76	18	.	.	PUNCT
dpc-5264	77	1	in	in	ADP
dpc-5264	77	2	comparison	comparison	NOUN
dpc-5264	77	3	to	to	ADP
dpc-5264	77	4	the	the	DET
dpc-5264	77	5	control	control	NOUN
dpc-5264	77	6	group	group	NOUN
dpc-5264	77	7	,	,	PUNCT
dpc-5264	77	8	those	those	PRON
dpc-5264	77	9	with	with	ADP
dpc-5264	77	10	kc	kc	PROPN
dpc-5264	77	11	were	be	AUX
dpc-5264	77	12	more	more	ADV
dpc-5264	77	13	likely	likely	ADJ
dpc-5264	77	14	to	to	PART
dpc-5264	77	15	have	have	VERB
dpc-5264	77	16	rosacea	rosacea	NOUN
dpc-5264	77	17	(	(	PUNCT
dpc-5264	77	18	54.5	54.5	NUM
dpc-5264	77	19	%	%	NOUN
dpc-5264	77	20	vs	vs	ADP
dpc-5264	77	21	14	14	NUM
dpc-5264	77	22	%	%	NOUN
dpc-5264	77	23	,	,	PUNCT
dpc-5264	77	24	p=0.000	p=0.000	PROPN
dpc-5264	77	25	)	)	PUNCT
dpc-5264	77	26	,	,	PUNCT
dpc-5264	77	27	dysplastic	dysplastic	ADJ
dpc-5264	77	28	nevi	nevi	NOUN
dpc-5264	77	29	(	(	PUNCT
dpc-5264	77	30	2.5	2.5	NUM
dpc-5264	77	31	%	%	NOUN
dpc-5264	77	32	vs	vs	ADP
dpc-5264	77	33	0	0	NUM
dpc-5264	77	34	%	%	NOUN
dpc-5264	77	35	,	,	PUNCT
dpc-5264	77	36	p=0.024	p=0.024	NOUN
dpc-5264	77	37	)	)	PUNCT
dpc-5264	77	38	,	,	PUNCT
dpc-5264	77	39	and	and	CCONJ
dpc-5264	77	40	bowen	bowen	PROPN
dpc-5264	77	41	’s	’s	PART
dpc-5264	77	42	disease	disease	NOUN
dpc-5264	77	43	(	(	PUNCT
dpc-5264	77	44	2.5	2.5	NUM
dpc-5264	77	45	%	%	NOUN
dpc-5264	77	46	vs	vs	ADP
dpc-5264	77	47	0	0	NUM
dpc-5264	77	48	%	%	NOUN
dpc-5264	77	49	,	,	PUNCT
dpc-5264	77	50	p=0.024	p=0.024	NOUN
dpc-5264	77	51	)	)	PUNCT
dpc-5264	77	52	.	.	PUNCT
dpc-5264	78	1	patients	patient	NOUN
dpc-5264	78	2	with	with	ADP
dpc-5264	78	3	kc	kc	PROPN
dpc-5264	78	4	exhibited	exhibit	VERB
dpc-5264	78	5	a	a	DET
dpc-5264	78	6	significantly	significantly	ADV
dpc-5264	78	7	elevated	elevate	VERB
dpc-5264	78	8	odds	odd	NOUN
dpc-5264	78	9	ratio	ratio	NOUN
dpc-5264	78	10	for	for	ADP
dpc-5264	78	11	the	the	DET
dpc-5264	78	12	presence	presence	NOUN
dpc-5264	78	13	of	of	ADP
dpc-5264	78	14	rosacea	rosacea	NOUN
dpc-5264	78	15	(	(	PUNCT
dpc-5264	78	16	or	or	CCONJ
dpc-5264	78	17	5.13	5.13	NUM
dpc-5264	78	18	,	,	PUNCT
dpc-5264	78	19	95	95	NUM
dpc-5264	78	20	%	%	NOUN
dpc-5264	78	21	ci	ci	NOUN
dpc-5264	78	22	:	:	PUNCT
dpc-5264	78	23	3.2–8.3	3.2–8.3	NUM
dpc-5264	78	24	,	,	PUNCT
dpc-5264	78	25	p=0.000	p=0.000	NUM
dpc-5264	78	26	)	)	PUNCT
dpc-5264	78	27	and	and	CCONJ
dpc-5264	78	28	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5264	78	29	rosacea	rosacea	PROPN
dpc-5264	78	30	(	(	PUNCT
dpc-5264	78	31	etr	etr	PROPN
dpc-5264	78	32	)	)	PUNCT
dpc-5264	78	33	(	(	PUNCT
dpc-5264	78	34	or	or	CCONJ
dpc-5264	78	35	5.03	5.03	NUM
dpc-5264	78	36	,	,	PUNCT
dpc-5264	78	37	95	95	NUM
dpc-5264	78	38	%	%	NOUN
dpc-5264	78	39	ci	ci	NOUN
dpc-5264	78	40	:	:	PUNCT
dpc-5264	78	41	3.1–8.2	3.1–8.2	NUM
dpc-5264	78	42	,	,	PUNCT
dpc-5264	78	43	p=0.000	p=0.000	NUM
dpc-5264	78	44	)	)	PUNCT
dpc-5264	78	45	(	(	PUNCT
dpc-5264	78	46	table	table	NOUN
dpc-5264	78	47	 	 	SPACE
dpc-5264	78	48	2	2	NUM
dpc-5264	78	49	)	)	PUNCT
dpc-5264	78	50	.	.	PUNCT
dpc-5264	79	1	in	in	ADP
dpc-5264	79	2	the	the	DET
dpc-5264	79	3	control	control	NOUN
dpc-5264	79	4	group	group	NOUN
dpc-5264	79	5	,	,	PUNCT
dpc-5264	79	6	solar	solar	PROPN
dpc-5264	79	7	lentigo	lentigo	ADJ
dpc-5264	79	8	,	,	PUNCT
dpc-5264	79	9	xerosis	xerosis	NOUN
dpc-5264	79	10	cutis	cutis	NOUN
dpc-5264	79	11	,	,	PUNCT
dpc-5264	79	12	dermal	dermal	ADJ
dpc-5264	79	13	nevi	nevi	NOUN
dpc-5264	79	14	,	,	PUNCT
dpc-5264	79	15	and	and	CCONJ
dpc-5264	79	16	lichen	lichen	NOUN
dpc-5264	79	17	simplex	simplex	NOUN
dpc-5264	79	18	chronicus	chronicus	NOUN
dpc-5264	79	19	were	be	AUX
dpc-5264	79	20	significantly	significantly	ADV
dpc-5264	79	21	higher	high	ADJ
dpc-5264	79	22	(	(	PUNCT
dpc-5264	79	23	p=0.013	p=0.013	NOUN
dpc-5264	79	24	,	,	PUNCT
dpc-5264	79	25	p=0.000	p=0.000	NUM
dpc-5264	79	26	,	,	PUNCT
dpc-5264	79	27	p=0.043	p=0.043	NOUN
dpc-5264	79	28	,	,	PUNCT
dpc-5264	79	29	and	and	CCONJ
dpc-5264	79	30	p=0.044	p=0.044	NOUN
dpc-5264	79	31	,	,	PUNCT
dpc-5264	79	32	respectively	respectively	ADV
dpc-5264	79	33	)	)	PUNCT
dpc-5264	79	34	.	.	PUNCT
dpc-5264	80	1	a	a	DET
dpc-5264	80	2	roc	roc	PROPN
dpc-5264	80	3	curve	curve	NOUN
dpc-5264	80	4	analysis	analysis	NOUN
dpc-5264	80	5	was	be	AUX
dpc-5264	80	6	conducted	conduct	VERB
dpc-5264	80	7	to	to	PART
dpc-5264	80	8	assess	assess	VERB
dpc-5264	80	9	the	the	DET
dpc-5264	80	10	efficacy	efficacy	NOUN
dpc-5264	80	11	of	of	ADP
dpc-5264	80	12	rosacea	rosacea	NOUN
dpc-5264	80	13	in	in	ADP
dpc-5264	80	14	differentiating	differentiate	VERB
dpc-5264	80	15	between	between	ADP
dpc-5264	80	16	the	the	DET
dpc-5264	80	17	control	control	NOUN
dpc-5264	80	18	group	group	NOUN
dpc-5264	80	19	and	and	CCONJ
dpc-5264	80	20	patients	patient	NOUN
dpc-5264	80	21	with	with	ADP
dpc-5264	80	22	kc	kc	PROPN
dpc-5264	80	23	.	.	PUNCT
dpc-5264	81	1	the	the	DET
dpc-5264	81	2	sensitivity	sensitivity	NOUN
dpc-5264	81	3	,	,	PUNCT
dpc-5264	81	4	specificity	specificity	NOUN
dpc-5264	81	5	,	,	PUNCT
dpc-5264	81	6	negative	negative	ADJ
dpc-5264	81	7	predictive	predictive	ADJ
dpc-5264	81	8	value	value	NOUN
dpc-5264	81	9	(	(	PUNCT
dpc-5264	81	10	npv	npv	NOUN
dpc-5264	81	11	)	)	PUNCT
dpc-5264	81	12	,	,	PUNCT
dpc-5264	81	13	and	and	CCONJ
dpc-5264	81	14	positive	positive	ADJ
dpc-5264	81	15	predictive	predictive	ADJ
dpc-5264	81	16	value	value	NOUN
dpc-5264	81	17	(	(	PUNCT
dpc-5264	81	18	ppv	ppv	NOUN
dpc-5264	81	19	)	)	PUNCT
dpc-5264	81	20	for	for	ADP
dpc-5264	81	21	rosacea	rosacea	NOUN
dpc-5264	81	22	were	be	AUX
dpc-5264	81	23	45.5	45.5	NUM
dpc-5264	81	24	%	%	NOUN
dpc-5264	81	25	,	,	PUNCT
dpc-5264	81	26	86	86	NUM
dpc-5264	81	27	%	%	NOUN
dpc-5264	81	28	,	,	PUNCT
dpc-5264	81	29	61.2	61.2	NUM
dpc-5264	81	30	%	%	NOUN
dpc-5264	81	31	,	,	PUNCT
dpc-5264	81	32	and	and	CCONJ
dpc-5264	81	33	76.5	76.5	NUM
dpc-5264	81	34	%	%	NOUN
dpc-5264	81	35	,	,	PUNCT
dpc-5264	81	36	respectively	respectively	ADV
dpc-5264	81	37	(	(	PUNCT
dpc-5264	81	38	auc	auc	NOUN
dpc-5264	81	39	0.658	0.658	NUM
dpc-5264	81	40	,	,	PUNCT
dpc-5264	81	41	95	95	NUM
dpc-5264	81	42	%	%	NOUN
dpc-5264	81	43	ci	ci	NOUN
dpc-5264	81	44	:	:	PUNCT
dpc-5264	81	45	0.604–0.711	0.604–0.711	NOUN
dpc-5264	81	46	,	,	PUNCT
dpc-5264	81	47	p=0.000	p=0.000	NOUN
dpc-5264	81	48	)	)	PUNCT
dpc-5264	81	49	,	,	PUNCT
dpc-5264	81	50	while	while	SCONJ
dpc-5264	81	51	for	for	ADP
dpc-5264	81	52	etr	etr	PROPN
dpc-5264	81	53	it	it	PRON
dpc-5264	81	54	was	be	AUX
dpc-5264	81	55	44	44	NUM
dpc-5264	81	56	%	%	NOUN
dpc-5264	81	57	,	,	PUNCT
dpc-5264	81	58	86.5	86.5	NUM
dpc-5264	81	59	%	%	NOUN
dpc-5264	81	60	,	,	PUNCT
dpc-5264	81	61	60.7	60.7	NUM
dpc-5264	81	62	%	%	NOUN
dpc-5264	81	63	,	,	PUNCT
dpc-5264	81	64	and	and	CCONJ
dpc-5264	81	65	76.5	76.5	NUM
dpc-5264	81	66	%	%	NOUN
dpc-5264	81	67	,	,	PUNCT
dpc-5264	81	68	respectively	respectively	ADV
dpc-5264	81	69	(	(	PUNCT
dpc-5264	81	70	auc	auc	NOUN
dpc-5264	81	71	0.653	0.653	NUM
dpc-5264	81	72	,	,	PUNCT
dpc-5264	81	73	95	95	NUM
dpc-5264	81	74	%	%	NOUN
dpc-5264	81	75	ci	ci	NOUN
dpc-5264	81	76	:	:	PUNCT
dpc-5264	81	77	0.599–0.706	0.599–0.706	NOUN
dpc-5264	81	78	,	,	PUNCT
dpc-5264	81	79	p=0.000	p=0.000	NUM
dpc-5264	81	80	)	)	PUNCT
dpc-5264	81	81	(	(	PUNCT
dpc-5264	81	82	figure	figure	NOUN
dpc-5264	81	83	1	1	NUM
dpc-5264	81	84	)	)	PUNCT
dpc-5264	81	85	.	.	PUNCT
dpc-5264	82	1	the	the	DET
dpc-5264	82	2	effectiveness	effectiveness	NOUN
dpc-5264	82	3	of	of	ADP
dpc-5264	82	4	the	the	DET
dpc-5264	82	5	presence	presence	NOUN
dpc-5264	82	6	of	of	ADP
dpc-5264	82	7	rosacea	rosacea	NOUN
dpc-5264	82	8	in	in	ADP
dpc-5264	82	9	terms	term	NOUN
dpc-5264	82	10	of	of	ADP
dpc-5264	82	11	age	age	NOUN
dpc-5264	82	12	,	,	PUNCT
dpc-5264	82	13	sex	sex	NOUN
dpc-5264	82	14	,	,	PUNCT
dpc-5264	82	15	family	family	NOUN
dpc-5264	82	16	history	history	NOUN
dpc-5264	82	17	,	,	PUNCT
dpc-5264	82	18	skin	skin	NOUN
dpc-5264	82	19	type	type	NOUN
dpc-5264	82	20	,	,	PUNCT
dpc-5264	82	21	tumor	tumor	NOUN
dpc-5264	82	22	type	type	NOUN
dpc-5264	82	23	,	,	PUNCT
dpc-5264	82	24	and	and	CCONJ
dpc-5264	82	25	localization	localization	NOUN
dpc-5264	82	26	in	in	ADP
dpc-5264	82	27	differentiating	differentiate	VERB
dpc-5264	82	28	patients	patient	NOUN
dpc-5264	82	29	with	with	ADP
dpc-5264	82	30	kc	kc	PROPN
dpc-5264	82	31	from	from	ADP
dpc-5264	82	32	the	the	DET
dpc-5264	82	33	control	control	NOUN
dpc-5264	82	34	group	group	NOUN
dpc-5264	82	35	was	be	AUX
dpc-5264	82	36	examined	examine	VERB
dpc-5264	82	37	.	.	PUNCT
dpc-5264	83	1	the	the	DET
dpc-5264	83	2	results	result	NOUN
dpc-5264	83	3	demonstrated	demonstrate	VERB
dpc-5264	83	4	a	a	DET
dpc-5264	83	5	significant	significant	ADJ
dpc-5264	83	6	efficacy	efficacy	NOUN
dpc-5264	83	7	of	of	ADP
dpc-5264	83	8	rosacea	rosacea	NOUN
dpc-5264	83	9	in	in	ADP
dpc-5264	83	10	differentiating	differentiate	VERB
dpc-5264	83	11	patients	patient	NOUN
dpc-5264	83	12	with	with	ADP
dpc-5264	83	13	kc	kc	PROPN
dpc-5264	83	14	from	from	ADP
dpc-5264	83	15	the	the	DET
dpc-5264	83	16	control	control	NOUN
dpc-5264	83	17	group	group	NOUN
dpc-5264	83	18	in	in	ADP
dpc-5264	83	19	both	both	DET
dpc-5264	83	20	patients	patient	NOUN
dpc-5264	83	21	under	under	ADP
dpc-5264	83	22	and	and	CCONJ
dpc-5264	83	23	those	those	DET
dpc-5264	83	24	over	over	ADP
dpc-5264	83	25	65	65	NUM
dpc-5264	83	26	years	year	NOUN
dpc-5264	83	27	of	of	ADP
dpc-5264	83	28	age	age	NOUN
dpc-5264	83	29	(	(	PUNCT
dpc-5264	83	30	or	or	CCONJ
dpc-5264	83	31	4.5	4.5	NUM
dpc-5264	83	32	,	,	PUNCT
dpc-5264	83	33	95	95	NUM
dpc-5264	83	34	%	%	NOUN
dpc-5264	83	35	ci	ci	NOUN
dpc-5264	83	36	:	:	PUNCT
dpc-5264	83	37	2.1–9.6	2.1–9.6	NOUN
dpc-5264	83	38	,	,	PUNCT
dpc-5264	83	39	p=0.000	p=0.000	NOUN
dpc-5264	83	40	and	and	CCONJ
dpc-5264	83	41	or	or	CCONJ
dpc-5264	83	42	5.5	5.5	NUM
dpc-5264	83	43	,	,	PUNCT
dpc-5264	83	44	95	95	NUM
dpc-5264	83	45	%	%	NOUN
dpc-5264	83	46	ci	ci	NOUN
dpc-5264	83	47	:	:	PUNCT
dpc-5264	83	48	2.9–10.4	2.9–10.4	NUM
dpc-5264	83	49	,	,	PUNCT
dpc-5264	83	50	p=0.000	p=0.000	NUM
dpc-5264	83	51	,	,	PUNCT
dpc-5264	83	52	respectively	respectively	ADV
dpc-5264	83	53	)	)	PUNCT
dpc-5264	83	54	.	.	PUNCT
dpc-5264	84	1	significant	significant	ADJ
dpc-5264	84	2	efficacy	efficacy	NOUN
dpc-5264	84	3	of	of	ADP
dpc-5264	84	4	rosacea	rosacea	NOUN
dpc-5264	84	5	in	in	ADP
dpc-5264	84	6	differentiating	differentiate	VERB
dpc-5264	84	7	between	between	ADP
dpc-5264	84	8	kc	kc	PROPN
dpc-5264	84	9	patients	patient	NOUN
dpc-5264	84	10	and	and	CCONJ
dpc-5264	84	11	the	the	DET
dpc-5264	84	12	control	control	NOUN
dpc-5264	84	13	group	group	NOUN
dpc-5264	84	14	was	be	AUX
dpc-5264	84	15	observed	observe	VERB
dpc-5264	84	16	in	in	ADP
dpc-5264	84	17	both	both	PRON
dpc-5264	84	18	females	female	NOUN
dpc-5264	84	19	and	and	CCONJ
dpc-5264	84	20	males	male	NOUN
dpc-5264	84	21	(	(	PUNCT
dpc-5264	84	22	or	or	CCONJ
dpc-5264	84	23	4.67	4.67	NUM
dpc-5264	84	24	,	,	PUNCT
dpc-5264	84	25	95	95	NUM
dpc-5264	84	26	%	%	NOUN
dpc-5264	84	27	ci	ci	NOUN
dpc-5264	84	28	:	:	PUNCT
dpc-5264	84	29	2.4–9.1	2.4–9.1	NUM
dpc-5264	84	30	,	,	PUNCT
dpc-5264	84	31	p=0.000	p=0.000	NOUN
dpc-5264	84	32	and	and	CCONJ
dpc-5264	84	33	or	or	CCONJ
dpc-5264	84	34	5.99	5.99	NUM
dpc-5264	84	35	95	95	NUM
dpc-5264	84	36	%	%	NOUN
dpc-5264	84	37	ci	ci	NOUN
dpc-5264	84	38	:	:	PUNCT
dpc-5264	84	39	2.9–12.4	2.9–12.4	NUM
dpc-5264	84	40	,	,	PUNCT
dpc-5264	84	41	p=0.000	p=0.000	NUM
dpc-5264	84	42	,	,	PUNCT
dpc-5264	84	43	respectively	respectively	ADV
dpc-5264	84	44	)	)	PUNCT
dpc-5264	84	45	.	.	PUNCT
dpc-5264	85	1	in	in	ADP
dpc-5264	85	2	the	the	DET
dpc-5264	85	3	group	group	NOUN
dpc-5264	85	4	with	with	ADP
dpc-5264	85	5	a	a	DET
dpc-5264	85	6	family	family	NOUN
dpc-5264	85	7	history	history	NOUN
dpc-5264	85	8	,	,	PUNCT
dpc-5264	85	9	the	the	DET
dpc-5264	85	10	presence	presence	NOUN
dpc-5264	85	11	of	of	ADP
dpc-5264	85	12	rosacea	rosacea	NOUN
dpc-5264	85	13	was	be	AUX
dpc-5264	85	14	found	find	VERB
dpc-5264	85	15	to	to	PART
dpc-5264	85	16	be	be	AUX
dpc-5264	85	17	significantly	significantly	ADV
dpc-5264	85	18	effective	effective	ADJ
dpc-5264	85	19	in	in	ADP
dpc-5264	85	20	differentiating	differentiate	VERB
dpc-5264	85	21	between	between	ADP
dpc-5264	85	22	the	the	DET
dpc-5264	85	23	kc	kc	PROPN
dpc-5264	85	24	and	and	CCONJ
dpc-5264	85	25	control	control	NOUN
dpc-5264	85	26	groups	group	NOUN
dpc-5264	85	27	(	(	PUNCT
dpc-5264	85	28	or	or	CCONJ
dpc-5264	85	29	12.29	12.29	NUM
dpc-5264	85	30	,	,	PUNCT
dpc-5264	85	31	95	95	NUM
dpc-5264	85	32	%	%	NOUN
dpc-5264	85	33	ci	ci	NOUN
dpc-5264	85	34	:	:	PUNCT
dpc-5264	85	35	3.5–43.5	3.5–43.5	NUM
dpc-5264	85	36	,	,	PUNCT
dpc-5264	85	37	p=0.000	p=0.000	NOUN
dpc-5264	85	38	)	)	PUNCT
dpc-5264	85	39	.	.	PUNCT
dpc-5264	86	1	in	in	ADP
dpc-5264	86	2	the	the	DET
dpc-5264	86	3	group	group	NOUN
dpc-5264	86	4	with	with	ADP
dpc-5264	86	5	skin	skin	NOUN
dpc-5264	86	6	types	type	NOUN
dpc-5264	86	7	ii	ii	PROPN
dpc-5264	86	8	and	and	CCONJ
dpc-5264	86	9	iii	iii	PROPN
dpc-5264	86	10	,	,	PUNCT
dpc-5264	86	11	the	the	DET
dpc-5264	86	12	presence	presence	NOUN
dpc-5264	86	13	of	of	ADP
dpc-5264	86	14	rosacea	rosacea	NOUN
dpc-5264	86	15	was	be	AUX
dpc-5264	86	16	found	find	VERB
dpc-5264	86	17	to	to	PART
dpc-5264	86	18	be	be	AUX
dpc-5264	86	19	significantly	significantly	ADV
dpc-5264	86	20	effective	effective	ADJ
dpc-5264	86	21	in	in	ADP
dpc-5264	86	22	differentiating	differentiate	VERB
dpc-5264	86	23	between	between	ADP
dpc-5264	86	24	patients	patient	NOUN
dpc-5264	86	25	with	with	ADP
dpc-5264	86	26	kc	kc	PROPN
dpc-5264	86	27	and	and	CCONJ
dpc-5264	86	28	the	the	DET
dpc-5264	86	29	control	control	NOUN
dpc-5264	86	30	group	group	NOUN
dpc-5264	86	31	(	(	PUNCT
dpc-5264	86	32	or	or	CCONJ
dpc-5264	86	33	5.72	5.72	NUM
dpc-5264	86	34	,	,	PUNCT
dpc-5264	86	35	95	95	NUM
dpc-5264	86	36	%	%	NOUN
dpc-5264	86	37	ci	ci	NOUN
dpc-5264	86	38	:	:	PUNCT
dpc-5264	86	39	2.9–11.1	2.9–11.1	NUM
dpc-5264	86	40	,	,	PUNCT
dpc-5264	86	41	p=0.000	p=0.000	NOUN
dpc-5264	86	42	and	and	CCONJ
dpc-5264	86	43	or	or	CCONJ
dpc-5264	86	44	5.27	5.27	NUM
dpc-5264	86	45	,	,	PUNCT
dpc-5264	86	46	95	95	NUM
dpc-5264	86	47	%	%	NOUN
dpc-5264	86	48	ci	ci	NOUN
dpc-5264	86	49	:	:	PUNCT
dpc-5264	86	50	2.0–13.7	2.0–13.7	NOUN
dpc-5264	86	51	,	,	PUNCT
dpc-5264	86	52	p=0.001	p=0.001	NUM
dpc-5264	86	53	,	,	PUNCT
dpc-5264	86	54	respectively	respectively	ADV
dpc-5264	86	55	)	)	PUNCT
dpc-5264	86	56	.	.	PUNCT
dpc-5264	87	1	the	the	DET
dpc-5264	87	2	presence	presence	NOUN
dpc-5264	87	3	of	of	ADP
dpc-5264	87	4	rosacea	rosacea	NOUN
dpc-5264	87	5	in	in	ADP
dpc-5264	87	6	bcc	bcc	PROPN
dpc-5264	87	7	,	,	PUNCT
dpc-5264	87	8	nodular	nodular	ADJ
dpc-5264	87	9	bcc	bcc	PROPN
dpc-5264	87	10	,	,	PUNCT
dpc-5264	87	11	infiltrative	infiltrative	ADJ
dpc-5264	87	12	bcc	bcc	PROPN
dpc-5264	87	13	,	,	PUNCT
dpc-5264	87	14	adenoid	adenoid	ADJ
dpc-5264	87	15	bcc	bcc	PROPN
dpc-5264	87	16	,	,	PUNCT
dpc-5264	87	17	and	and	CCONJ
dpc-5264	87	18	scc	scc	NOUN
dpc-5264	87	19	,	,	PUNCT
dpc-5264	87	20	as	as	SCONJ
dpc-5264	87	21	determined	determine	VERB
dpc-5264	87	22	by	by	ADP
dpc-5264	87	23	histopathological	histopathological	ADJ
dpc-5264	87	24	type	type	NOUN
dpc-5264	87	25	,	,	PUNCT
dpc-5264	87	26	demonstrated	demonstrate	VERB
dpc-5264	87	27	a	a	DET
dpc-5264	87	28	significant	significant	ADJ
dpc-5264	87	29	efficacy	efficacy	NOUN
dpc-5264	87	30	in	in	ADP
dpc-5264	87	31	differentiating	differentiate	VERB
dpc-5264	87	32	between	between	ADP
dpc-5264	87	33	patients	patient	NOUN
dpc-5264	87	34	with	with	ADP
dpc-5264	87	35	cancer	cancer	NOUN
dpc-5264	87	36	patients	patient	NOUN
dpc-5264	87	37	and	and	CCONJ
dpc-5264	87	38	the	the	DET
dpc-5264	87	39	control	control	NOUN
dpc-5264	87	40	group	group	NOUN
dpc-5264	87	41	(	(	PUNCT
dpc-5264	87	42	or	or	CCONJ
dpc-5264	87	43	4.8	4.8	NUM
dpc-5264	87	44	,	,	PUNCT
dpc-5264	87	45	95	95	NUM
dpc-5264	87	46	%	%	NOUN
dpc-5264	87	47	ci	ci	NOUN
dpc-5264	87	48	:	:	PUNCT
dpc-5264	87	49	2.9–7.9	2.9–7.9	NUM
dpc-5264	87	50	,	,	PUNCT
dpc-5264	87	51	p=0.000	p=0.000	NUM
dpc-5264	87	52	;	;	PUNCT
dpc-5264	87	53	or	or	CCONJ
dpc-5264	87	54	4.67	4.67	NUM
dpc-5264	87	55	,	,	PUNCT
dpc-5264	87	56	95	95	NUM
dpc-5264	87	57	%	%	NOUN
dpc-5264	87	58	ci	ci	NOUN
dpc-5264	87	59	:	:	PUNCT
dpc-5264	87	60	2.8–7.9	2.8–7.9	NOUN
dpc-5264	87	61	,	,	PUNCT
dpc-5264	87	62	p=0.000	p=0.000	NUM
dpc-5264	87	63	;	;	PUNCT
dpc-5264	87	64	or	or	CCONJ
dpc-5264	87	65	6.14	6.14	NUM
dpc-5264	87	66	,	,	PUNCT
dpc-5264	87	67	95	95	NUM
dpc-5264	87	68	%	%	NOUN
dpc-5264	87	69	ci	ci	NOUN
dpc-5264	87	70	:	:	PUNCT
dpc-5264	87	71	2.8–13.4	2.8–13.4	NUM
dpc-5264	87	72	,	,	PUNCT
dpc-5264	87	73	p=0.000	p=0.000	NUM
dpc-5264	87	74	;	;	PUNCT
dpc-5264	87	75	or	or	CCONJ
dpc-5264	87	76	24.57	24.57	NUM
dpc-5264	87	77	,	,	PUNCT
dpc-5264	87	78	95	95	NUM
dpc-5264	87	79	%	%	NOUN
dpc-5264	87	80	ci	ci	NOUN
dpc-5264	87	81	:	:	PUNCT
dpc-5264	87	82	2.6–58	2.6–58	NUM
dpc-5264	87	83	,	,	PUNCT
dpc-5264	87	84	p=0.005	p=0.005	X
dpc-5264	87	85	;	;	PUNCT
dpc-5264	87	86	or	or	CCONJ
dpc-5264	87	87	10.44	10.44	NUM
dpc-5264	87	88	,	,	PUNCT
dpc-5264	87	89	95	95	NUM
dpc-5264	87	90	%	%	NOUN
dpc-5264	87	91	ci	ci	NOUN
dpc-5264	87	92	:	:	PUNCT
dpc-5264	87	93	4.3–25.1	4.3–25.1	NUM
dpc-5264	87	94	,	,	PUNCT
dpc-5264	87	95	p=0.000	p=0.000	NUM
dpc-5264	87	96	,	,	PUNCT
dpc-5264	87	97	respectively	respectively	ADV
dpc-5264	87	98	)	)	PUNCT
dpc-5264	87	99	.	.	PUNCT
dpc-5264	88	1	the	the	DET
dpc-5264	88	2	presence	presence	NOUN
dpc-5264	88	3	of	of	ADP
dpc-5264	88	4	rosacea	rosacea	NOUN
dpc-5264	88	5	demonstrated	demonstrate	VERB
dpc-5264	88	6	a	a	DET
dpc-5264	88	7	significant	significant	ADJ
dpc-5264	88	8	efficacy	efficacy	NOUN
dpc-5264	88	9	in	in	ADP
dpc-5264	88	10	differentiating	differentiate	VERB
dpc-5264	88	11	between	between	ADP
dpc-5264	88	12	patients	patient	NOUN
dpc-5264	88	13	with	with	ADP
dpc-5264	88	14	kc	kc	PROPN
dpc-5264	88	15	and	and	CCONJ
dpc-5264	88	16	the	the	DET
dpc-5264	88	17	control	control	NOUN
dpc-5264	88	18	group	group	NOUN
dpc-5264	88	19	in	in	ADP
dpc-5264	88	20	all	all	DET
dpc-5264	88	21	localizations	localization	NOUN
dpc-5264	88	22	(	(	PUNCT
dpc-5264	88	23	p<0.05	p<0.05	NOUN
dpc-5264	88	24	)	)	PUNCT
dpc-5264	88	25	(	(	PUNCT
dpc-5264	88	26	figure	figure	NOUN
dpc-5264	88	27	2	2	NUM
dpc-5264	88	28	)	)	PUNCT
dpc-5264	88	29	.	.	PUNCT
dpc-5264	89	1	discussion	discussion	NOUN
dpc-5264	89	2	the	the	DET
dpc-5264	89	3	present	present	ADJ
dpc-5264	89	4	study	study	NOUN
dpc-5264	89	5	revealed	reveal	VERB
dpc-5264	89	6	a	a	DET
dpc-5264	89	7	robust	robust	ADJ
dpc-5264	89	8	positive	positive	ADJ
dpc-5264	89	9	association	association	NOUN
dpc-5264	89	10	between	between	ADP
dpc-5264	89	11	kcs	kcs	PROPN
dpc-5264	89	12	and	and	CCONJ
dpc-5264	89	13	rosacea	rosacea	NOUN
dpc-5264	89	14	.	.	PUNCT
dpc-5264	90	1	it	it	PRON
dpc-5264	90	2	is	be	AUX
dpc-5264	90	3	established	establish	VERB
dpc-5264	90	4	that	that	DET
dpc-5264	90	5	uvr	uvr	NOUN
dpc-5264	90	6	represents	represent	VERB
dpc-5264	90	7	a	a	DET
dpc-5264	90	8	significant	significant	ADJ
dpc-5264	90	9	risk	risk	NOUN
dpc-5264	90	10	factor	factor	NOUN
dpc-5264	90	11	for	for	ADP
dpc-5264	90	12	the	the	DET
dpc-5264	90	13	development	development	NOUN
dpc-5264	90	14	of	of	ADP
dpc-5264	90	15	skin	skin	NOUN
dpc-5264	90	16	cancers	cancer	NOUN
dpc-5264	90	17	.	.	PUNCT
dpc-5264	91	1	furthermore	furthermore	ADV
dpc-5264	91	2	,	,	PUNCT
dpc-5264	91	3	there	there	PRON
dpc-5264	91	4	is	be	VERB
dpc-5264	91	5	compelling	compelling	ADJ
dpc-5264	91	6	evidence	evidence	NOUN
dpc-5264	91	7	to	to	PART
dpc-5264	91	8	suggest	suggest	VERB
dpc-5264	91	9	that	that	SCONJ
dpc-5264	91	10	uvr	uvr	NOUN
dpc-5264	91	11	plays	play	VERB
dpc-5264	91	12	an	an	DET
dpc-5264	91	13	important	important	ADJ
dpc-5264	91	14	role	role	NOUN
dpc-5264	91	15	in	in	ADP
dpc-5264	91	16	the	the	DET
dpc-5264	91	17	pathogenesis	pathogenesis	NOUN
dpc-5264	91	18	of	of	ADP
dpc-5264	91	19	rosacea	rosacea	NOUN
dpc-5264	91	20	,	,	PUNCT
dpc-5264	91	21	with	with	ADP
dpc-5264	91	22	the	the	DET
dpc-5264	91	23	production	production	NOUN
dpc-5264	91	24	of	of	ADP
dpc-5264	91	25	reactive	reactive	ADJ
dpc-5264	91	26	oxygen	oxygen	NOUN
dpc-5264	91	27	species	specie	NOUN
dpc-5264	91	28	and	and	CCONJ
dpc-5264	91	29	the	the	DET
dpc-5264	91	30	expression	expression	NOUN
dpc-5264	91	31	of	of	ADP
dpc-5264	91	32	cathelicidin	cathelicidin	VERB
dpc-5264	91	33	(	(	PUNCT
dpc-5264	91	34	in	in	ADP
dpc-5264	91	35	particular	particular	ADJ
dpc-5264	91	36	,	,	PUNCT
dpc-5264	91	37	ll-37	ll-37	NOUN
dpc-5264	91	38	)	)	PUNCT
dpc-5264	91	39	being	be	AUX
dpc-5264	91	40	of	of	ADP
dpc-5264	91	41	particular	particular	ADJ
dpc-5264	91	42	importance	importance	NOUN
dpc-5264	91	43	[	[	X
dpc-5264	91	44	7	7	NUM
dpc-5264	91	45	]	]	PUNCT
dpc-5264	91	46	.	.	PUNCT
dpc-5264	92	1	ll-37	ll-37	NOUN
dpc-5264	92	2	may	may	AUX
dpc-5264	92	3	modulate	modulate	VERB
dpc-5264	92	4	the	the	DET
dpc-5264	92	5	pro	pro	ADJ
dpc-5264	92	6	inflammatory	inflammatory	ADJ
dpc-5264	92	7	effects	effect	NOUN
dpc-5264	92	8	of	of	ADP
dpc-5264	92	9	uvr	uvr	NOUN
dpc-5264	92	10	,	,	PUNCT
dpc-5264	92	11	thereby	thereby	ADV
dpc-5264	92	12	contributing	contribute	VERB
dpc-5264	92	13	to	to	ADP
dpc-5264	92	14	increased	increase	VERB
dpc-5264	92	15	sensitization	sensitization	NOUN
dpc-5264	92	16	to	to	ADP
dpc-5264	92	17	sun	sun	NOUN
dpc-5264	92	18	exposure	exposure	NOUN
dpc-5264	92	19	in	in	ADP
dpc-5264	92	20	rosacea	rosacea	NOUN
dpc-5264	92	21	patients	patient	NOUN
dpc-5264	92	22	[	[	X
dpc-5264	92	23	8	8	NUM
dpc-5264	92	24	]	]	PUNCT
dpc-5264	92	25	.	.	PUNCT
dpc-5264	93	1	it	it	PRON
dpc-5264	93	2	is	be	AUX
dpc-5264	93	3	hypothesized	hypothesize	VERB
dpc-5264	93	4	that	that	SCONJ
dpc-5264	93	5	patients	patient	NOUN
dpc-5264	93	6	with	with	ADP
dpc-5264	93	7	rosacea	rosacea	NOUN
dpc-5264	93	8	have	have	VERB
dpc-5264	93	9	an	an	DET
dpc-5264	93	10	altered	altered	ADJ
dpc-5264	93	11	skin	skin	NOUN
dpc-5264	93	12	barrier	barrier	NOUN
dpc-5264	93	13	and	and	CCONJ
dpc-5264	93	14	are	be	AUX
dpc-5264	93	15	more	more	ADV
dpc-5264	93	16	susceptible	susceptible	ADJ
dpc-5264	93	17	to	to	ADP
dpc-5264	93	18	higher	high	ADJ
dpc-5264	93	19	levels	level	NOUN
dpc-5264	93	20	of	of	ADP
dpc-5264	93	21	uv	uv	NOUN
dpc-5264	93	22	exposure	exposure	NOUN
dpc-5264	93	23	at	at	ADP
dpc-5264	93	24	an	an	DET
dpc-5264	93	25	early	early	ADJ
dpc-5264	93	26	age	age	NOUN
dpc-5264	93	27	,	,	PUNCT
dpc-5264	93	28	which	which	PRON
dpc-5264	93	29	may	may	AUX
dpc-5264	93	30	increase	increase	VERB
dpc-5264	93	31	their	their	PRON
dpc-5264	93	32	risk	risk	NOUN
dpc-5264	93	33	of	of	ADP
dpc-5264	93	34	developing	develop	VERB
dpc-5264	93	35	skin	skin	NOUN
dpc-5264	93	36	cancers	cancer	NOUN
dpc-5264	93	37	such	such	ADJ
dpc-5264	93	38	as	as	ADP
dpc-5264	93	39	scc	scc	NOUN
dpc-5264	93	40	and	and	CCONJ
dpc-5264	93	41	bcc	bcc	PROPN
dpc-5264	94	1	[	[	X
dpc-5264	94	2	3,4,9	3,4,9	NUM
dpc-5264	94	3	]	]	PUNCT
dpc-5264	94	4	.	.	PUNCT
dpc-5264	95	1	chronic	chronic	ADJ
dpc-5264	95	2	sunlight	sunlight	NOUN
dpc-5264	95	3	exposure	exposure	NOUN
dpc-5264	95	4	has	have	AUX
dpc-5264	95	5	been	be	AUX
dpc-5264	95	6	demonstrated	demonstrate	VERB
dpc-5264	95	7	to	to	PART
dpc-5264	95	8	impair	impair	VERB
dpc-5264	95	9	the	the	DET
dpc-5264	95	10	capacity	capacity	NOUN
dpc-5264	95	11	of	of	ADP
dpc-5264	95	12	cells	cell	NOUN
dpc-5264	95	13	to	to	PART
dpc-5264	95	14	repair	repair	VERB
dpc-5264	95	15	damage	damage	NOUN
dpc-5264	95	16	to	to	ADP
dpc-5264	95	17	their	their	PRON
dpc-5264	95	18	dna	dna	NOUN
dpc-5264	95	19	.	.	PUNCT
dpc-5264	96	1	patients	patient	NOUN
dpc-5264	96	2	with	with	ADP
dpc-5264	96	3	kc	kc	PROPN
dpc-5264	96	4	have	have	AUX
dpc-5264	96	5	been	be	AUX
dpc-5264	96	6	shown	show	VERB
dpc-5264	96	7	to	to	PART
dpc-5264	96	8	exhibit	exhibit	VERB
dpc-5264	96	9	a	a	DET
dpc-5264	96	10	decreased	decrease	VERB
dpc-5264	96	11	capacity	capacity	NOUN
dpc-5264	96	12	for	for	ADP
dpc-5264	96	13	dna	dna	PROPN
dpc-5264	96	14	repair	repair	NOUN
dpc-5264	96	15	.	.	PUNCT
dpc-5264	97	1	pathogen	pathogen	NOUN
dpc-5264	97	2	-	-	PUNCT
dpc-5264	97	3	associated	associate	VERB
dpc-5264	97	4	molecular	molecular	ADJ
dpc-5264	97	5	patterns	pattern	NOUN
dpc-5264	97	6	(	(	PUNCT
dpc-5264	97	7	pamps	pamp	NOUN
dpc-5264	97	8	)	)	PUNCT
dpc-5264	97	9	derived	derive	VERB
dpc-5264	97	10	from	from	ADP
dpc-5264	97	11	bacillus	bacillus	NOUN
dpc-5264	97	12	oleronius	oleronius	NOUN
dpc-5264	97	13	or	or	CCONJ
dpc-5264	97	14	demodex	demodex	NOUN
dpc-5264	97	15	mites	mite	NOUN
dpc-5264	97	16	have	have	AUX
dpc-5264	97	17	been	be	AUX
dpc-5264	97	18	proposed	propose	VERB
dpc-5264	97	19	to	to	PART
dpc-5264	97	20	contribute	contribute	VERB
dpc-5264	97	21	to	to	ADP
dpc-5264	97	22	the	the	DET
dpc-5264	97	23	pathogenesis	pathogenesis	NOUN
dpc-5264	97	24	of	of	ADP
dpc-5264	97	25	4	4	NUM
dpc-5264	97	26	original	original	ADJ
dpc-5264	97	27	article	article	NOUN
dpc-5264	97	28	|	|	ADV
dpc-5264	97	29	dermatol	dermatol	ADJ
dpc-5264	97	30	pract	pract	NOUN
dpc-5264	97	31	concept	concept	NOUN
dpc-5264	97	32	.	.	PUNCT
dpc-5264	98	1	2025;15(3):5264	2025;15(3):5264	NUM
dpc-5264	98	2	table	table	NOUN
dpc-5264	98	3	1	1	NUM
dpc-5264	98	4	.	.	PUNCT
dpc-5264	98	5	demographic	demographic	ADJ
dpc-5264	98	6	and	and	CCONJ
dpc-5264	98	7	clinical	clinical	ADJ
dpc-5264	98	8	characteristics	characteristic	NOUN
dpc-5264	98	9	of	of	ADP
dpc-5264	98	10	the	the	DET
dpc-5264	98	11	study	study	NOUN
dpc-5264	98	12	groups	group	NOUN
dpc-5264	98	13	.	.	PUNCT
dpc-5264	99	1	kcs	kcs	PROPN
dpc-5264	99	2	  	  	SPACE
dpc-5264	99	3	controls	control	VERB
dpc-5264	99	4	p	p	NOUN
dpc-5264	99	5	(	(	PUNCT
dpc-5264	99	6	n=200	n=200	PROPN
dpc-5264	99	7	)	)	PUNCT
dpc-5264	99	8	  	  	SPACE
dpc-5264	99	9	(	(	PUNCT
dpc-5264	99	10	n=200	n=200	X
dpc-5264	99	11	)	)	PUNCT
dpc-5264	99	12	age	age	NOUN
dpc-5264	99	13	(	(	PUNCT
dpc-5264	99	14	years	year	NOUN
dpc-5264	99	15	)	)	PUNCT
dpc-5264	100	1	mean±sd	mean±sd	PROPN
dpc-5264	100	2	(	(	PUNCT
dpc-5264	100	3	med	med	PROPN
dpc-5264	100	4	)	)	PUNCT
dpc-5264	100	5	68.2	68.2	NUM
dpc-5264	100	6	±	±	NUM
dpc-5264	100	7	13.3	13.3	NUM
dpc-5264	100	8	(	(	PUNCT
dpc-5264	100	9	70.0	70.0	NUM
dpc-5264	100	10	)	)	PUNCT
dpc-5264	100	11	  	  	SPACE
dpc-5264	100	12	65.5	65.5	NUM
dpc-5264	100	13	±	±	NUM
dpc-5264	100	14	14.2	14.2	NUM
dpc-5264	100	15	(	(	PUNCT
dpc-5264	100	16	67.0	67.0	NUM
dpc-5264	100	17	)	)	PUNCT
dpc-5264	100	18	0.059	0.059	NUM
dpc-5264	100	19	m	m	NOUN
dpc-5264	100	20	age	age	NOUN
dpc-5264	100	21	(	(	PUNCT
dpc-5264	100	22	years	year	NOUN
dpc-5264	100	23	)	)	PUNCT
dpc-5264	100	24	(	(	PUNCT
dpc-5264	100	25	n/%	n/%	PROPN
dpc-5264	100	26	)	)	PUNCT
dpc-5264	100	27	≤	≤	NUM
dpc-5264	100	28	50	50	NUM
dpc-5264	100	29	24	24	NUM
dpc-5264	100	30	  	  	SPACE
dpc-5264	100	31	12.0	12.0	NUM
dpc-5264	100	32	%	%	NOUN
dpc-5264	100	33	    	    	SPACE
dpc-5264	100	34	27	27	NUM
dpc-5264	100	35	  	  	SPACE
dpc-5264	100	36	13.5	13.5	NUM
dpc-5264	100	37	%	%	NOUN
dpc-5264	100	38	  	  	SPACE
dpc-5264	100	39	0.419	0.419	NUM
dpc-5264	100	40	x²	x²	PROPN
dpc-5264	100	41	51	51	NUM
dpc-5264	100	42	-	-	SYM
dpc-5264	100	43	65	65	NUM
dpc-5264	100	44	56	56	NUM
dpc-5264	100	45	28.0	28.0	NUM
dpc-5264	100	46	%	%	NOUN
dpc-5264	100	47	66	66	NUM
dpc-5264	100	48	33.0	33.0	NUM
dpc-5264	100	49	%	%	NOUN
dpc-5264	100	50	66	66	NUM
dpc-5264	100	51	-	-	SYM
dpc-5264	100	52	96	96	NUM
dpc-5264	100	53	120	120	NUM
dpc-5264	100	54	  	  	SPACE
dpc-5264	100	55	60.0	60.0	NUM
dpc-5264	100	56	%	%	NOUN
dpc-5264	100	57	    	    	SPACE
dpc-5264	100	58	107	107	NUM
dpc-5264	100	59	  	  	SPACE
dpc-5264	100	60	53.5	53.5	NUM
dpc-5264	100	61	%	%	NOUN
dpc-5264	100	62	  	  	SPACE
dpc-5264	100	63	sex	sex	NOUN
dpc-5264	100	64	(	(	PUNCT
dpc-5264	100	65	n/%	n/%	PROPN
dpc-5264	100	66	)	)	PUNCT
dpc-5264	100	67	female	female	NOUN
dpc-5264	100	68	87	87	NUM
dpc-5264	100	69	  	  	SPACE
dpc-5264	100	70	43.5	43.5	NUM
dpc-5264	100	71	%	%	NOUN
dpc-5264	100	72	    	    	SPACE
dpc-5264	100	73	106	106	NUM
dpc-5264	100	74	  	  	SPACE
dpc-5264	100	75	53.0	53.0	NUM
dpc-5264	100	76	%	%	NOUN
dpc-5264	100	77	  	  	SPACE
dpc-5264	100	78	0.057	0.057	NUM
dpc-5264	100	79	x²	x²	PROPN
dpc-5264	100	80	male	male	NOUN
dpc-5264	100	81	113	113	NUM
dpc-5264	100	82	  	  	SPACE
dpc-5264	100	83	56.5	56.5	NUM
dpc-5264	100	84	%	%	NOUN
dpc-5264	100	85	    	    	SPACE
dpc-5264	100	86	94	94	NUM
dpc-5264	100	87	  	  	SPACE
dpc-5264	100	88	47.0	47.0	NUM
dpc-5264	100	89	%	%	NOUN
dpc-5264	100	90	  	  	SPACE
dpc-5264	100	91	skin	skin	NOUN
dpc-5264	100	92	type	type	NOUN
dpc-5264	100	93	(	(	PUNCT
dpc-5264	100	94	n/%	n/%	PROPN
dpc-5264	100	95	)	)	PUNCT
dpc-5264	100	96	ii	ii	PROPN
dpc-5264	100	97	94	94	NUM
dpc-5264	100	98	  	  	SPACE
dpc-5264	100	99	47.0	47.0	NUM
dpc-5264	100	100	%	%	NOUN
dpc-5264	100	101	    	    	SPACE
dpc-5264	100	102	79	79	NUM
dpc-5264	100	103	  	  	SPACE
dpc-5264	100	104	39.5	39.5	NUM
dpc-5264	100	105	%	%	NOUN
dpc-5264	100	106	  	  	SPACE
dpc-5264	100	107	0.098	0.098	NUM
dpc-5264	100	108	x²	x²	PROPN
dpc-5264	100	109	iii	iii	NUM
dpc-5264	100	110	87	87	NUM
dpc-5264	100	111	43.5	43.5	NUM
dpc-5264	100	112	%	%	NOUN
dpc-5264	100	113	89	89	NUM
dpc-5264	100	114	44.5	44.5	NUM
dpc-5264	100	115	%	%	NOUN
dpc-5264	100	116	iv	iv	NUM
dpc-5264	100	117	19	19	NUM
dpc-5264	100	118	  	  	SPACE
dpc-5264	100	119	9.5	9.5	NUM
dpc-5264	100	120	%	%	NOUN
dpc-5264	100	121	    	    	SPACE
dpc-5264	100	122	32	32	NUM
dpc-5264	100	123	  	  	SPACE
dpc-5264	100	124	16	16	NUM
dpc-5264	100	125	%	%	NOUN
dpc-5264	100	126	  	  	SPACE
dpc-5264	100	127	sunscreen	sunscreen	NOUN
dpc-5264	100	128	use	use	NOUN
dpc-5264	100	129	(	(	PUNCT
dpc-5264	100	130	n/%	n/%	PROPN
dpc-5264	100	131	)	)	PUNCT
dpc-5264	100	132	(	(	PUNCT
dpc-5264	100	133	-	-	SYM
dpc-5264	100	134	)	)	PUNCT
dpc-5264	100	135	194	194	NUM
dpc-5264	100	136	  	  	SPACE
dpc-5264	100	137	97.0	97.0	NUM
dpc-5264	100	138	%	%	NOUN
dpc-5264	100	139	    	    	SPACE
dpc-5264	100	140	198	198	NUM
dpc-5264	100	141	  	  	SPACE
dpc-5264	100	142	99.0	99.0	NUM
dpc-5264	100	143	%	%	NOUN
dpc-5264	100	144	  	  	SPACE
dpc-5264	100	145	0.284	0.284	NUM
dpc-5264	100	146	x²	x²	PROPN
dpc-5264	100	147	(	(	PUNCT
dpc-5264	100	148	+	+	NOUN
dpc-5264	100	149	)	)	PUNCT
dpc-5264	100	150	6	6	NUM
dpc-5264	100	151	  	  	SPACE
dpc-5264	100	152	3.0	3.0	NUM
dpc-5264	100	153	%	%	NOUN
dpc-5264	100	154	    	    	SPACE
dpc-5264	100	155	2	2	NUM
dpc-5264	100	156	  	  	SPACE
dpc-5264	100	157	1.0	1.0	NUM
dpc-5264	100	158	%	%	NOUN
dpc-5264	100	159	  	  	SPACE
dpc-5264	100	160	family	family	NOUN
dpc-5264	100	161	history	history	NOUN
dpc-5264	100	162	(	(	PUNCT
dpc-5264	100	163	n/%	n/%	PROPN
dpc-5264	100	164	)	)	PUNCT
dpc-5264	100	165	(	(	PUNCT
dpc-5264	100	166	-	-	PUNCT
dpc-5264	100	167	)	)	PUNCT
dpc-5264	100	168	(	(	PUNCT
dpc-5264	100	169	+	+	NOUN
dpc-5264	100	170	)	)	PUNCT
dpc-5264	100	171	188	188	NUM
dpc-5264	100	172	12	12	NUM
dpc-5264	100	173	94.0	94.0	NUM
dpc-5264	100	174	%	%	NOUN
dpc-5264	100	175	6.0	6.0	NUM
dpc-5264	100	176	%	%	NOUN
dpc-5264	100	177	type	type	NOUN
dpc-5264	100	178	of	of	ADP
dpc-5264	100	179	kcs	kcs	NOUN
dpc-5264	100	180	(	(	PUNCT
dpc-5264	100	181	n/%	n/%	PROPN
dpc-5264	100	182	)	)	PUNCT
dpc-5264	100	183	bcc	bcc	PROPN
dpc-5264	100	184	175	175	NUM
dpc-5264	100	185	87.5	87.5	NUM
dpc-5264	100	186	%	%	NOUN
dpc-5264	100	187	nodular	nodular	ADJ
dpc-5264	100	188	bcc	bcc	PROPN
dpc-5264	100	189	132	132	NUM
dpc-5264	100	190	66.0	66.0	NUM
dpc-5264	100	191	%	%	NOUN
dpc-5264	100	192	infiltrative	infiltrative	ADJ
dpc-5264	100	193	bcc	bcc	PROPN
dpc-5264	100	194	34	34	NUM
dpc-5264	100	195	17.0	17.0	NUM
dpc-5264	100	196	%	%	NOUN
dpc-5264	100	197	morpheaform	morpheaform	NOUN
dpc-5264	100	198	bcc	bcc	PROPN
dpc-5264	100	199	1	1	NUM
dpc-5264	100	200	0.5	0.5	NUM
dpc-5264	100	201	%	%	NOUN
dpc-5264	100	202	superficial	superficial	ADJ
dpc-5264	100	203	bcc	bcc	PROPN
dpc-5264	100	204	19	19	NUM
dpc-5264	100	205	9.5	9.5	NUM
dpc-5264	100	206	%	%	NOUN
dpc-5264	100	207	adenoid	adenoid	ADJ
dpc-5264	100	208	bcc	bcc	PROPN
dpc-5264	100	209	5	5	NUM
dpc-5264	100	210	2.5	2.5	NUM
dpc-5264	100	211	%	%	NOUN
dpc-5264	100	212	pigmented	pigment	VERB
dpc-5264	100	213	bcc	bcc	PROPN
dpc-5264	100	214	1	1	NUM
dpc-5264	100	215	0.5	0.5	NUM
dpc-5264	100	216	%	%	NOUN
dpc-5264	100	217	basosquamous	basosquamous	ADJ
dpc-5264	100	218	4	4	NUM
dpc-5264	100	219	2.0	2.0	NUM
dpc-5264	100	220	%	%	NOUN
dpc-5264	100	221	scc	scc	NOUN
dpc-5264	100	222	27	27	NUM
dpc-5264	100	223	13.5	13.5	NUM
dpc-5264	100	224	%	%	NOUN
dpc-5264	100	225	localization	localization	NOUN
dpc-5264	100	226	(	(	PUNCT
dpc-5264	100	227	n/%	n/%	PROPN
dpc-5264	100	228	)	)	PUNCT
dpc-5264	100	229	scalp	scalp	VERB
dpc-5264	100	230	15	15	NUM
dpc-5264	100	231	7.5	7.5	NUM
dpc-5264	100	232	%	%	NOUN
dpc-5264	100	233	face	face	NOUN
dpc-5264	100	234	153	153	NUM
dpc-5264	100	235	76.5	76.5	NUM
dpc-5264	100	236	%	%	NOUN
dpc-5264	100	237	ear	ear	NOUN
dpc-5264	100	238	6	6	NUM
dpc-5264	100	239	3.0	3.0	NUM
dpc-5264	100	240	%	%	NOUN
dpc-5264	100	241	neck	neck	NOUN
dpc-5264	100	242	6	6	NUM
dpc-5264	100	243	3.0	3.0	NUM
dpc-5264	100	244	%	%	NOUN
dpc-5264	100	245	trunk	trunk	NOUN
dpc-5264	100	246	22	22	NUM
dpc-5264	100	247	11.0	11.0	NUM
dpc-5264	100	248	%	%	NOUN
dpc-5264	100	249	upper	upper	ADJ
dpc-5264	100	250	extremity	extremity	NOUN
dpc-5264	100	251	5	5	NUM
dpc-5264	100	252	2.5	2.5	NUM
dpc-5264	100	253	%	%	NOUN
dpc-5264	100	254	lower	low	ADJ
dpc-5264	100	255	extremity	extremity	NOUN
dpc-5264	100	256	6	6	NUM
dpc-5264	100	257	3.0	3.0	NUM
dpc-5264	100	258	%	%	NOUN
dpc-5264	100	259	number	number	NOUN
dpc-5264	100	260	of	of	ADP
dpc-5264	100	261	kcs	kcs	PROPN
dpc-5264	100	262	(	(	PUNCT
dpc-5264	100	263	n/%	n/%	PROPN
dpc-5264	100	264	)	)	PUNCT
dpc-5264	100	265	i	i	PRON
dpc-5264	100	266	165	165	NUM
dpc-5264	100	267	82.5	82.5	NUM
dpc-5264	100	268	%	%	NOUN
dpc-5264	100	269	ii	ii	NOUN
dpc-5264	100	270	23	23	NUM
dpc-5264	100	271	11.5	11.5	NUM
dpc-5264	100	272	%	%	NOUN
dpc-5264	100	273	iii	iii	NUM
dpc-5264	100	274	10	10	NUM
dpc-5264	100	275	5.0	5.0	NUM
dpc-5264	100	276	%	%	NOUN
dpc-5264	100	277	iv	iv	NUM
dpc-5264	100	278	1	1	NUM
dpc-5264	100	279	0.5	0.5	NUM
dpc-5264	100	280	%	%	NOUN
dpc-5264	100	281	v	v	ADP
dpc-5264	100	282	1	1	NUM
dpc-5264	100	283	0.5	0.5	NUM
dpc-5264	100	284	%	%	NOUN
dpc-5264	100	285	m	m	NOUN
dpc-5264	100	286	mann	mann	PROPN
dpc-5264	100	287	-	-	PUNCT
dpc-5264	100	288	whitney	whitney	PROPN
dpc-5264	100	289	u	u	PROPN
dpc-5264	100	290	test	test	NOUN
dpc-5264	100	291	/	/	SYM
dpc-5264	100	292	x²	x²	PROPN
dpc-5264	100	293	chi	chi	ADJ
dpc-5264	100	294	-	-	PUNCT
dpc-5264	100	295	squared	square	VERB
dpc-5264	100	296	test	test	NOUN
dpc-5264	100	297	(	(	PUNCT
dpc-5264	100	298	fischer	fischer	PROPN
dpc-5264	100	299	test	test	PROPN
dpc-5264	100	300	)	)	PUNCT
dpc-5264	100	301	.	.	PUNCT
dpc-5264	101	1	abbreviation	abbreviation	NOUN
dpc-5264	101	2	:	:	PUNCT
dpc-5264	101	3	kc	kc	PROPN
dpc-5264	101	4	:	:	PUNCT
dpc-5264	101	5	keratinocyte	keratinocyte	NOUN
dpc-5264	101	6	cancer	cancer	NOUN
dpc-5264	101	7	,	,	PUNCT
dpc-5264	101	8	sd	sd	ADP
dpc-5264	101	9	:	:	PUNCT
dpc-5264	101	10	standard	standard	ADJ
dpc-5264	101	11	deviation	deviation	NOUN
dpc-5264	101	12	rosacea	rosacea	NOUN
dpc-5264	102	1	[	[	X
dpc-5264	102	2	7,10	7,10	X
dpc-5264	102	3	]	]	PUNCT
dpc-5264	102	4	.	.	PUNCT
dpc-5264	103	1	these	these	DET
dpc-5264	103	2	biological	biological	ADJ
dpc-5264	103	3	triggers	trigger	NOUN
dpc-5264	103	4	are	be	AUX
dpc-5264	103	5	known	know	VERB
dpc-5264	103	6	to	to	PART
dpc-5264	103	7	activate	activate	VERB
dpc-5264	103	8	toll	toll	NOUN
dpc-5264	103	9	-	-	PUNCT
dpc-5264	103	10	like	like	ADJ
dpc-5264	103	11	receptors	receptor	NOUN
dpc-5264	103	12	(	(	PUNCT
dpc-5264	103	13	tlrs	tlrs	NOUN
dpc-5264	103	14	)	)	PUNCT
dpc-5264	103	15	,	,	PUNCT
dpc-5264	103	16	including	include	VERB
dpc-5264	103	17	tlr-2	tlr-2	NUM
dpc-5264	103	18	.	.	PUNCT
dpc-5264	104	1	tlr	tlr	PROPN
dpc-5264	104	2	stimulation	stimulation	NOUN
dpc-5264	104	3	results	result	NOUN
dpc-5264	104	4	in	in	ADP
dpc-5264	104	5	the	the	DET
dpc-5264	104	6	activation	activation	NOUN
dpc-5264	104	7	of	of	ADP
dpc-5264	104	8	the	the	DET
dpc-5264	104	9	nuclear	nuclear	ADJ
dpc-5264	104	10	factor	factor	NOUN
dpc-5264	104	11	kappa	kappa	PROPN
dpc-5264	104	12	b	b	PROPN
dpc-5264	104	13	(	(	PUNCT
dpc-5264	104	14	nf	nf	NOUN
dpc-5264	104	15	-	-	PUNCT
dpc-5264	104	16	κb	κb	NOUN
dpc-5264	104	17	)	)	PUNCT
dpc-5264	104	18	pathway	pathway	NOUN
dpc-5264	104	19	,	,	PUNCT
dpc-5264	104	20	which	which	PRON
dpc-5264	104	21	in	in	ADP
dpc-5264	104	22	turn	turn	NOUN
dpc-5264	104	23	leads	lead	VERB
dpc-5264	104	24	to	to	ADP
dpc-5264	104	25	the	the	DET
dpc-5264	104	26	production	production	NOUN
dpc-5264	104	27	of	of	ADP
dpc-5264	104	28	cytokines	cytokine	NOUN
dpc-5264	104	29	,	,	PUNCT
dpc-5264	104	30	chemokines	chemokine	NOUN
dpc-5264	104	31	,	,	PUNCT
dpc-5264	104	32	and	and	CCONJ
dpc-5264	104	33	antimicrobial	antimicrobial	ADJ
dpc-5264	104	34	peptides	peptide	NOUN
dpc-5264	104	35	[	[	X
dpc-5264	104	36	11	11	NUM
dpc-5264	104	37	]	]	PUNCT
dpc-5264	104	38	.	.	PUNCT
dpc-5264	105	1	the	the	DET
dpc-5264	105	2	janus	janus	PROPN
dpc-5264	105	3	kinase	kinase	PROPN
dpc-5264	105	4	/	/	SYM
dpc-5264	105	5	signal	signal	NOUN
dpc-5264	105	6	transducers	transducer	NOUN
dpc-5264	105	7	and	and	CCONJ
dpc-5264	105	8	activators	activator	NOUN
dpc-5264	105	9	of	of	ADP
dpc-5264	105	10	transcription	transcription	NOUN
dpc-5264	105	11	(	(	PUNCT
dpc-5264	105	12	jak	jak	PROPN
dpc-5264	105	13	/	/	SYM
dpc-5264	105	14	stat	stat	PROPN
dpc-5264	105	15	)	)	PUNCT
dpc-5264	105	16	pathway	pathway	NOUN
dpc-5264	105	17	plays	play	VERB
dpc-5264	105	18	a	a	DET
dpc-5264	105	19	role	role	NOUN
dpc-5264	105	20	in	in	ADP
dpc-5264	105	21	the	the	DET
dpc-5264	105	22	ll-37	ll-37	NOUN
dpc-5264	105	23	mediated	mediate	VERB
dpc-5264	105	24	inflammatory	inflammatory	ADJ
dpc-5264	105	25	mechanism	mechanism	NOUN
dpc-5264	105	26	of	of	ADP
dpc-5264	105	27	rosacea	rosacea	NOUN
dpc-5264	105	28	[	[	X
dpc-5264	105	29	12	12	NUM
dpc-5264	105	30	]	]	PUNCT
dpc-5264	105	31	.	.	PUNCT
dpc-5264	106	1	in	in	ADP
dpc-5264	106	2	a	a	DET
dpc-5264	106	3	recent	recent	ADJ
dpc-5264	106	4	study	study	NOUN
dpc-5264	106	5	,	,	PUNCT
dpc-5264	106	6	deng	deng	PROPN
dpc-5264	106	7	and	and	CCONJ
dpc-5264	106	8	colleagues	colleague	NOUN
dpc-5264	106	9	reported	report	VERB
dpc-5264	106	10	that	that	SCONJ
dpc-5264	106	11	the	the	DET
dpc-5264	106	12	mechanistic	mechanistic	ADJ
dpc-5264	106	13	target	target	NOUN
dpc-5264	106	14	of	of	ADP
dpc-5264	106	15	rapamycin	rapamycin	NOUN
dpc-5264	106	16	complex	complex	ADJ
dpc-5264	106	17	1	1	NUM
dpc-5264	106	18	(	(	PUNCT
dpc-5264	106	19	mtorc1	mtorc1	NOUN
dpc-5264	106	20	)	)	PUNCT
dpc-5264	106	21	pathway	pathway	NOUN
dpc-5264	106	22	is	be	AUX
dpc-5264	106	23	original	original	ADJ
dpc-5264	106	24	article	article	NOUN
dpc-5264	106	25	|	|	ADV
dpc-5264	106	26	dermatol	dermatol	ADJ
dpc-5264	106	27	pract	pract	NOUN
dpc-5264	106	28	concept	concept	NOUN
dpc-5264	106	29	.	.	PUNCT
dpc-5264	107	1	2025;15(3):5264	2025;15(3):5264	NUM
dpc-5264	107	2	5	5	NUM
dpc-5264	107	3	table	table	NOUN
dpc-5264	107	4	2	2	NUM
dpc-5264	107	5	.	.	PUNCT
dpc-5264	107	6	cutaneous	cutaneous	ADJ
dpc-5264	107	7	comorbidities	comorbiditie	NOUN
dpc-5264	107	8	accompanying	accompany	VERB
dpc-5264	107	9	the	the	DET
dpc-5264	107	10	kc	kc	PROPN
dpc-5264	107	11	and	and	CCONJ
dpc-5264	107	12	control	control	NOUN
dpc-5264	107	13	groups	group	NOUN
dpc-5264	107	14	and	and	CCONJ
dpc-5264	107	15	their	their	PRON
dpc-5264	107	16	comparison	comparison	NOUN
dpc-5264	107	17	.	.	PUNCT
dpc-5264	108	1	controls	control	VERB
dpc-5264	108	2	kcs	kcs	PROPN
dpc-5264	108	3	p*n	p*n	PROPN
dpc-5264	108	4	(	(	PUNCT
dpc-5264	108	5	%	%	NOUN
dpc-5264	108	6	)	)	PUNCT
dpc-5264	108	7	n	n	PROPN
dpc-5264	108	8	(	(	PUNCT
dpc-5264	108	9	%	%	INTJ
dpc-5264	108	10	)	)	PUNCT
dpc-5264	108	11	or	or	CCONJ
dpc-5264	108	12	(	(	PUNCT
dpc-5264	108	13	95	95	NUM
dpc-5264	108	14	%	%	NOUN
dpc-5264	108	15	ci	ci	NOUN
dpc-5264	108	16	)	)	PUNCT
dpc-5264	108	17	rosacea	rosacea	NOUN
dpc-5264	108	18	28	28	NUM
dpc-5264	108	19	(	(	PUNCT
dpc-5264	108	20	14.0	14.0	NUM
dpc-5264	108	21	)	)	SYM
dpc-5264	108	22	91	91	NUM
dpc-5264	108	23	(	(	PUNCT
dpc-5264	108	24	54.5	54.5	NUM
dpc-5264	108	25	)	)	PUNCT
dpc-5264	108	26	5.13	5.13	NUM
dpc-5264	108	27	(	(	PUNCT
dpc-5264	108	28	3.2	3.2	NUM
dpc-5264	108	29	-	-	SYM
dpc-5264	108	30	8.3	8.3	NUM
dpc-5264	108	31	)	)	PUNCT
dpc-5264	108	32	0.000	0.000	NUM
dpc-5264	108	33	erythematotelangiectatic	erythematotelangiectatic	ADJ
dpc-5264	108	34	rosacea	rosacea	NOUN
dpc-5264	108	35	27	27	NUM
dpc-5264	108	36	(	(	PUNCT
dpc-5264	108	37	13.5	13.5	NUM
dpc-5264	108	38	)	)	PUNCT
dpc-5264	108	39	88	88	NUM
dpc-5264	108	40	(	(	PUNCT
dpc-5264	108	41	44	44	NUM
dpc-5264	108	42	)	)	PUNCT
dpc-5264	108	43	5.03	5.03	NUM
dpc-5264	108	44	(	(	PUNCT
dpc-5264	108	45	3.1	3.1	NUM
dpc-5264	108	46	-	-	SYM
dpc-5264	108	47	8.2	8.2	NUM
dpc-5264	108	48	)	)	PUNCT
dpc-5264	108	49	0.000	0.000	NUM
dpc-5264	108	50	papulopustular	papulopustular	ADJ
dpc-5264	108	51	rosacea	rosacea	NOUN
dpc-5264	108	52	0	0	NUM
dpc-5264	109	1	(	(	PUNCT
dpc-5264	109	2	0.0	0.0	NUM
dpc-5264	109	3	)	)	PUNCT
dpc-5264	109	4	3	3	NUM
dpc-5264	109	5	(	(	PUNCT
dpc-5264	109	6	1.5	1.5	NUM
dpc-5264	109	7	)	)	PUNCT
dpc-5264	109	8	0.248	0.248	NUM
dpc-5264	109	9	phymatous	phymatous	ADJ
dpc-5264	109	10	rosacea	rosacea	NOUN
dpc-5264	109	11	1	1	NUM
dpc-5264	109	12	(	(	PUNCT
dpc-5264	109	13	0.5	0.5	NUM
dpc-5264	109	14	)	)	PUNCT
dpc-5264	109	15	4	4	NUM
dpc-5264	109	16	(	(	PUNCT
dpc-5264	109	17	2.0	2.0	NUM
dpc-5264	109	18	)	)	PUNCT
dpc-5264	109	19	4.06	4.06	NUM
dpc-5264	109	20	(	(	PUNCT
dpc-5264	109	21	0.5	0.5	NUM
dpc-5264	109	22	-	-	SYM
dpc-5264	109	23	36.7	36.7	NUM
dpc-5264	109	24	)	)	PUNCT
dpc-5264	109	25	0.177	0.177	NUM
dpc-5264	109	26	seborrheic	seborrheic	ADJ
dpc-5264	109	27	keratosis	keratosis	NOUN
dpc-5264	109	28	62	62	NUM
dpc-5264	109	29	(	(	PUNCT
dpc-5264	109	30	31.0	31.0	NUM
dpc-5264	109	31	)	)	PUNCT
dpc-5264	109	32	79	79	NUM
dpc-5264	109	33	(	(	PUNCT
dpc-5264	109	34	39.5	39.5	NUM
dpc-5264	109	35	)	)	PUNCT
dpc-5264	109	36	1.45	1.45	NUM
dpc-5264	109	37	(	(	PUNCT
dpc-5264	109	38	1.0	1.0	NUM
dpc-5264	109	39	-	-	SYM
dpc-5264	109	40	2.2	2.2	NUM
dpc-5264	109	41	)	)	PUNCT
dpc-5264	109	42	0.075	0.075	NUM
dpc-5264	109	43	cherry	cherry	NOUN
dpc-5264	109	44	angioma	angioma	ADJ
dpc-5264	109	45	42	42	NUM
dpc-5264	109	46	(	(	PUNCT
dpc-5264	109	47	21.0	21.0	NUM
dpc-5264	109	48	)	)	PUNCT
dpc-5264	109	49	32	32	NUM
dpc-5264	109	50	(	(	PUNCT
dpc-5264	109	51	16.0	16.0	NUM
dpc-5264	109	52	)	)	PUNCT
dpc-5264	109	53	0.72	0.72	NUM
dpc-5264	109	54	(	(	PUNCT
dpc-5264	109	55	0.4	0.4	NUM
dpc-5264	109	56	-	-	SYM
dpc-5264	109	57	1.2	1.2	NUM
dpc-5264	109	58	)	)	PUNCT
dpc-5264	109	59	0.198	0.198	NUM
dpc-5264	109	60	actinic	actinic	ADJ
dpc-5264	109	61	keratosis	keratosis	NOUN
dpc-5264	109	62	24	24	NUM
dpc-5264	109	63	(	(	PUNCT
dpc-5264	109	64	12.0	12.0	NUM
dpc-5264	109	65	)	)	PUNCT
dpc-5264	109	66	33	33	NUM
dpc-5264	109	67	(	(	PUNCT
dpc-5264	109	68	16.5	16.5	NUM
dpc-5264	109	69	)	)	PUNCT
dpc-5264	109	70	1.45	1.45	NUM
dpc-5264	109	71	(	(	PUNCT
dpc-5264	109	72	0.8	0.8	NUM
dpc-5264	109	73	-	-	SYM
dpc-5264	109	74	2.6	2.6	NUM
dpc-5264	109	75	)	)	PUNCT
dpc-5264	109	76	0.198	0.198	NUM
dpc-5264	109	77	solar	solar	ADJ
dpc-5264	109	78	lentigo	lentigo	PROPN
dpc-5264	109	79	28	28	NUM
dpc-5264	109	80	(	(	PUNCT
dpc-5264	109	81	14.0	14.0	NUM
dpc-5264	109	82	)	)	PUNCT
dpc-5264	109	83	13	13	NUM
dpc-5264	109	84	(	(	PUNCT
dpc-5264	109	85	6.5	6.5	NUM
dpc-5264	109	86	)	)	PUNCT
dpc-5264	109	87	0.43	0.43	NUM
dpc-5264	109	88	(	(	PUNCT
dpc-5264	109	89	0.2	0.2	NUM
dpc-5264	109	90	-	-	PUNCT
dpc-5264	109	91	0.9	0.9	NUM
dpc-5264	109	92	)	)	PUNCT
dpc-5264	109	93	0.013	0.013	NUM
dpc-5264	109	94	skin	skin	NOUN
dpc-5264	109	95	tag	tag	NOUN
dpc-5264	109	96	20	20	NUM
dpc-5264	109	97	(	(	PUNCT
dpc-5264	109	98	10.0	10.0	NUM
dpc-5264	109	99	)	)	PUNCT
dpc-5264	109	100	15	15	NUM
dpc-5264	109	101	(	(	PUNCT
dpc-5264	109	102	7.5	7.5	NUM
dpc-5264	109	103	)	)	PUNCT
dpc-5264	109	104	0.73	0.73	NUM
dpc-5264	109	105	(	(	PUNCT
dpc-5264	109	106	0.4	0.4	NUM
dpc-5264	109	107	-	-	SYM
dpc-5264	109	108	1.5	1.5	NUM
dpc-5264	109	109	)	)	PUNCT
dpc-5264	109	110	0.376	0.376	NUM
dpc-5264	109	111	xerosis	xerosis	NOUN
dpc-5264	109	112	cutis	cutis	PROPN
dpc-5264	109	113	22	22	NUM
dpc-5264	109	114	(	(	PUNCT
dpc-5264	109	115	11.0	11.0	NUM
dpc-5264	109	116	)	)	SYM
dpc-5264	109	117	4	4	NUM
dpc-5264	109	118	(	(	PUNCT
dpc-5264	109	119	2.0	2.0	NUM
dpc-5264	109	120	)	)	PUNCT
dpc-5264	109	121	0.17	0.17	NUM
dpc-5264	109	122	(	(	PUNCT
dpc-5264	109	123	0.1	0.1	NUM
dpc-5264	109	124	-	-	SYM
dpc-5264	109	125	0.5	0.5	NUM
dpc-5264	109	126	)	)	PUNCT
dpc-5264	109	127	0.000	0.000	NUM
dpc-5264	109	128	dermal	dermal	ADJ
dpc-5264	109	129	nevi	nevi	NOUN
dpc-5264	109	130	18	18	NUM
dpc-5264	109	131	(	(	PUNCT
dpc-5264	109	132	9.0	9.0	NUM
dpc-5264	109	133	)	)	SYM
dpc-5264	109	134	8	8	NUM
dpc-5264	109	135	(	(	PUNCT
dpc-5264	109	136	4.0	4.0	NUM
dpc-5264	109	137	)	)	PUNCT
dpc-5264	109	138	0.42	0.42	NUM
dpc-5264	109	139	(	(	PUNCT
dpc-5264	109	140	0.2	0.2	NUM
dpc-5264	109	141	-	-	SYM
dpc-5264	109	142	1.0	1.0	NUM
dpc-5264	109	143	)	)	PUNCT
dpc-5264	109	144	0.043	0.043	NUM
dpc-5264	109	145	dermatofibroma	dermatofibroma	NOUN
dpc-5264	109	146	8	8	NUM
dpc-5264	109	147	(	(	PUNCT
dpc-5264	109	148	4.0	4.0	NUM
dpc-5264	109	149	)	)	PUNCT
dpc-5264	109	150	7	7	NUM
dpc-5264	109	151	(	(	PUNCT
dpc-5264	109	152	3.5	3.5	NUM
dpc-5264	109	153	)	)	PUNCT
dpc-5264	109	154	0.87	0.87	NUM
dpc-5264	109	155	(	(	PUNCT
dpc-5264	109	156	0.3	0.3	NUM
dpc-5264	109	157	-	-	SYM
dpc-5264	109	158	2.5	2.5	NUM
dpc-5264	109	159	)	)	PUNCT
dpc-5264	109	160	0.792	0.792	NUM
dpc-5264	109	161	seborrheic	seborrheic	VERB
dpc-5264	109	162	dermatitis	dermatitis	NOUN
dpc-5264	109	163	4	4	NUM
dpc-5264	109	164	(	(	PUNCT
dpc-5264	109	165	2.0	2.0	NUM
dpc-5264	109	166	)	)	SYM
dpc-5264	109	167	5	5	NUM
dpc-5264	109	168	(	(	PUNCT
dpc-5264	109	169	2.5	2.5	NUM
dpc-5264	109	170	)	)	PUNCT
dpc-5264	109	171	1.26	1.26	NUM
dpc-5264	109	172	(	(	PUNCT
dpc-5264	109	173	0.3	0.3	NUM
dpc-5264	109	174	-	-	SYM
dpc-5264	109	175	4.8	4.8	NUM
dpc-5264	109	176	)	)	PUNCT
dpc-5264	109	177	0.736	0.736	NUM
dpc-5264	109	178	verruca	verruca	NOUN
dpc-5264	109	179	vulgaris	vulgaris	NOUN
dpc-5264	109	180	3	3	NUM
dpc-5264	109	181	(	(	PUNCT
dpc-5264	109	182	1.5	1.5	NUM
dpc-5264	109	183	)	)	SYM
dpc-5264	109	184	5	5	NUM
dpc-5264	109	185	(	(	PUNCT
dpc-5264	109	186	2.5	2.5	NUM
dpc-5264	109	187	)	)	PUNCT
dpc-5264	109	188	1.68	1.68	NUM
dpc-5264	109	189	(	(	PUNCT
dpc-5264	109	190	0.4	0.4	NUM
dpc-5264	109	191	-	-	SYM
dpc-5264	109	192	7.1	7.1	NUM
dpc-5264	109	193	)	)	PUNCT
dpc-5264	109	194	0.425	0.425	NUM
dpc-5264	109	195	psoriasis	psoriasis	NOUN
dpc-5264	109	196	vulgaris	vulgaris	NOUN
dpc-5264	109	197	5	5	NUM
dpc-5264	109	198	(	(	PUNCT
dpc-5264	109	199	2.5	2.5	NUM
dpc-5264	109	200	)	)	PUNCT
dpc-5264	109	201	3	3	NUM
dpc-5264	109	202	(	(	PUNCT
dpc-5264	109	203	1.5	1.5	NUM
dpc-5264	109	204	)	)	PUNCT
dpc-5264	109	205	0.59	0.59	NUM
dpc-5264	109	206	(	(	PUNCT
dpc-5264	109	207	0.1	0.1	NUM
dpc-5264	109	208	-	-	SYM
dpc-5264	109	209	2.5	2.5	NUM
dpc-5264	109	210	)	)	PUNCT
dpc-5264	109	211	0.475	0.475	NUM
dpc-5264	109	212	stasis	stasis	NOUN
dpc-5264	109	213	dermatitis	dermatitis	NOUN
dpc-5264	109	214	5	5	NUM
dpc-5264	109	215	(	(	PUNCT
dpc-5264	109	216	2.5	2.5	NUM
dpc-5264	109	217	)	)	SYM
dpc-5264	109	218	2	2	NUM
dpc-5264	109	219	(	(	PUNCT
dpc-5264	109	220	1.0	1.0	NUM
dpc-5264	109	221	)	)	PUNCT
dpc-5264	109	222	0.39	0.39	NUM
dpc-5264	109	223	(	(	PUNCT
dpc-5264	109	224	0.1	0.1	NUM
dpc-5264	109	225	-	-	SYM
dpc-5264	109	226	2.1	2.1	NUM
dpc-5264	109	227	)	)	PUNCT
dpc-5264	109	228	0.253	0.253	NUM
dpc-5264	109	229	tinea	tinea	NOUN
dpc-5264	109	230	unguium	unguium	NOUN
dpc-5264	109	231	5	5	NUM
dpc-5264	109	232	(	(	PUNCT
dpc-5264	109	233	2.5	2.5	NUM
dpc-5264	109	234	)	)	SYM
dpc-5264	109	235	2	2	NUM
dpc-5264	109	236	(	(	PUNCT
dpc-5264	109	237	1.0	1.0	NUM
dpc-5264	109	238	)	)	PUNCT
dpc-5264	109	239	0.39	0.39	NUM
dpc-5264	109	240	(	(	PUNCT
dpc-5264	109	241	0.1	0.1	NUM
dpc-5264	109	242	-	-	SYM
dpc-5264	109	243	2.1	2.1	NUM
dpc-5264	109	244	)	)	PUNCT
dpc-5264	109	245	0.253	0.253	NUM
dpc-5264	109	246	sebaceous	sebaceous	ADJ
dpc-5264	109	247	hyperplasia	hyperplasia	NOUN
dpc-5264	109	248	3	3	NUM
dpc-5264	109	249	(	(	PUNCT
dpc-5264	109	250	1.5	1.5	NUM
dpc-5264	109	251	)	)	PUNCT
dpc-5264	109	252	3	3	NUM
dpc-5264	109	253	(	(	PUNCT
dpc-5264	109	254	1.5	1.5	NUM
dpc-5264	109	255	)	)	PUNCT
dpc-5264	109	256	1.0	1.0	NUM
dpc-5264	109	257	(	(	PUNCT
dpc-5264	109	258	0.2	0.2	NUM
dpc-5264	109	259	-	-	SYM
dpc-5264	109	260	5.0	5.0	NUM
dpc-5264	109	261	)	)	PUNCT
dpc-5264	109	262	1,000	1,000	NUM
dpc-5264	109	263	dysplastic	dysplastic	ADJ
dpc-5264	109	264	nevi	nevi	NOUN
dpc-5264	109	265	0	0	NUM
dpc-5264	109	266	(	(	PUNCT
dpc-5264	109	267	0.0	0.0	NUM
dpc-5264	109	268	)	)	PUNCT
dpc-5264	109	269	5	5	NUM
dpc-5264	109	270	(	(	PUNCT
dpc-5264	109	271	2.5	2.5	NUM
dpc-5264	109	272	)	)	PUNCT
dpc-5264	109	273	0.024	0.024	NUM
dpc-5264	109	274	bowen	bowen	NOUN
dpc-5264	109	275	disease	disease	NOUN
dpc-5264	109	276	0	0	NUM
dpc-5264	110	1	(	(	PUNCT
dpc-5264	110	2	0.0	0.0	NUM
dpc-5264	110	3	)	)	PUNCT
dpc-5264	110	4	5	5	NUM
dpc-5264	110	5	(	(	PUNCT
dpc-5264	110	6	2.5	2.5	NUM
dpc-5264	110	7	)	)	PUNCT
dpc-5264	110	8	0.024	0.024	NUM
dpc-5264	110	9	lichen	lichen	NOUN
dpc-5264	110	10	simplex	simplex	NOUN
dpc-5264	110	11	chronicus	chronicus	NOUN
dpc-5264	110	12	4	4	NUM
dpc-5264	110	13	(	(	PUNCT
dpc-5264	110	14	2.0	2.0	NUM
dpc-5264	110	15	)	)	PUNCT
dpc-5264	110	16	0	0	NUM
dpc-5264	111	1	(	(	PUNCT
dpc-5264	111	2	0.0	0.0	NUM
dpc-5264	111	3	)	)	PUNCT
dpc-5264	111	4	0.044	0.044	NUM
dpc-5264	111	5	acne	acne	NOUN
dpc-5264	111	6	vulgaris	vulgaris	NOUN
dpc-5264	111	7	2	2	NUM
dpc-5264	111	8	(	(	PUNCT
dpc-5264	111	9	1.0	1.0	NUM
dpc-5264	111	10	)	)	SYM
dpc-5264	111	11	1	1	NUM
dpc-5264	111	12	(	(	PUNCT
dpc-5264	111	13	0.5	0.5	NUM
dpc-5264	111	14	)	)	PUNCT
dpc-5264	111	15	0.50	0.50	NUM
dpc-5264	111	16	(	(	PUNCT
dpc-5264	111	17	0.1	0.1	NUM
dpc-5264	111	18	-	-	SYM
dpc-5264	111	19	5.5	5.5	NUM
dpc-5264	111	20	)	)	PUNCT
dpc-5264	111	21	1,000	1,000	NUM
dpc-5264	111	22	urticaria	urticaria	NOUN
dpc-5264	111	23	1	1	NUM
dpc-5264	111	24	(	(	PUNCT
dpc-5264	111	25	0.5	0.5	NUM
dpc-5264	111	26	)	)	SYM
dpc-5264	111	27	2	2	NUM
dpc-5264	111	28	(	(	PUNCT
dpc-5264	111	29	1.0	1.0	NUM
dpc-5264	111	30	)	)	PUNCT
dpc-5264	111	31	2.01	2.01	NUM
dpc-5264	111	32	(	(	PUNCT
dpc-5264	111	33	0.2	0.2	NUM
dpc-5264	111	34	-	-	PUNCT
dpc-5264	111	35	22,4	22,4	NUM
dpc-5264	111	36	)	)	PUNCT
dpc-5264	111	37	1,000	1,000	NUM
dpc-5264	111	38	vitiligo	vitiligo	NOUN
dpc-5264	111	39	2	2	NUM
dpc-5264	111	40	(	(	PUNCT
dpc-5264	111	41	1.0	1.0	NUM
dpc-5264	111	42	)	)	SYM
dpc-5264	111	43	1	1	NUM
dpc-5264	111	44	(	(	PUNCT
dpc-5264	111	45	0.5	0.5	NUM
dpc-5264	111	46	)	)	PUNCT
dpc-5264	111	47	0.50	0.50	NUM
dpc-5264	111	48	(	(	PUNCT
dpc-5264	111	49	0.1	0.1	NUM
dpc-5264	111	50	-	-	SYM
dpc-5264	111	51	5.5	5.5	NUM
dpc-5264	111	52	)	)	PUNCT
dpc-5264	111	53	1,000	1,000	NUM
dpc-5264	111	54	post	post	ADJ
dpc-5264	111	55	-	-	ADJ
dpc-5264	111	56	inflammatory	inflammatory	ADJ
dpc-5264	111	57	hyperpigmentation	hyperpigmentation	NOUN
dpc-5264	111	58	2	2	NUM
dpc-5264	111	59	(	(	PUNCT
dpc-5264	111	60	1.0	1.0	NUM
dpc-5264	111	61	)	)	SYM
dpc-5264	111	62	1	1	NUM
dpc-5264	111	63	(	(	PUNCT
dpc-5264	111	64	0.5	0.5	NUM
dpc-5264	111	65	)	)	PUNCT
dpc-5264	111	66	0.50	0.50	NUM
dpc-5264	111	67	(	(	PUNCT
dpc-5264	111	68	0.1	0.1	NUM
dpc-5264	111	69	-	-	SYM
dpc-5264	111	70	5.5	5.5	NUM
dpc-5264	111	71	)	)	PUNCT
dpc-5264	111	72	1,000	1,000	NUM
dpc-5264	111	73	keratoacanthoma	keratoacanthoma	X
dpc-5264	111	74	0	0	NUM
dpc-5264	111	75	(	(	PUNCT
dpc-5264	111	76	0.0	0.0	NUM
dpc-5264	111	77	)	)	PUNCT
dpc-5264	111	78	3	3	NUM
dpc-5264	111	79	(	(	PUNCT
dpc-5264	111	80	1.5	1.5	NUM
dpc-5264	111	81	)	)	PUNCT
dpc-5264	111	82	0.248	0.248	NUM
dpc-5264	111	83	xanthelasma	xanthelasma	NOUN
dpc-5264	111	84	0	0	NUM
dpc-5264	111	85	(	(	PUNCT
dpc-5264	111	86	0.0	0.0	NUM
dpc-5264	111	87	)	)	PUNCT
dpc-5264	111	88	2	2	NUM
dpc-5264	111	89	(	(	PUNCT
dpc-5264	111	90	1.0	1.0	NUM
dpc-5264	111	91	)	)	PUNCT
dpc-5264	111	92	0.499	0.499	NUM
dpc-5264	111	93	pityriasis	pityriasis	NOUN
dpc-5264	111	94	versicolor	versicolor	NOUN
dpc-5264	111	95	2	2	NUM
dpc-5264	111	96	(	(	PUNCT
dpc-5264	111	97	1.0	1.0	NUM
dpc-5264	111	98	)	)	PUNCT
dpc-5264	111	99	0	0	NUM
dpc-5264	111	100	(	(	PUNCT
dpc-5264	111	101	0.0	0.0	NUM
dpc-5264	111	102	)	)	PUNCT
dpc-5264	111	103	0.499	0.499	NUM
dpc-5264	111	104	tinea	tinea	NOUN
dpc-5264	111	105	pedis	pedi	VERB
dpc-5264	111	106	2	2	NUM
dpc-5264	111	107	(	(	PUNCT
dpc-5264	111	108	1.0	1.0	NUM
dpc-5264	111	109	)	)	PUNCT
dpc-5264	111	110	0	0	NUM
dpc-5264	112	1	(	(	PUNCT
dpc-5264	112	2	0.0	0.0	NUM
dpc-5264	112	3	)	)	PUNCT
dpc-5264	112	4	0.499	0.499	NUM
dpc-5264	112	5	callus	callus	NOUN
dpc-5264	112	6	1	1	NUM
dpc-5264	112	7	(	(	PUNCT
dpc-5264	112	8	0.5	0.5	NUM
dpc-5264	112	9	)	)	PUNCT
dpc-5264	112	10	1	1	NUM
dpc-5264	112	11	(	(	PUNCT
dpc-5264	112	12	0.5	0.5	NUM
dpc-5264	112	13	)	)	PUNCT
dpc-5264	112	14	1	1	NUM
dpc-5264	112	15	(	(	PUNCT
dpc-5264	112	16	0.1	0.1	NUM
dpc-5264	112	17	-	-	SYM
dpc-5264	112	18	16.1	16.1	NUM
dpc-5264	112	19	)	)	PUNCT
dpc-5264	112	20	1,000	1,000	NUM
dpc-5264	112	21	lichen	lichen	NOUN
dpc-5264	112	22	sclerosus	sclerosus	NOUN
dpc-5264	112	23	0	0	NUM
dpc-5264	113	1	(	(	PUNCT
dpc-5264	113	2	0.0	0.0	NUM
dpc-5264	113	3	)	)	PUNCT
dpc-5264	113	4	1	1	NUM
dpc-5264	113	5	(	(	PUNCT
dpc-5264	113	6	0.5	0.5	NUM
dpc-5264	113	7	)	)	PUNCT
dpc-5264	113	8	1,000	1,000	NUM
dpc-5264	113	9	melasma	melasma	NOUN
dpc-5264	113	10	0	0	NUM
dpc-5264	113	11	(	(	PUNCT
dpc-5264	113	12	0.0	0.0	NUM
dpc-5264	113	13	)	)	PUNCT
dpc-5264	113	14	1	1	NUM
dpc-5264	113	15	(	(	PUNCT
dpc-5264	113	16	0.5	0.5	NUM
dpc-5264	113	17	)	)	PUNCT
dpc-5264	113	18	1,000	1,000	NUM
dpc-5264	113	19	melanoma	melanoma	NOUN
dpc-5264	113	20	0	0	NUM
dpc-5264	113	21	(	(	PUNCT
dpc-5264	113	22	0.0	0.0	NUM
dpc-5264	113	23	)	)	PUNCT
dpc-5264	113	24	1	1	NUM
dpc-5264	113	25	(	(	PUNCT
dpc-5264	113	26	0.5	0.5	NUM
dpc-5264	113	27	)	)	PUNCT
dpc-5264	113	28	1,000	1,000	NUM
dpc-5264	113	29	diabetic	diabetic	ADJ
dpc-5264	113	30	foot	foot	NOUN
dpc-5264	113	31	infection	infection	NOUN
dpc-5264	113	32	1	1	NUM
dpc-5264	113	33	(	(	PUNCT
dpc-5264	113	34	0.5	0.5	NUM
dpc-5264	113	35	)	)	PUNCT
dpc-5264	113	36	0	0	NUM
dpc-5264	114	1	(	(	PUNCT
dpc-5264	114	2	0.0	0.0	NUM
dpc-5264	114	3	)	)	PUNCT
dpc-5264	114	4	1,000	1,000	NUM
dpc-5264	114	5	decubitus	decubitus	NOUN
dpc-5264	114	6	ulcer	ulcer	NOUN
dpc-5264	114	7	1	1	NUM
dpc-5264	114	8	(	(	PUNCT
dpc-5264	114	9	0.5	0.5	NUM
dpc-5264	114	10	)	)	PUNCT
dpc-5264	114	11	0	0	NUM
dpc-5264	114	12	(	(	PUNCT
dpc-5264	114	13	0.0	0.0	NUM
dpc-5264	114	14	)	)	PUNCT
dpc-5264	114	15	1,000	1,000	NUM
dpc-5264	114	16	epidermal	epidermal	ADJ
dpc-5264	114	17	cysts	cyst	NOUN
dpc-5264	114	18	0	0	NUM
dpc-5264	114	19	(	(	PUNCT
dpc-5264	114	20	0.0	0.0	NUM
dpc-5264	114	21	)	)	PUNCT
dpc-5264	114	22	1	1	NUM
dpc-5264	114	23	(	(	PUNCT
dpc-5264	114	24	0.5	0.5	NUM
dpc-5264	114	25	)	)	SYM
dpc-5264	114	26	1,000	1,000	NUM
dpc-5264	114	27	angiokeratoma	angiokeratoma	NOUN
dpc-5264	114	28	0	0	NUM
dpc-5264	114	29	(	(	PUNCT
dpc-5264	114	30	0.0	0.0	NUM
dpc-5264	114	31	)	)	PUNCT
dpc-5264	114	32	1	1	NUM
dpc-5264	114	33	(	(	PUNCT
dpc-5264	114	34	0.5	0.5	NUM
dpc-5264	114	35	)	)	PUNCT
dpc-5264	114	36	1,000	1,000	NUM
dpc-5264	114	37	hidradenitis	hidradenitis	PROPN
dpc-5264	114	38	suppurativa	suppurativa	NOUN
dpc-5264	114	39	0	0	NUM
dpc-5264	114	40	(	(	PUNCT
dpc-5264	114	41	0.0	0.0	NUM
dpc-5264	114	42	)	)	PUNCT
dpc-5264	114	43	1	1	NUM
dpc-5264	114	44	(	(	PUNCT
dpc-5264	114	45	0.5	0.5	NUM
dpc-5264	114	46	)	)	PUNCT
dpc-5264	114	47	1,000	1,000	NUM
dpc-5264	114	48	milia	milia	NOUN
dpc-5264	114	49	0	0	NUM
dpc-5264	115	1	(	(	PUNCT
dpc-5264	115	2	0.0	0.0	NUM
dpc-5264	115	3	)	)	PUNCT
dpc-5264	115	4	1	1	NUM
dpc-5264	115	5	(	(	PUNCT
dpc-5264	115	6	0.5	0.5	NUM
dpc-5264	115	7	)	)	PUNCT
dpc-5264	115	8	1,000	1,000	NUM
dpc-5264	115	9	nevus	nevus	NOUN
dpc-5264	115	10	spilus	spilus	NOUN
dpc-5264	115	11	0	0	NUM
dpc-5264	115	12	(	(	PUNCT
dpc-5264	115	13	0.0	0.0	NUM
dpc-5264	115	14	)	)	PUNCT
dpc-5264	115	15	1	1	NUM
dpc-5264	115	16	(	(	PUNCT
dpc-5264	115	17	0.5	0.5	NUM
dpc-5264	115	18	)	)	SYM
dpc-5264	115	19	1,000	1,000	NUM
dpc-5264	115	20	recurrent	recurrent	ADJ
dpc-5264	115	21	aphthous	aphthous	ADJ
dpc-5264	115	22	stomatitis	stomatitis	NOUN
dpc-5264	115	23	0	0	NUM
dpc-5264	115	24	(	(	PUNCT
dpc-5264	115	25	0.0	0.0	NUM
dpc-5264	115	26	)	)	PUNCT
dpc-5264	115	27	1	1	NUM
dpc-5264	115	28	(	(	PUNCT
dpc-5264	115	29	0.5	0.5	NUM
dpc-5264	115	30	)	)	PUNCT
dpc-5264	115	31	1,000	1,000	NUM
dpc-5264	115	32	pemphigus	pemphigus	NOUN
dpc-5264	115	33	vulgaris	vulgaris	NOUN
dpc-5264	115	34	0	0	NUM
dpc-5264	115	35	(	(	PUNCT
dpc-5264	115	36	0.0	0.0	NUM
dpc-5264	115	37	)	)	PUNCT
dpc-5264	115	38	1	1	NUM
dpc-5264	115	39	(	(	PUNCT
dpc-5264	115	40	0.5	0.5	NUM
dpc-5264	115	41	)	)	PUNCT
dpc-5264	115	42	1,000	1,000	NUM
dpc-5264	115	43	granuloma	granuloma	NOUN
dpc-5264	115	44	annulare	annulare	NOUN
dpc-5264	115	45	0	0	NUM
dpc-5264	115	46	(	(	PUNCT
dpc-5264	115	47	0.0	0.0	NUM
dpc-5264	115	48	)	)	PUNCT
dpc-5264	115	49	1	1	NUM
dpc-5264	115	50	(	(	PUNCT
dpc-5264	115	51	0.5	0.5	NUM
dpc-5264	115	52	)	)	PUNCT
dpc-5264	115	53	1,000	1,000	NUM
dpc-5264	115	54	frontal	frontal	ADJ
dpc-5264	115	55	fibrosing	fibrose	VERB
dpc-5264	115	56	alopecia	alopecia	NOUN
dpc-5264	115	57	0	0	NUM
dpc-5264	115	58	(	(	PUNCT
dpc-5264	115	59	0.0	0.0	NUM
dpc-5264	115	60	)	)	PUNCT
dpc-5264	115	61	1	1	NUM
dpc-5264	115	62	(	(	PUNCT
dpc-5264	115	63	0.5	0.5	NUM
dpc-5264	115	64	)	)	PUNCT
dpc-5264	115	65	1,000	1,000	NUM
dpc-5264	115	66	syringoma	syringoma	NOUN
dpc-5264	115	67	1	1	NUM
dpc-5264	115	68	(	(	PUNCT
dpc-5264	115	69	0.5	0.5	NUM
dpc-5264	115	70	)	)	PUNCT
dpc-5264	115	71	0	0	NUM
dpc-5264	116	1	(	(	PUNCT
dpc-5264	116	2	0.0	0.0	NUM
dpc-5264	116	3	)	)	PUNCT
dpc-5264	116	4	1,000	1,000	NUM
dpc-5264	116	5	prurigo	prurigo	PROPN
dpc-5264	116	6	nodularis	nodularis	PROPN
dpc-5264	116	7	1	1	NUM
dpc-5264	116	8	(	(	PUNCT
dpc-5264	116	9	0.5	0.5	NUM
dpc-5264	116	10	)	)	PUNCT
dpc-5264	116	11	0	0	NUM
dpc-5264	117	1	(	(	PUNCT
dpc-5264	117	2	0.0	0.0	NUM
dpc-5264	117	3	)	)	PUNCT
dpc-5264	117	4	1,000	1,000	NUM
dpc-5264	117	5	herpes	herpe	NOUN
dpc-5264	117	6	zoster	zoster	NOUN
dpc-5264	117	7	1	1	NUM
dpc-5264	117	8	(	(	PUNCT
dpc-5264	117	9	0.5	0.5	NUM
dpc-5264	117	10	)	)	PUNCT
dpc-5264	117	11	0	0	NUM
dpc-5264	118	1	(	(	PUNCT
dpc-5264	118	2	0.0	0.0	NUM
dpc-5264	118	3	)	)	PUNCT
dpc-5264	118	4	1,000	1,000	NUM
dpc-5264	118	5	*	*	PUNCT
dpc-5264	118	6	chi	chi	ADJ
dpc-5264	118	7	-	-	PUNCT
dpc-5264	118	8	squared	square	VERB
dpc-5264	118	9	test	test	NOUN
dpc-5264	118	10	(	(	PUNCT
dpc-5264	118	11	fischer	fischer	PROPN
dpc-5264	118	12	test	test	PROPN
dpc-5264	118	13	)	)	PUNCT
dpc-5264	118	14	.	.	PUNCT
dpc-5264	119	1	abbreviation	abbreviation	NOUN
dpc-5264	119	2	:	:	PUNCT
dpc-5264	119	3	kc	kc	PROPN
dpc-5264	119	4	:	:	PUNCT
dpc-5264	119	5	keratinocyte	keratinocyte	NOUN
dpc-5264	119	6	cancer	cancer	NOUN
dpc-5264	119	7	.	.	PUNCT
dpc-5264	120	1	6	6	NUM
dpc-5264	120	2	original	original	ADJ
dpc-5264	120	3	article	article	NOUN
dpc-5264	120	4	|	|	ADV
dpc-5264	120	5	dermatol	dermatol	ADJ
dpc-5264	120	6	pract	pract	NOUN
dpc-5264	120	7	concept	concept	NOUN
dpc-5264	120	8	.	.	PUNCT
dpc-5264	121	1	2025;15(3):5264	2025;15(3):5264	NUM
dpc-5264	121	2	figure	figure	NOUN
dpc-5264	121	3	1	1	NUM
dpc-5264	121	4	.	.	PUNCT
dpc-5264	122	1	roc	roc	PROPN
dpc-5264	122	2	curve	curve	NOUN
dpc-5264	122	3	of	of	ADP
dpc-5264	122	4	rosacea	rosacea	PROPN
dpc-5264	122	5	and	and	CCONJ
dpc-5264	122	6	etr	etr	PROPN
dpc-5264	122	7	for	for	ADP
dpc-5264	122	8	predicting	predict	VERB
dpc-5264	122	9	kcs	kcs	PROPN
dpc-5264	122	10	.	.	PUNCT
dpc-5264	123	1	(	(	PUNCT
dpc-5264	123	2	auc	auc	X
dpc-5264	123	3	area	area	NOUN
dpc-5264	123	4	under	under	ADP
dpc-5264	123	5	curve	curve	NOUN
dpc-5264	123	6	;	;	PUNCT
dpc-5264	123	7	npv	npv	NOUN
dpc-5264	123	8	,	,	PUNCT
dpc-5264	123	9	negative	negative	ADJ
dpc-5264	123	10	predictive	predictive	ADJ
dpc-5264	123	11	value	value	NOUN
dpc-5264	123	12	;	;	PUNCT
dpc-5264	123	13	ppv	ppv	NOUN
dpc-5264	123	14	,	,	PUNCT
dpc-5264	123	15	positive	positive	ADJ
dpc-5264	123	16	predictive	predictive	ADJ
dpc-5264	123	17	value	value	NOUN
dpc-5264	123	18	;	;	PUNCT
dpc-5264	123	19	roc	roc	NOUN
dpc-5264	123	20	:	:	PUNCT
dpc-5264	123	21	receiver	receiver	ADJ
dpc-5264	123	22	operating	operate	VERB
dpc-5264	123	23	characteristic	characteristic	NOUN
dpc-5264	123	24	;	;	PUNCT
dpc-5264	123	25	etr	etr	PROPN
dpc-5264	123	26	:	:	PUNCT
dpc-5264	123	27	erythematotelangiectatic	erythematotelangiectatic	PROPN
dpc-5264	123	28	rosacea	rosacea	PROPN
dpc-5264	123	29	;	;	PUNCT
dpc-5264	123	30	kc	kc	PROPN
dpc-5264	123	31	:	:	PUNCT
dpc-5264	123	32	keratinocyte	keratinocyte	NOUN
dpc-5264	123	33	cancer	cancer	NOUN
dpc-5264	123	34	figure	figure	NOUN
dpc-5264	123	35	2	2	NUM
dpc-5264	123	36	.	.	PUNCT
dpc-5264	124	1	forest	forest	NOUN
dpc-5264	124	2	plot	plot	NOUN
dpc-5264	124	3	for	for	ADP
dpc-5264	124	4	the	the	DET
dpc-5264	124	5	effect	effect	NOUN
dpc-5264	124	6	of	of	ADP
dpc-5264	124	7	the	the	DET
dpc-5264	124	8	presence	presence	NOUN
dpc-5264	124	9	of	of	ADP
dpc-5264	124	10	rosacea	rosacea	NOUN
dpc-5264	124	11	on	on	ADP
dpc-5264	124	12	keratinocyte	keratinocyte	NOUN
dpc-5264	124	13	cancers	cancer	NOUN
dpc-5264	124	14	in	in	ADP
dpc-5264	124	15	terms	term	NOUN
dpc-5264	124	16	of	of	ADP
dpc-5264	124	17	age	age	NOUN
dpc-5264	124	18	,	,	PUNCT
dpc-5264	124	19	sex	sex	NOUN
dpc-5264	124	20	,	,	PUNCT
dpc-5264	124	21	family	family	NOUN
dpc-5264	124	22	history	history	NOUN
dpc-5264	124	23	,	,	PUNCT
dpc-5264	124	24	skin	skin	NOUN
dpc-5264	124	25	type	type	NOUN
dpc-5264	124	26	,	,	PUNCT
dpc-5264	124	27	cancer	cancer	NOUN
dpc-5264	124	28	subtype	subtype	NOUN
dpc-5264	124	29	,	,	PUNCT
dpc-5264	124	30	and	and	CCONJ
dpc-5264	124	31	localization	localization	NOUN
dpc-5264	124	32	.	.	PUNCT
dpc-5264	124	33	hyperactivated	hyperactivate	VERB
dpc-5264	124	34	in	in	ADP
dpc-5264	124	35	rosacea	rosacea	NOUN
dpc-5264	124	36	[	[	X
dpc-5264	124	37	13	13	NUM
dpc-5264	124	38	]	]	PUNCT
dpc-5264	124	39	.	.	PUNCT
dpc-5264	125	1	mtor	mtor	PROPN
dpc-5264	125	2	is	be	AUX
dpc-5264	125	3	a	a	DET
dpc-5264	125	4	key	key	ADJ
dpc-5264	125	5	regulator	regulator	NOUN
dpc-5264	125	6	of	of	ADP
dpc-5264	125	7	several	several	ADJ
dpc-5264	125	8	fundamental	fundamental	ADJ
dpc-5264	125	9	cellular	cellular	ADJ
dpc-5264	125	10	processes	process	NOUN
dpc-5264	125	11	,	,	PUNCT
dpc-5264	125	12	including	include	VERB
dpc-5264	125	13	cell	cell	NOUN
dpc-5264	125	14	growth	growth	NOUN
dpc-5264	125	15	,	,	PUNCT
dpc-5264	125	16	proliferation	proliferation	NOUN
dpc-5264	125	17	,	,	PUNCT
dpc-5264	125	18	differentiation	differentiation	NOUN
dpc-5264	125	19	,	,	PUNCT
dpc-5264	125	20	survival	survival	NOUN
dpc-5264	125	21	,	,	PUNCT
dpc-5264	125	22	autophagy	autophagy	NOUN
dpc-5264	125	23	,	,	PUNCT
dpc-5264	125	24	and	and	CCONJ
dpc-5264	125	25	motility	motility	NOUN
dpc-5264	125	26	as	as	ADV
dpc-5264	125	27	well	well	ADV
dpc-5264	125	28	as	as	ADP
dpc-5264	125	29	angiogenesis	angiogenesis	NOUN
dpc-5264	125	30	and	and	CCONJ
dpc-5264	125	31	lymphangiogenesis	lymphangiogenesis	NOUN
dpc-5264	125	32	.	.	PUNCT
dpc-5264	126	1	the	the	DET
dpc-5264	126	2	authors	author	NOUN
dpc-5264	126	3	observed	observe	VERB
dpc-5264	126	4	a	a	DET
dpc-5264	126	5	positive	positive	ADJ
dpc-5264	126	6	correlation	correlation	NOUN
dpc-5264	126	7	between	between	ADP
dpc-5264	126	8	epidermal	epidermal	ADJ
dpc-5264	126	9	activation	activation	NOUN
dpc-5264	126	10	of	of	ADP
dpc-5264	126	11	the	the	DET
dpc-5264	126	12	mtorc1	mtorc1	NOUN
dpc-5264	126	13	pathway	pathway	NOUN
dpc-5264	126	14	and	and	CCONJ
dpc-5264	126	15	the	the	DET
dpc-5264	126	16	severity	severity	NOUN
dpc-5264	126	17	of	of	ADP
dpc-5264	126	18	the	the	DET
dpc-5264	126	19	rosacea	rosacea	NOUN
dpc-5264	126	20	,	,	PUNCT
dpc-5264	126	21	thereby	thereby	ADV
dpc-5264	126	22	identifying	identify	VERB
dpc-5264	126	23	a	a	DET
dpc-5264	126	24	mechanism	mechanism	NOUN
dpc-5264	126	25	linking	link	VERB
dpc-5264	126	26	the	the	DET
dpc-5264	126	27	dysregulation	dysregulation	NOUN
dpc-5264	126	28	of	of	ADP
dpc-5264	126	29	the	the	DET
dpc-5264	126	30	innate	innate	ADJ
dpc-5264	126	31	immune	immune	ADJ
dpc-5264	126	32	system	system	NOUN
dpc-5264	126	33	and	and	CCONJ
dpc-5264	126	34	the	the	DET
dpc-5264	126	35	inflammatory	inflammatory	ADJ
dpc-5264	126	36	response	response	NOUN
dpc-5264	126	37	in	in	ADP
dpc-5264	126	38	the	the	DET
dpc-5264	126	39	disease	disease	NOUN
dpc-5264	126	40	.	.	PUNCT
dpc-5264	127	1	a	a	DET
dpc-5264	127	2	substantial	substantial	ADJ
dpc-5264	127	3	body	body	NOUN
dpc-5264	127	4	of	of	ADP
dpc-5264	127	5	evidence	evidence	NOUN
dpc-5264	127	6	indicates	indicate	VERB
dpc-5264	127	7	that	that	SCONJ
dpc-5264	127	8	the	the	DET
dpc-5264	127	9	pi3k/	pi3k/	PROPN
dpc-5264	127	10	akt	akt	PROPN
dpc-5264	127	11	/	/	SYM
dpc-5264	127	12	mtor	mtor	PROPN
dpc-5264	127	13	/	/	SYM
dpc-5264	127	14	s6k1	s6k1	NOUN
dpc-5264	127	15	pathway	pathway	NOUN
dpc-5264	127	16	can	can	AUX
dpc-5264	127	17	be	be	AUX
dpc-5264	127	18	activated	activate	VERB
dpc-5264	127	19	by	by	ADP
dpc-5264	127	20	uvr	uvr	ADJ
dpc-5264	127	21	exposure	exposure	NOUN
dpc-5264	127	22	in	in	ADP
dpc-5264	127	23	the	the	DET
dpc-5264	127	24	development	development	NOUN
dpc-5264	127	25	of	of	ADP
dpc-5264	127	26	skin	skin	NOUN
dpc-5264	127	27	cancers	cancer	NOUN
dpc-5264	127	28	[	[	X
dpc-5264	127	29	14,15	14,15	NUM
dpc-5264	127	30	]	]	PUNCT
dpc-5264	127	31	.	.	PUNCT
dpc-5264	128	1	hyperactivation	hyperactivation	NOUN
dpc-5264	128	2	of	of	ADP
dpc-5264	128	3	the	the	DET
dpc-5264	128	4	pi3k	pi3k	PROPN
dpc-5264	128	5	/	/	SYM
dpc-5264	128	6	akt	akt	PROPN
dpc-5264	128	7	/	/	SYM
dpc-5264	128	8	mtor	mtor	PROPN
dpc-5264	128	9	axis	axis	NOUN
dpc-5264	128	10	was	be	AUX
dpc-5264	128	11	identified	identify	VERB
dpc-5264	128	12	in	in	ADP
dpc-5264	128	13	both	both	CCONJ
dpc-5264	128	14	scc	scc	NOUN
dpc-5264	128	15	and	and	CCONJ
dpc-5264	128	16	bcc	bcc	PROPN
dpc-5264	128	17	skin	skin	NOUN
dpc-5264	128	18	tissues	tissue	NOUN
dpc-5264	128	19	,	,	PUNCT
dpc-5264	128	20	indicating	indicate	VERB
dpc-5264	128	21	a	a	DET
dpc-5264	128	22	potential	potential	ADJ
dpc-5264	128	23	involvement	involvement	NOUN
dpc-5264	128	24	in	in	ADP
dpc-5264	128	25	the	the	DET
dpc-5264	128	26	pathogenesis	pathogenesis	NOUN
dpc-5264	128	27	and	and	CCONJ
dpc-5264	128	28	malignant	malignant	ADJ
dpc-5264	128	29	progression	progression	NOUN
dpc-5264	128	30	of	of	ADP
dpc-5264	128	31	these	these	DET
dpc-5264	128	32	tumors	tumor	NOUN
dpc-5264	129	1	[	[	X
dpc-5264	129	2	16,17	16,17	NUM
dpc-5264	129	3	]	]	PUNCT
dpc-5264	129	4	.	.	PUNCT
dpc-5264	130	1	furthermore	furthermore	ADV
dpc-5264	130	2	,	,	PUNCT
dpc-5264	130	3	the	the	DET
dpc-5264	130	4	activation	activation	NOUN
dpc-5264	130	5	of	of	ADP
dpc-5264	130	6	the	the	DET
dpc-5264	130	7	stat3	stat3	NOUN
dpc-5264	130	8	and	and	CCONJ
dpc-5264	130	9	nf	nf	ADJ
dpc-5264	130	10	-	-	PUNCT
dpc-5264	130	11	κb	κb	NOUN
dpc-5264	130	12	pathways	pathway	NOUN
dpc-5264	130	13	is	be	AUX
dpc-5264	130	14	also	also	ADV
dpc-5264	130	15	a	a	DET
dpc-5264	130	16	significant	significant	ADJ
dpc-5264	130	17	factor	factor	NOUN
dpc-5264	130	18	in	in	ADP
dpc-5264	130	19	the	the	DET
dpc-5264	130	20	development	development	NOUN
dpc-5264	130	21	of	of	ADP
dpc-5264	130	22	kc	kc	PROPN
dpc-5264	131	1	[	[	X
dpc-5264	131	2	18	18	NUM
dpc-5264	131	3	]	]	PUNCT
dpc-5264	131	4	.	.	PUNCT
dpc-5264	132	1	the	the	DET
dpc-5264	132	2	expression	expression	NOUN
dpc-5264	132	3	of	of	ADP
dpc-5264	132	4	vascular	vascular	ADJ
dpc-5264	132	5	endothelial	endothelial	ADJ
dpc-5264	132	6	growth	growth	NOUN
dpc-5264	132	7	factor	factor	NOUN
dpc-5264	132	8	(	(	PUNCT
dpc-5264	132	9	vegf	vegf	PROPN
dpc-5264	132	10	)	)	PUNCT
dpc-5264	132	11	,	,	PUNCT
dpc-5264	132	12	a	a	DET
dpc-5264	132	13	crucial	crucial	ADJ
dpc-5264	132	14	regulator	regulator	NOUN
dpc-5264	132	15	of	of	ADP
dpc-5264	132	16	angiogenesis	angiogenesis	NOUN
dpc-5264	132	17	and	and	CCONJ
dpc-5264	132	18	tumor	tumor	NOUN
dpc-5264	132	19	growth	growth	NOUN
dpc-5264	132	20	,	,	PUNCT
dpc-5264	132	21	is	be	AUX
dpc-5264	132	22	elevated	elevate	VERB
dpc-5264	132	23	in	in	ADP
dpc-5264	132	24	both	both	DET
dpc-5264	132	25	rosacea	rosacea	NOUN
dpc-5264	132	26	and	and	CCONJ
dpc-5264	132	27	kcs	kcs	PROPN
dpc-5264	132	28	.	.	PUNCT
dpc-5264	133	1	the	the	DET
dpc-5264	133	2	observation	observation	NOUN
dpc-5264	133	3	that	that	SCONJ
dpc-5264	133	4	these	these	DET
dpc-5264	133	5	two	two	NUM
dpc-5264	133	6	diseases	disease	NOUN
dpc-5264	133	7	share	share	VERB
dpc-5264	133	8	common	common	ADJ
dpc-5264	133	9	pathogenic	pathogenic	ADJ
dpc-5264	133	10	mechanisms	mechanism	NOUN
dpc-5264	133	11	may	may	AUX
dpc-5264	133	12	be	be	AUX
dpc-5264	133	13	associated	associate	VERB
dpc-5264	133	14	with	with	ADP
dpc-5264	133	15	the	the	DET
dpc-5264	133	16	increased	increase	VERB
dpc-5264	133	17	prevalence	prevalence	NOUN
dpc-5264	133	18	of	of	ADP
dpc-5264	133	19	kc	kc	PROPN
dpc-5264	133	20	in	in	ADP
dpc-5264	133	21	patients	patient	NOUN
dpc-5264	133	22	with	with	ADP
dpc-5264	133	23	rosacea	rosacea	NOUN
dpc-5264	133	24	.	.	PUNCT
dpc-5264	134	1	original	original	ADJ
dpc-5264	134	2	article	article	NOUN
dpc-5264	134	3	|	|	ADV
dpc-5264	134	4	dermatol	dermatol	ADJ
dpc-5264	134	5	pract	pract	NOUN
dpc-5264	134	6	concept	concept	NOUN
dpc-5264	134	7	.	.	PUNCT
dpc-5264	135	1	2025;15(3):5264	2025;15(3):5264	NUM
dpc-5264	135	2	7	7	NUM
dpc-5264	135	3	was	be	AUX
dpc-5264	135	4	observed	observe	VERB
dpc-5264	135	5	for	for	ADP
dpc-5264	135	6	nodular	nodular	ADJ
dpc-5264	135	7	,	,	PUNCT
dpc-5264	135	8	infiltrative	infiltrative	ADJ
dpc-5264	135	9	,	,	PUNCT
dpc-5264	135	10	and	and	CCONJ
dpc-5264	135	11	adenoid	adenoid	PROPN
dpc-5264	135	12	bccs	bccs	PROPN
dpc-5264	135	13	.	.	PUNCT
dpc-5264	136	1	conversely	conversely	ADV
dpc-5264	136	2	,	,	PUNCT
dpc-5264	136	3	no	no	DET
dpc-5264	136	4	significant	significant	ADJ
dpc-5264	136	5	risk	risk	NOUN
dpc-5264	136	6	was	be	AUX
dpc-5264	136	7	identified	identify	VERB
dpc-5264	136	8	for	for	ADP
dpc-5264	136	9	superficial	superficial	ADJ
dpc-5264	136	10	bccs	bccs	NOUN
dpc-5264	136	11	and	and	CCONJ
dpc-5264	136	12	basosquamous	basosquamous	ADJ
dpc-5264	136	13	carcinomas	carcinoma	NOUN
dpc-5264	136	14	.	.	PUNCT
dpc-5264	137	1	morpheaform	morpheaform	NOUN
dpc-5264	137	2	and	and	CCONJ
dpc-5264	137	3	pigmented	pigmented	ADJ
dpc-5264	137	4	bcc	bcc	PROPN
dpc-5264	137	5	were	be	AUX
dpc-5264	137	6	observed	observe	VERB
dpc-5264	137	7	in	in	ADP
dpc-5264	137	8	a	a	DET
dpc-5264	137	9	single	single	ADJ
dpc-5264	137	10	patient	patient	NOUN
dpc-5264	137	11	.	.	PUNCT
dpc-5264	138	1	the	the	DET
dpc-5264	138	2	findings	finding	NOUN
dpc-5264	138	3	of	of	ADP
dpc-5264	138	4	our	our	PRON
dpc-5264	138	5	study	study	NOUN
dpc-5264	138	6	indicate	indicate	VERB
dpc-5264	138	7	that	that	SCONJ
dpc-5264	138	8	the	the	DET
dpc-5264	138	9	presence	presence	NOUN
dpc-5264	138	10	of	of	ADP
dpc-5264	138	11	rosacea	rosacea	NOUN
dpc-5264	138	12	is	be	AUX
dpc-5264	138	13	an	an	DET
dpc-5264	138	14	independent	independent	ADJ
dpc-5264	138	15	risk	risk	NOUN
dpc-5264	138	16	factor	factor	NOUN
dpc-5264	138	17	for	for	ADP
dpc-5264	138	18	kcs	kcs	NOUN
dpc-5264	138	19	,	,	PUNCT
dpc-5264	138	20	irrespective	irrespective	ADV
dpc-5264	138	21	of	of	ADP
dpc-5264	138	22	age	age	NOUN
dpc-5264	138	23	and	and	CCONJ
dpc-5264	138	24	sex	sex	NOUN
dpc-5264	138	25	,	,	PUNCT
dpc-5264	138	26	and	and	CCONJ
dpc-5264	138	27	in	in	ADP
dpc-5264	138	28	patients	patient	NOUN
dpc-5264	138	29	with	with	ADP
dpc-5264	138	30	skin	skin	NOUN
dpc-5264	138	31	types	type	NOUN
dpc-5264	138	32	ii	ii	PROPN
dpc-5264	138	33	and	and	CCONJ
dpc-5264	138	34	iii	iii	PROPN
dpc-5264	138	35	.	.	PROPN
dpc-5264	139	1	regarding	regard	VERB
dpc-5264	139	2	other	other	ADJ
dpc-5264	139	3	cutaneous	cutaneous	ADJ
dpc-5264	139	4	comorbidities	comorbiditie	NOUN
dpc-5264	139	5	,	,	PUNCT
dpc-5264	139	6	the	the	DET
dpc-5264	139	7	prevalence	prevalence	NOUN
dpc-5264	139	8	of	of	ADP
dpc-5264	139	9	dysplastic	dysplastic	ADJ
dpc-5264	139	10	nevus	nevus	NOUN
dpc-5264	139	11	and	and	CCONJ
dpc-5264	139	12	bowen	bowen	PROPN
dpc-5264	139	13	’s	’s	PART
dpc-5264	139	14	disease	disease	NOUN
dpc-5264	139	15	was	be	AUX
dpc-5264	139	16	significantly	significantly	ADV
dpc-5264	139	17	higher	high	ADJ
dpc-5264	139	18	in	in	ADP
dpc-5264	139	19	the	the	DET
dpc-5264	139	20	group	group	NOUN
dpc-5264	139	21	of	of	ADP
dpc-5264	139	22	patients	patient	NOUN
dpc-5264	139	23	with	with	ADP
dpc-5264	139	24	kc	kc	PROPN
dpc-5264	139	25	compared	compare	VERB
dpc-5264	139	26	to	to	ADP
dpc-5264	139	27	the	the	DET
dpc-5264	139	28	control	control	NOUN
dpc-5264	139	29	group	group	NOUN
dpc-5264	139	30	.	.	PUNCT
dpc-5264	140	1	however	however	ADV
dpc-5264	140	2	,	,	PUNCT
dpc-5264	140	3	the	the	DET
dpc-5264	140	4	number	number	NOUN
dpc-5264	140	5	of	of	ADP
dpc-5264	140	6	cases	case	NOUN
dpc-5264	140	7	was	be	AUX
dpc-5264	140	8	limited	limit	VERB
dpc-5264	140	9	to	to	ADP
dpc-5264	140	10	five	five	NUM
dpc-5264	140	11	patients	patient	NOUN
dpc-5264	140	12	in	in	ADP
dpc-5264	140	13	the	the	DET
dpc-5264	140	14	kc	kc	PROPN
dpc-5264	140	15	group	group	NOUN
dpc-5264	140	16	,	,	PUNCT
dpc-5264	140	17	with	with	ADP
dpc-5264	140	18	no	no	DET
dpc-5264	140	19	case	case	NOUN
dpc-5264	140	20	observed	observe	VERB
dpc-5264	140	21	in	in	ADP
dpc-5264	140	22	the	the	DET
dpc-5264	140	23	control	control	NOUN
dpc-5264	140	24	group	group	NOUN
dpc-5264	140	25	.	.	PUNCT
dpc-5264	141	1	in	in	ADP
dpc-5264	141	2	a	a	DET
dpc-5264	141	3	cohort	cohort	NOUN
dpc-5264	141	4	of	of	ADP
dpc-5264	141	5	11,420	11,420	NUM
dpc-5264	141	6	patients	patient	NOUN
dpc-5264	141	7	with	with	ADP
dpc-5264	141	8	rosacea	rosacea	NOUN
dpc-5264	141	9	,	,	PUNCT
dpc-5264	141	10	cho	cho	PROPN
dpc-5264	141	11	et	et	PROPN
dpc-5264	141	12	al	al	PROPN
dpc-5264	141	13	.	.	PROPN
dpc-5264	141	14	reported	report	VERB
dpc-5264	141	15	an	an	DET
dpc-5264	141	16	increased	increase	VERB
dpc-5264	141	17	risk	risk	NOUN
dpc-5264	141	18	of	of	ADP
dpc-5264	141	19	actinic	actinic	ADJ
dpc-5264	141	20	keratosis	keratosis	NOUN
dpc-5264	141	21	and	and	CCONJ
dpc-5264	141	22	kc	kc	X
dpc-5264	142	1	[	[	X
dpc-5264	142	2	22	22	NUM
dpc-5264	142	3	]	]	PUNCT
dpc-5264	142	4	.	.	PUNCT
dpc-5264	143	1	the	the	DET
dpc-5264	143	2	present	present	ADJ
dpc-5264	143	3	study	study	NOUN
dpc-5264	143	4	did	do	AUX
dpc-5264	143	5	not	not	PART
dpc-5264	143	6	find	find	VERB
dpc-5264	143	7	an	an	DET
dpc-5264	143	8	increased	increase	VERB
dpc-5264	143	9	risk	risk	NOUN
dpc-5264	143	10	of	of	ADP
dpc-5264	143	11	actinic	actinic	ADJ
dpc-5264	143	12	keratosis	keratosis	NOUN
dpc-5264	143	13	.	.	PUNCT
dpc-5264	144	1	limitations	limitation	NOUN
dpc-5264	144	2	the	the	DET
dpc-5264	144	3	study	study	NOUN
dpc-5264	144	4	’s	’s	PART
dpc-5264	144	5	key	key	ADJ
dpc-5264	144	6	strengths	strength	NOUN
dpc-5264	144	7	are	be	AUX
dpc-5264	144	8	its	its	PRON
dpc-5264	144	9	prospective	prospective	ADJ
dpc-5264	144	10	case	case	NOUN
dpc-5264	144	11	-	-	PUNCT
dpc-5264	144	12	control	control	NOUN
dpc-5264	144	13	design	design	NOUN
dpc-5264	144	14	and	and	CCONJ
dpc-5264	144	15	its	its	PRON
dpc-5264	144	16	ability	ability	NOUN
dpc-5264	144	17	to	to	PART
dpc-5264	144	18	compare	compare	VERB
dpc-5264	144	19	tumor	tumor	NOUN
dpc-5264	144	20	localization	localization	NOUN
dpc-5264	144	21	and	and	CCONJ
dpc-5264	144	22	subtype	subtype	NOUN
dpc-5264	144	23	.	.	PUNCT
dpc-5264	145	1	however	however	ADV
dpc-5264	145	2	,	,	PUNCT
dpc-5264	145	3	it	it	PRON
dpc-5264	145	4	has	have	VERB
dpc-5264	145	5	several	several	ADJ
dpc-5264	145	6	limitations	limitation	NOUN
dpc-5264	145	7	.	.	PUNCT
dpc-5264	146	1	first	first	ADV
dpc-5264	146	2	,	,	PUNCT
dpc-5264	146	3	it	it	PRON
dpc-5264	146	4	was	be	AUX
dpc-5264	146	5	conducted	conduct	VERB
dpc-5264	146	6	at	at	ADP
dpc-5264	146	7	a	a	DET
dpc-5264	146	8	single	single	ADJ
dpc-5264	146	9	center	center	NOUN
dpc-5264	146	10	,	,	PUNCT
dpc-5264	146	11	which	which	PRON
dpc-5264	146	12	may	may	AUX
dpc-5264	146	13	have	have	AUX
dpc-5264	146	14	introduced	introduce	VERB
dpc-5264	146	15	some	some	DET
dpc-5264	146	16	bias	bias	NOUN
dpc-5264	146	17	.	.	PUNCT
dpc-5264	147	1	second	second	ADJ
dpc-5264	147	2	,	,	PUNCT
dpc-5264	147	3	due	due	ADP
dpc-5264	147	4	to	to	ADP
dpc-5264	147	5	the	the	DET
dpc-5264	147	6	demographic	demographic	ADJ
dpc-5264	147	7	characteristics	characteristic	NOUN
dpc-5264	147	8	of	of	ADP
dpc-5264	147	9	our	our	PRON
dpc-5264	147	10	region	region	NOUN
dpc-5264	147	11	,	,	PUNCT
dpc-5264	147	12	there	there	PRON
dpc-5264	147	13	was	be	VERB
dpc-5264	147	14	no	no	DET
dpc-5264	147	15	patient	patient	NOUN
dpc-5264	147	16	with	with	ADP
dpc-5264	147	17	fitzpatrick	fitzpatrick	PROPN
dpc-5264	147	18	skin	skin	PROPN
dpc-5264	147	19	type	type	PROPN
dpc-5264	147	20	i.	i.	PROPN
dpc-5264	147	21	conclusion	conclusion	NOUN
dpc-5264	147	22	this	this	DET
dpc-5264	147	23	prospective	prospective	ADJ
dpc-5264	147	24	case	case	NOUN
dpc-5264	147	25	-	-	PUNCT
dpc-5264	147	26	control	control	NOUN
dpc-5264	147	27	study	study	NOUN
dpc-5264	147	28	investigated	investigate	VERB
dpc-5264	147	29	cutaneous	cutaneous	ADJ
dpc-5264	147	30	comorbidities	comorbiditie	NOUN
dpc-5264	147	31	in	in	ADP
dpc-5264	147	32	patients	patient	NOUN
dpc-5264	147	33	with	with	ADP
dpc-5264	147	34	kc	kc	PROPN
dpc-5264	147	35	in	in	ADP
dpc-5264	147	36	detail	detail	NOUN
dpc-5264	147	37	.	.	PUNCT
dpc-5264	148	1	the	the	DET
dpc-5264	148	2	risk	risk	NOUN
dpc-5264	148	3	of	of	ADP
dpc-5264	148	4	rosacea	rosacea	NOUN
dpc-5264	148	5	in	in	ADP
dpc-5264	148	6	patients	patient	NOUN
dpc-5264	148	7	with	with	ADP
dpc-5264	148	8	kc	kc	PROPN
dpc-5264	148	9	,	,	PUNCT
dpc-5264	148	10	particularly	particularly	ADV
dpc-5264	148	11	those	those	PRON
dpc-5264	148	12	with	with	ADP
dpc-5264	148	13	the	the	DET
dpc-5264	148	14	etr	etr	PROPN
dpc-5264	148	15	subtype	subtype	NOUN
dpc-5264	148	16	,	,	PUNCT
dpc-5264	148	17	was	be	AUX
dpc-5264	148	18	found	find	VERB
dpc-5264	148	19	to	to	PART
dpc-5264	148	20	be	be	AUX
dpc-5264	148	21	significantly	significantly	ADV
dpc-5264	148	22	elevated	elevate	VERB
dpc-5264	148	23	,	,	PUNCT
dpc-5264	148	24	irrespective	irrespective	ADV
dpc-5264	148	25	of	of	ADP
dpc-5264	148	26	age	age	NOUN
dpc-5264	148	27	,	,	PUNCT
dpc-5264	148	28	sex	sex	NOUN
dpc-5264	148	29	,	,	PUNCT
dpc-5264	148	30	or	or	CCONJ
dpc-5264	148	31	localization	localization	NOUN
dpc-5264	148	32	.	.	PUNCT
dpc-5264	149	1	we	we	PRON
dpc-5264	149	2	recommend	recommend	VERB
dpc-5264	149	3	that	that	SCONJ
dpc-5264	149	4	individuals	individual	NOUN
dpc-5264	149	5	with	with	ADP
dpc-5264	149	6	rosacea	rosacea	NOUN
dpc-5264	149	7	undergo	undergo	VERB
dpc-5264	149	8	regular	regular	ADJ
dpc-5264	149	9	examinations	examination	NOUN
dpc-5264	149	10	for	for	ADP
dpc-5264	149	11	the	the	DET
dpc-5264	149	12	development	development	NOUN
dpc-5264	149	13	of	of	ADP
dpc-5264	149	14	kc	kc	PROPN
dpc-5264	149	15	and	and	CCONJ
dpc-5264	149	16	that	that	SCONJ
dpc-5264	149	17	patients	patient	NOUN
dpc-5264	149	18	be	be	AUX
dpc-5264	149	19	made	make	VERB
dpc-5264	149	20	aware	aware	ADJ
dpc-5264	149	21	of	of	ADP
dpc-5264	149	22	the	the	DET
dpc-5264	149	23	importance	importance	NOUN
dpc-5264	149	24	of	of	ADP
dpc-5264	149	25	sun	sun	NOUN
dpc-5264	149	26	protection	protection	NOUN
dpc-5264	149	27	.	.	PUNCT
dpc-5264	150	1	ethics	ethic	NOUN
dpc-5264	150	2	approval	approval	NOUN
dpc-5264	150	3	:	:	PUNCT
dpc-5264	150	4	the	the	DET
dpc-5264	150	5	clinical	clinical	ADJ
dpc-5264	150	6	study	study	NOUN
dpc-5264	150	7	was	be	AUX
dpc-5264	150	8	approved	approve	VERB
dpc-5264	150	9	by	by	ADP
dpc-5264	150	10	the	the	DET
dpc-5264	150	11	university	university	PROPN
dpc-5264	150	12	of	of	ADP
dpc-5264	150	13	health	health	PROPN
dpc-5264	150	14	sciences	sciences	PROPN
dpc-5264	150	15	,	,	PUNCT
dpc-5264	150	16	şişli	şişli	NOUN
dpc-5264	150	17	hamidiye	hamidiye	NOUN
dpc-5264	150	18	etfal	etfal	NOUN
dpc-5264	150	19	training	training	NOUN
dpc-5264	150	20	and	and	CCONJ
dpc-5264	150	21	research	research	NOUN
dpc-5264	150	22	hospital	hospital	NOUN
dpc-5264	150	23	local	local	ADJ
dpc-5264	150	24	ethics	ethic	NOUN
dpc-5264	150	25	committee	committee	PROPN
dpc-5264	150	26	(	(	PUNCT
dpc-5264	150	27	approval	approval	NOUN
dpc-5264	150	28	number	number	NOUN
dpc-5264	150	29	:	:	PUNCT
dpc-5264	150	30	4493	4493	NUM
dpc-5264	150	31	)	)	PUNCT
dpc-5264	150	32	,	,	PUNCT
dpc-5264	150	33	and	and	CCONJ
dpc-5264	150	34	was	be	AUX
dpc-5264	150	35	performed	perform	VERB
dpc-5264	150	36	in	in	ADP
dpc-5264	150	37	accordance	accordance	NOUN
dpc-5264	150	38	with	with	ADP
dpc-5264	150	39	the	the	DET
dpc-5264	150	40	ethical	ethical	ADJ
dpc-5264	150	41	standards	standard	NOUN
dpc-5264	150	42	of	of	ADP
dpc-5264	150	43	the	the	DET
dpc-5264	150	44	declaration	declaration	NOUN
dpc-5264	150	45	of	of	ADP
dpc-5264	150	46	helsinki	helsinki	PROPN
dpc-5264	150	47	.	.	PUNCT
dpc-5264	151	1	informed	informed	ADJ
dpc-5264	151	2	consent	consent	NOUN
dpc-5264	151	3	:	:	PUNCT
dpc-5264	151	4	informed	inform	VERB
dpc-5264	151	5	consent	consent	NOUN
dpc-5264	151	6	was	be	AUX
dpc-5264	151	7	obtained	obtain	VERB
dpc-5264	151	8	from	from	ADP
dpc-5264	151	9	all	all	DET
dpc-5264	151	10	patients	patient	NOUN
dpc-5264	151	11	and	and	CCONJ
dpc-5264	151	12	control	control	NOUN
dpc-5264	151	13	participants	participant	NOUN
dpc-5264	151	14	included	include	VERB
dpc-5264	151	15	in	in	ADP
dpc-5264	151	16	the	the	DET
dpc-5264	151	17	study	study	NOUN
dpc-5264	151	18	.	.	PUNCT
dpc-5264	152	1	references	reference	NOUN
dpc-5264	152	2	1	1	NUM
dpc-5264	152	3	.	.	PUNCT
dpc-5264	152	4	fahradyan	fahradyan	PROPN
dpc-5264	152	5	a	a	X
dpc-5264	152	6	,	,	PUNCT
dpc-5264	152	7	howell	howell	PROPN
dpc-5264	152	8	ac	ac	PROPN
dpc-5264	152	9	,	,	PUNCT
dpc-5264	152	10	wolfswinkel	wolfswinkel	ADP
dpc-5264	152	11	em	em	PRON
dpc-5264	152	12	,	,	PUNCT
dpc-5264	152	13	tsuha	tsuha	PROPN
dpc-5264	152	14	m	m	PROPN
dpc-5264	152	15	,	,	PUNCT
dpc-5264	152	16	sheth	sheth	PROPN
dpc-5264	152	17	p	p	PROPN
dpc-5264	152	18	,	,	PUNCT
dpc-5264	152	19	wong	wong	PROPN
dpc-5264	152	20	ak	ak	PROPN
dpc-5264	152	21	.	.	PROPN
dpc-5264	152	22	updates	update	NOUN
dpc-5264	152	23	on	on	ADP
dpc-5264	152	24	the	the	DET
dpc-5264	152	25	management	management	NOUN
dpc-5264	152	26	of	of	ADP
dpc-5264	152	27	non	non	ADJ
dpc-5264	152	28	-	-	ADJ
dpc-5264	152	29	melanoma	melanoma	ADJ
dpc-5264	152	30	skin	skin	NOUN
dpc-5264	152	31	cancer	cancer	NOUN
dpc-5264	152	32	(	(	PUNCT
dpc-5264	152	33	nmsc	nmsc	NOUN
dpc-5264	152	34	)	)	PUNCT
dpc-5264	152	35	.	.	PUNCT
dpc-5264	153	1	healthcare	healthcare	PROPN
dpc-5264	153	2	(	(	PUNCT
dpc-5264	153	3	basel	basel	PROPN
dpc-5264	153	4	)	)	PUNCT
dpc-5264	153	5	.	.	PUNCT
dpc-5264	154	1	2017;5(4):82	2017;5(4):82	NUM
dpc-5264	154	2	.	.	X
dpc-5264	154	3	doi	doi	NOUN
dpc-5264	154	4	:	:	PUNCT
dpc-5264	154	5	10.3390	10.3390	NUM
dpc-5264	154	6	/	/	SYM
dpc-5264	154	7	healthcare5040082	healthcare5040082	PROPN
dpc-5264	154	8	.	.	PUNCT
dpc-5264	155	1	pmid	pmid	NOUN
dpc-5264	155	2	:	:	PUNCT
dpc-5264	155	3	29104226	29104226	NUM
dpc-5264	155	4	in	in	ADP
dpc-5264	155	5	our	our	PRON
dpc-5264	155	6	study	study	NOUN
dpc-5264	155	7	,	,	PUNCT
dpc-5264	155	8	the	the	DET
dpc-5264	155	9	sensitivity	sensitivity	NOUN
dpc-5264	155	10	,	,	PUNCT
dpc-5264	155	11	specificity	specificity	NOUN
dpc-5264	155	12	,	,	PUNCT
dpc-5264	155	13	npv	npv	NOUN
dpc-5264	155	14	,	,	PUNCT
dpc-5264	155	15	and	and	CCONJ
dpc-5264	155	16	ppv	ppv	NOUN
dpc-5264	155	17	of	of	ADP
dpc-5264	155	18	the	the	DET
dpc-5264	155	19	effectiveness	effectiveness	NOUN
dpc-5264	155	20	of	of	ADP
dpc-5264	155	21	the	the	DET
dpc-5264	155	22	presence	presence	NOUN
dpc-5264	155	23	of	of	ADP
dpc-5264	155	24	rosacea	rosacea	NOUN
dpc-5264	155	25	in	in	ADP
dpc-5264	155	26	differentiating	differentiate	VERB
dpc-5264	155	27	between	between	ADP
dpc-5264	155	28	patients	patient	NOUN
dpc-5264	155	29	with	with	ADP
dpc-5264	155	30	kc	kc	PROPN
dpc-5264	155	31	and	and	CCONJ
dpc-5264	155	32	the	the	DET
dpc-5264	155	33	control	control	NOUN
dpc-5264	155	34	group	group	NOUN
dpc-5264	155	35	were	be	AUX
dpc-5264	155	36	45.5	45.5	NUM
dpc-5264	155	37	%	%	NOUN
dpc-5264	155	38	,	,	PUNCT
dpc-5264	155	39	86.0	86.0	NUM
dpc-5264	155	40	%	%	NOUN
dpc-5264	155	41	,	,	PUNCT
dpc-5264	155	42	61.2	61.2	NUM
dpc-5264	155	43	%	%	NOUN
dpc-5264	155	44	,	,	PUNCT
dpc-5264	155	45	and	and	CCONJ
dpc-5264	155	46	76.5	76.5	NUM
dpc-5264	155	47	%	%	NOUN
dpc-5264	155	48	,	,	PUNCT
dpc-5264	155	49	respectively	respectively	ADV
dpc-5264	155	50	.	.	PUNCT
dpc-5264	156	1	for	for	ADP
dpc-5264	156	2	etr	etr	PROPN
dpc-5264	156	3	,	,	PUNCT
dpc-5264	156	4	the	the	DET
dpc-5264	156	5	corresponding	corresponding	ADJ
dpc-5264	156	6	values	value	NOUN
dpc-5264	156	7	were	be	AUX
dpc-5264	156	8	44.0	44.0	NUM
dpc-5264	156	9	%	%	NOUN
dpc-5264	156	10	,	,	PUNCT
dpc-5264	156	11	86.5	86.5	NUM
dpc-5264	156	12	%	%	NOUN
dpc-5264	156	13	,	,	PUNCT
dpc-5264	156	14	60.7	60.7	NUM
dpc-5264	156	15	%	%	NOUN
dpc-5264	156	16	,	,	PUNCT
dpc-5264	156	17	and	and	CCONJ
dpc-5264	156	18	76.5	76.5	NUM
dpc-5264	156	19	%	%	NOUN
dpc-5264	156	20	.	.	PUNCT
dpc-5264	157	1	recent	recent	ADJ
dpc-5264	157	2	studies	study	NOUN
dpc-5264	157	3	have	have	AUX
dpc-5264	157	4	indicated	indicate	VERB
dpc-5264	157	5	that	that	SCONJ
dpc-5264	157	6	there	there	PRON
dpc-5264	157	7	is	be	VERB
dpc-5264	157	8	an	an	DET
dpc-5264	157	9	association	association	NOUN
dpc-5264	157	10	between	between	ADP
dpc-5264	157	11	rosacea	rosacea	NOUN
dpc-5264	157	12	and	and	CCONJ
dpc-5264	157	13	numerous	numerous	ADJ
dpc-5264	157	14	comorbidities	comorbiditie	NOUN
dpc-5264	157	15	,	,	PUNCT
dpc-5264	157	16	including	include	VERB
dpc-5264	157	17	hypertension	hypertension	NOUN
dpc-5264	157	18	,	,	PUNCT
dpc-5264	157	19	autoimmune	autoimmune	ADJ
dpc-5264	157	20	disease	disease	NOUN
dpc-5264	157	21	,	,	PUNCT
dpc-5264	157	22	cardiovascular	cardiovascular	ADJ
dpc-5264	157	23	disease	disease	NOUN
dpc-5264	157	24	,	,	PUNCT
dpc-5264	157	25	gastrointestinal	gastrointestinal	ADJ
dpc-5264	157	26	disorders	disorder	NOUN
dpc-5264	157	27	,	,	PUNCT
dpc-5264	157	28	dyslipidemia	dyslipidemia	NOUN
dpc-5264	157	29	,	,	PUNCT
dpc-5264	157	30	and	and	CCONJ
dpc-5264	157	31	psychiatric	psychiatric	ADJ
dpc-5264	157	32	disorders	disorder	NOUN
dpc-5264	157	33	[	[	X
dpc-5264	157	34	19,20	19,20	X
dpc-5264	157	35	]	]	PUNCT
dpc-5264	157	36	.	.	PUNCT
dpc-5264	158	1	furthermore	furthermore	ADV
dpc-5264	158	2	,	,	PUNCT
dpc-5264	158	3	numerous	numerous	ADJ
dpc-5264	158	4	studies	study	NOUN
dpc-5264	158	5	have	have	AUX
dpc-5264	158	6	investigated	investigate	VERB
dpc-5264	158	7	the	the	DET
dpc-5264	158	8	potential	potential	ADJ
dpc-5264	158	9	link	link	NOUN
dpc-5264	158	10	between	between	ADP
dpc-5264	158	11	rosacea	rosacea	NOUN
dpc-5264	158	12	and	and	CCONJ
dpc-5264	158	13	various	various	ADJ
dpc-5264	158	14	forms	form	NOUN
dpc-5264	158	15	of	of	ADP
dpc-5264	158	16	cancer	cancer	NOUN
dpc-5264	158	17	.	.	PUNCT
dpc-5264	159	1	in	in	ADP
dpc-5264	159	2	a	a	DET
dpc-5264	159	3	two	two	NUM
dpc-5264	159	4	-	-	PUNCT
dpc-5264	159	5	sample	sample	NOUN
dpc-5264	159	6	bidirectional	bidirectional	ADJ
dpc-5264	159	7	mendelian	mendelian	ADJ
dpc-5264	159	8	randomization	randomization	NOUN
dpc-5264	159	9	study	study	NOUN
dpc-5264	159	10	,	,	PUNCT
dpc-5264	159	11	luo	luo	PROPN
dpc-5264	159	12	et	et	PROPN
dpc-5264	159	13	al	al	PROPN
dpc-5264	159	14	.	.	PROPN
dpc-5264	159	15	identified	identify	VERB
dpc-5264	159	16	a	a	DET
dpc-5264	159	17	positive	positive	ADJ
dpc-5264	159	18	association	association	NOUN
dpc-5264	159	19	between	between	ADP
dpc-5264	159	20	rosacea	rosacea	NOUN
dpc-5264	159	21	and	and	CCONJ
dpc-5264	159	22	glioma	glioma	NOUN
dpc-5264	159	23	,	,	PUNCT
dpc-5264	159	24	nmsc	nmsc	NOUN
dpc-5264	159	25	,	,	PUNCT
dpc-5264	159	26	and	and	CCONJ
dpc-5264	159	27	breast	breast	NOUN
dpc-5264	159	28	cancer	cancer	NOUN
dpc-5264	159	29	[	[	X
dpc-5264	159	30	21	21	NUM
dpc-5264	159	31	]	]	PUNCT
dpc-5264	159	32	.	.	PUNCT
dpc-5264	160	1	in	in	ADP
dpc-5264	160	2	a	a	DET
dpc-5264	160	3	cohort	cohort	NOUN
dpc-5264	160	4	study	study	NOUN
dpc-5264	160	5	by	by	ADP
dpc-5264	160	6	egeberg	egeberg	PROPN
dpc-5264	160	7	et	et	PROPN
dpc-5264	160	8	al	al	PROPN
dpc-5264	160	9	.	.	PROPN
dpc-5264	160	10	analyzing	analyze	VERB
dpc-5264	160	11	data	datum	NOUN
dpc-5264	160	12	from	from	ADP
dpc-5264	160	13	nationwide	nationwide	ADJ
dpc-5264	160	14	danish	danish	ADJ
dpc-5264	160	15	registries	registry	NOUN
dpc-5264	160	16	,	,	PUNCT
dpc-5264	160	17	a	a	DET
dpc-5264	160	18	statistically	statistically	ADV
dpc-5264	160	19	significant	significant	ADJ
dpc-5264	160	20	association	association	NOUN
dpc-5264	160	21	was	be	AUX
dpc-5264	160	22	observed	observe	VERB
dpc-5264	160	23	between	between	ADP
dpc-5264	160	24	rosacea	rosacea	NOUN
dpc-5264	160	25	and	and	CCONJ
dpc-5264	160	26	nmsc	nmsc	NOUN
dpc-5264	160	27	[	[	X
dpc-5264	160	28	3	3	NUM
dpc-5264	160	29	]	]	PUNCT
dpc-5264	160	30	.	.	PUNCT
dpc-5264	161	1	patients	patient	NOUN
dpc-5264	161	2	with	with	ADP
dpc-5264	161	3	rosacea	rosacea	NOUN
dpc-5264	161	4	were	be	AUX
dpc-5264	161	5	more	more	ADV
dpc-5264	161	6	likely	likely	ADJ
dpc-5264	161	7	to	to	PART
dpc-5264	161	8	develop	develop	VERB
dpc-5264	161	9	nmsc	nmsc	NOUN
dpc-5264	161	10	compared	compare	VERB
dpc-5264	161	11	to	to	ADP
dpc-5264	161	12	patients	patient	NOUN
dpc-5264	161	13	in	in	ADP
dpc-5264	161	14	the	the	DET
dpc-5264	161	15	reference	reference	NOUN
dpc-5264	161	16	population	population	NOUN
dpc-5264	161	17	(	(	PUNCT
dpc-5264	161	18	hr	hr	NOUN
dpc-5264	161	19	1.36	1.36	NUM
dpc-5264	161	20	,	,	PUNCT
dpc-5264	161	21	95	95	NUM
dpc-5264	161	22	%	%	NOUN
dpc-5264	161	23	ci	ci	NOUN
dpc-5264	161	24	:	:	PUNCT
dpc-5264	161	25	1.26–1.47	1.26–1.47	NUM
dpc-5264	161	26	)	)	PUNCT
dpc-5264	161	27	.	.	PUNCT
dpc-5264	162	1	in	in	ADP
dpc-5264	162	2	another	another	DET
dpc-5264	162	3	study	study	NOUN
dpc-5264	162	4	,	,	PUNCT
dpc-5264	162	5	cho	cho	PROPN
dpc-5264	162	6	et	et	PROPN
dpc-5264	162	7	al	al	PROPN
dpc-5264	162	8	.	.	PROPN
dpc-5264	162	9	conducted	conduct	VERB
dpc-5264	162	10	a	a	DET
dpc-5264	162	11	nationwide	nationwide	ADJ
dpc-5264	162	12	,	,	PUNCT
dpc-5264	162	13	population	population	NOUN
dpc-5264	162	14	-	-	PUNCT
dpc-5264	162	15	based	base	VERB
dpc-5264	162	16	retrospective	retrospective	ADJ
dpc-5264	162	17	cohort	cohort	NOUN
dpc-5264	162	18	study	study	NOUN
dpc-5264	162	19	of	of	ADP
dpc-5264	162	20	11,420	11,420	NUM
dpc-5264	162	21	patients	patient	NOUN
dpc-5264	162	22	in	in	ADP
dpc-5264	162	23	south	south	PROPN
dpc-5264	162	24	korea	korea	PROPN
dpc-5264	163	1	[	[	X
dpc-5264	163	2	22	22	NUM
dpc-5264	163	3	]	]	PUNCT
dpc-5264	163	4	.	.	PUNCT
dpc-5264	164	1	the	the	DET
dpc-5264	164	2	results	result	NOUN
dpc-5264	164	3	demonstrated	demonstrate	VERB
dpc-5264	164	4	a	a	DET
dpc-5264	164	5	notable	notable	ADJ
dpc-5264	164	6	correlation	correlation	NOUN
dpc-5264	164	7	between	between	ADP
dpc-5264	164	8	rosacea	rosacea	NOUN
dpc-5264	164	9	and	and	CCONJ
dpc-5264	164	10	nmsc	nmsc	NOUN
dpc-5264	164	11	incidence	incidence	NOUN
dpc-5264	164	12	in	in	ADP
dpc-5264	164	13	comparison	comparison	NOUN
dpc-5264	164	14	to	to	ADP
dpc-5264	164	15	the	the	DET
dpc-5264	164	16	reference	reference	NOUN
dpc-5264	164	17	population	population	NOUN
dpc-5264	164	18	(	(	PUNCT
dpc-5264	164	19	hr	hr	NOUN
dpc-5264	164	20	2.66	2.66	NUM
dpc-5264	164	21	,	,	PUNCT
dpc-5264	164	22	95	95	NUM
dpc-5264	164	23	%	%	NOUN
dpc-5264	164	24	ci	ci	NOUN
dpc-5264	164	25	:	:	PUNCT
dpc-5264	164	26	1.53–4.61	1.53–4.61	NUM
dpc-5264	164	27	)	)	PUNCT
dpc-5264	164	28	.	.	PUNCT
dpc-5264	165	1	in	in	ADP
dpc-5264	165	2	contrast	contrast	NOUN
dpc-5264	165	3	,	,	PUNCT
dpc-5264	165	4	in	in	ADP
dpc-5264	165	5	the	the	DET
dpc-5264	165	6	study	study	NOUN
dpc-5264	165	7	by	by	ADP
dpc-5264	165	8	lin	lin	PROPN
dpc-5264	165	9	et	et	PROPN
dpc-5264	165	10	al	al	PROPN
dpc-5264	165	11	.	.	PROPN
dpc-5264	165	12	,	,	PUNCT
dpc-5264	165	13	2453	2453	NUM
dpc-5264	165	14	of	of	ADP
dpc-5264	165	15	the	the	DET
dpc-5264	165	16	4537	4537	NUM
dpc-5264	165	17	patients	patient	NOUN
dpc-5264	165	18	diagnosed	diagnose	VERB
dpc-5264	165	19	with	with	ADP
dpc-5264	165	20	bcc	bcc	PROPN
dpc-5264	165	21	had	have	VERB
dpc-5264	165	22	facial	facial	ADJ
dpc-5264	165	23	bcc	bcc	NOUN
dpc-5264	165	24	,	,	PUNCT
dpc-5264	165	25	and	and	CCONJ
dpc-5264	165	26	267	267	NUM
dpc-5264	165	27	of	of	ADP
dpc-5264	165	28	them	they	PRON
dpc-5264	165	29	had	have	VERB
dpc-5264	165	30	a	a	DET
dpc-5264	165	31	history	history	NOUN
dpc-5264	165	32	of	of	ADP
dpc-5264	165	33	rosacea	rosacea	NOUN
dpc-5264	166	1	[	[	X
dpc-5264	166	2	6	6	NUM
dpc-5264	166	3	]	]	PUNCT
dpc-5264	166	4	.	.	PUNCT
dpc-5264	167	1	the	the	DET
dpc-5264	167	2	results	result	NOUN
dpc-5264	167	3	of	of	ADP
dpc-5264	167	4	the	the	DET
dpc-5264	167	5	study	study	NOUN
dpc-5264	167	6	demonstrated	demonstrate	VERB
dpc-5264	167	7	that	that	SCONJ
dpc-5264	167	8	the	the	DET
dpc-5264	167	9	prevalence	prevalence	NOUN
dpc-5264	167	10	of	of	ADP
dpc-5264	167	11	facial	facial	ADJ
dpc-5264	167	12	bcc	bcc	NOUN
dpc-5264	167	13	in	in	ADP
dpc-5264	167	14	patients	patient	NOUN
dpc-5264	167	15	with	with	ADP
dpc-5264	167	16	a	a	DET
dpc-5264	167	17	history	history	NOUN
dpc-5264	167	18	of	of	ADP
dpc-5264	167	19	rosacea	rosacea	NOUN
dpc-5264	167	20	was	be	AUX
dpc-5264	167	21	markedly	markedly	ADV
dpc-5264	167	22	lower	low	ADJ
dpc-5264	167	23	than	than	ADP
dpc-5264	167	24	in	in	ADP
dpc-5264	167	25	patients	patient	NOUN
dpc-5264	167	26	without	without	ADP
dpc-5264	167	27	rosacea	rosacea	NOUN
dpc-5264	167	28	(	(	PUNCT
dpc-5264	167	29	3.80	3.80	NUM
dpc-5264	167	30	vs	vs	ADP
dpc-5264	167	31	5.07	5.07	NUM
dpc-5264	167	32	per	per	ADP
dpc-5264	167	33	100	100	NUM
dpc-5264	167	34	patients	patient	NOUN
dpc-5264	167	35	;	;	PUNCT
dpc-5264	167	36	p	p	X
dpc-5264	167	37	<	<	X
dpc-5264	167	38	0.001	0.001	NUM
dpc-5264	167	39	)	)	PUNCT
dpc-5264	167	40	.	.	PUNCT
dpc-5264	168	1	a	a	DET
dpc-5264	168	2	comparison	comparison	NOUN
dpc-5264	168	3	of	of	ADP
dpc-5264	168	4	bcc	bcc	PROPN
dpc-5264	168	5	of	of	ADP
dpc-5264	168	6	the	the	DET
dpc-5264	168	7	body	body	NOUN
dpc-5264	168	8	revealed	reveal	VERB
dpc-5264	168	9	no	no	DET
dpc-5264	168	10	significant	significant	ADJ
dpc-5264	168	11	difference	difference	NOUN
dpc-5264	168	12	between	between	ADP
dpc-5264	168	13	patients	patient	NOUN
dpc-5264	168	14	with	with	ADP
dpc-5264	168	15	and	and	CCONJ
dpc-5264	168	16	without	without	ADP
dpc-5264	168	17	a	a	DET
dpc-5264	168	18	history	history	NOUN
dpc-5264	168	19	of	of	ADP
dpc-5264	168	20	rosacea	rosacea	NOUN
dpc-5264	168	21	.	.	PUNCT
dpc-5264	169	1	lazzeri	lazzeri	PROPN
dpc-5264	169	2	et	et	PROPN
dpc-5264	169	3	al	al	PROPN
dpc-5264	169	4	.	.	PROPN
dpc-5264	169	5	presented	present	VERB
dpc-5264	169	6	a	a	DET
dpc-5264	169	7	case	case	NOUN
dpc-5264	169	8	series	series	NOUN
dpc-5264	169	9	and	and	CCONJ
dpc-5264	169	10	a	a	DET
dpc-5264	169	11	literature	literature	NOUN
dpc-5264	169	12	review	review	NOUN
dpc-5264	169	13	of	of	ADP
dpc-5264	169	14	a	a	DET
dpc-5264	169	15	total	total	NOUN
dpc-5264	169	16	of	of	ADP
dpc-5264	169	17	46	46	NUM
dpc-5264	169	18	patients	patient	NOUN
dpc-5264	169	19	with	with	ADP
dpc-5264	169	20	rhinophyma	rhinophyma	NOUN
dpc-5264	169	21	who	who	PRON
dpc-5264	169	22	subsequently	subsequently	ADV
dpc-5264	169	23	developed	develop	VERB
dpc-5264	169	24	skin	skin	NOUN
dpc-5264	169	25	cancer	cancer	NOUN
dpc-5264	169	26	[	[	X
dpc-5264	169	27	23	23	NUM
dpc-5264	169	28	]	]	PUNCT
dpc-5264	169	29	.	.	PUNCT
dpc-5264	170	1	of	of	ADP
dpc-5264	170	2	the	the	DET
dpc-5264	170	3	patients	patient	NOUN
dpc-5264	170	4	in	in	ADP
dpc-5264	170	5	question	question	NOUN
dpc-5264	170	6	,	,	PUNCT
dpc-5264	170	7	28	28	NUM
dpc-5264	170	8	were	be	AUX
dpc-5264	170	9	diagnosed	diagnose	VERB
dpc-5264	170	10	with	with	ADP
dpc-5264	170	11	bcc	bcc	PROPN
dpc-5264	170	12	,	,	PUNCT
dpc-5264	170	13	11	11	NUM
dpc-5264	170	14	with	with	ADP
dpc-5264	170	15	scc	scc	PROPN
dpc-5264	170	16	,	,	PUNCT
dpc-5264	170	17	four	four	NUM
dpc-5264	170	18	with	with	ADP
dpc-5264	170	19	both	both	CCONJ
dpc-5264	170	20	scc	scc	NOUN
dpc-5264	170	21	and	and	CCONJ
dpc-5264	170	22	bcc	bcc	PROPN
dpc-5264	170	23	,	,	PUNCT
dpc-5264	170	24	and	and	CCONJ
dpc-5264	170	25	one	one	NUM
dpc-5264	170	26	with	with	ADP
dpc-5264	170	27	angiosarcoma	angiosarcoma	NOUN
dpc-5264	170	28	.	.	PUNCT
dpc-5264	171	1	with	with	ADP
dpc-5264	171	2	regard	regard	NOUN
dpc-5264	171	3	to	to	ADP
dpc-5264	171	4	scc	scc	PROPN
dpc-5264	171	5	,	,	PUNCT
dpc-5264	171	6	577	577	NUM
dpc-5264	171	7	cases	case	NOUN
dpc-5264	171	8	of	of	ADP
dpc-5264	171	9	scc	scc	NOUN
dpc-5264	171	10	were	be	AUX
dpc-5264	171	11	identified	identify	VERB
dpc-5264	171	12	in	in	ADP
dpc-5264	171	13	a	a	DET
dpc-5264	171	14	population	population	NOUN
dpc-5264	171	15	of	of	ADP
dpc-5264	171	16	90,238	90,238	NUM
dpc-5264	171	17	women	woman	NOUN
dpc-5264	171	18	in	in	ADP
dpc-5264	171	19	the	the	DET
dpc-5264	171	20	usa	usa	PROPN
dpc-5264	172	1	[	[	X
dpc-5264	172	2	24	24	NUM
dpc-5264	172	3	]	]	PUNCT
dpc-5264	172	4	.	.	PUNCT
dpc-5264	173	1	the	the	DET
dpc-5264	173	2	results	result	NOUN
dpc-5264	173	3	demonstrated	demonstrate	VERB
dpc-5264	173	4	a	a	DET
dpc-5264	173	5	significant	significant	ADJ
dpc-5264	173	6	association	association	NOUN
dpc-5264	173	7	between	between	ADP
dpc-5264	173	8	rosacea	rosacea	NOUN
dpc-5264	173	9	and	and	CCONJ
dpc-5264	173	10	scc	scc	PROPN
dpc-5264	173	11	(	(	PUNCT
dpc-5264	173	12	rr	rr	PROPN
dpc-5264	173	13	1.40	1.40	NUM
dpc-5264	173	14	.	.	PUNCT
dpc-5264	174	1	95	95	NUM
dpc-5264	174	2	%	%	NOUN
dpc-5264	174	3	ci	ci	NOUN
dpc-5264	174	4	:	:	PUNCT
dpc-5264	174	5	1.02–1.93	1.02–1.93	NUM
dpc-5264	174	6	)	)	PUNCT
dpc-5264	174	7	.	.	PUNCT
dpc-5264	175	1	in	in	ADP
dpc-5264	175	2	this	this	DET
dpc-5264	175	3	study	study	NOUN
dpc-5264	175	4	,	,	PUNCT
dpc-5264	175	5	the	the	DET
dpc-5264	175	6	location	location	NOUN
dpc-5264	175	7	of	of	ADP
dpc-5264	175	8	scc	scc	PROPN
dpc-5264	175	9	was	be	AUX
dpc-5264	175	10	also	also	ADV
dpc-5264	175	11	divided	divide	VERB
dpc-5264	175	12	into	into	ADP
dpc-5264	175	13	two	two	NUM
dpc-5264	175	14	groups	group	NOUN
dpc-5264	175	15	:	:	PUNCT
dpc-5264	175	16	head	head	NOUN
dpc-5264	175	17	and	and	CCONJ
dpc-5264	175	18	neck	neck	NOUN
dpc-5264	175	19	and	and	CCONJ
dpc-5264	175	20	non	non	ADJ
dpc-5264	175	21	-	-	ADJ
dpc-5264	175	22	head	head	NOUN
dpc-5264	175	23	and	and	CCONJ
dpc-5264	175	24	neck	neck	NOUN
dpc-5264	175	25	.	.	PUNCT
dpc-5264	176	1	these	these	DET
dpc-5264	176	2	groups	group	NOUN
dpc-5264	176	3	were	be	AUX
dpc-5264	176	4	then	then	ADV
dpc-5264	176	5	compared	compare	VERB
dpc-5264	176	6	in	in	ADP
dpc-5264	176	7	terms	term	NOUN
dpc-5264	176	8	of	of	ADP
dpc-5264	176	9	the	the	DET
dpc-5264	176	10	history	history	NOUN
dpc-5264	176	11	of	of	ADP
dpc-5264	176	12	rosacea	rosacea	NOUN
dpc-5264	176	13	.	.	PUNCT
dpc-5264	177	1	the	the	DET
dpc-5264	177	2	results	result	NOUN
dpc-5264	177	3	demonstrated	demonstrate	VERB
dpc-5264	177	4	a	a	DET
dpc-5264	177	5	significant	significant	ADJ
dpc-5264	177	6	association	association	NOUN
dpc-5264	177	7	between	between	ADP
dpc-5264	177	8	rosacea	rosacea	NOUN
dpc-5264	177	9	and	and	CCONJ
dpc-5264	177	10	head	head	NOUN
dpc-5264	177	11	and	and	CCONJ
dpc-5264	177	12	neck	neck	PROPN
dpc-5264	177	13	scc	scc	PROPN
dpc-5264	177	14	(	(	PUNCT
dpc-5264	177	15	rr	rr	NOUN
dpc-5264	177	16	1.71	1.71	NUM
dpc-5264	177	17	,	,	PUNCT
dpc-5264	177	18	95	95	NUM
dpc-5264	177	19	%	%	NOUN
dpc-5264	177	20	ci	ci	NOUN
dpc-5264	177	21	:	:	PUNCT
dpc-5264	177	22	1.09–2.69	1.09–2.69	NUM
dpc-5264	177	23	)	)	PUNCT
dpc-5264	177	24	.	.	PUNCT
dpc-5264	178	1	the	the	DET
dpc-5264	178	2	findings	finding	NOUN
dpc-5264	178	3	of	of	ADP
dpc-5264	178	4	our	our	PRON
dpc-5264	178	5	study	study	NOUN
dpc-5264	178	6	indicate	indicate	VERB
dpc-5264	178	7	that	that	SCONJ
dpc-5264	178	8	the	the	DET
dpc-5264	178	9	presence	presence	NOUN
dpc-5264	178	10	of	of	ADP
dpc-5264	178	11	rosacea	rosacea	NOUN
dpc-5264	178	12	is	be	AUX
dpc-5264	178	13	associated	associate	VERB
dpc-5264	178	14	with	with	ADP
dpc-5264	178	15	an	an	DET
dpc-5264	178	16	increased	increase	VERB
dpc-5264	178	17	risk	risk	NOUN
dpc-5264	178	18	of	of	ADP
dpc-5264	178	19	kc	kc	PROPN
dpc-5264	178	20	in	in	ADP
dpc-5264	178	21	all	all	DET
dpc-5264	178	22	localizations	localization	NOUN
dpc-5264	178	23	.	.	PUNCT
dpc-5264	179	1	furthermore	furthermore	ADV
dpc-5264	179	2	,	,	PUNCT
dpc-5264	179	3	the	the	DET
dpc-5264	179	4	majority	majority	NOUN
dpc-5264	179	5	of	of	ADP
dpc-5264	179	6	patients	patient	NOUN
dpc-5264	179	7	with	with	ADP
dpc-5264	179	8	rosacea	rosacea	NOUN
dpc-5264	179	9	were	be	AUX
dpc-5264	179	10	observed	observe	VERB
dpc-5264	179	11	to	to	PART
dpc-5264	179	12	belong	belong	VERB
dpc-5264	179	13	to	to	ADP
dpc-5264	179	14	the	the	DET
dpc-5264	179	15	etr	etr	PROPN
dpc-5264	179	16	subgroup	subgroup	PROPN
dpc-5264	179	17	.	.	PUNCT
dpc-5264	180	1	concerning	concern	VERB
dpc-5264	180	2	the	the	DET
dpc-5264	180	3	risk	risk	NOUN
dpc-5264	180	4	of	of	ADP
dpc-5264	180	5	bcc	bcc	PROPN
dpc-5264	180	6	subgroups	subgroup	NOUN
dpc-5264	180	7	,	,	PUNCT
dpc-5264	180	8	a	a	DET
dpc-5264	180	9	significant	significant	ADJ
dpc-5264	180	10	and	and	CCONJ
dpc-5264	180	11	positive	positive	ADJ
dpc-5264	180	12	association	association	NOUN
dpc-5264	180	13	8	8	NUM
dpc-5264	180	14	original	original	ADJ
dpc-5264	180	15	article	article	NOUN
dpc-5264	180	16	|	|	ADV
dpc-5264	180	17	dermatol	dermatol	ADJ
dpc-5264	180	18	pract	pract	NOUN
dpc-5264	180	19	concept	concept	NOUN
dpc-5264	180	20	.	.	PUNCT
dpc-5264	181	1	2025;15(3):5264	2025;15(3):5264	NUM
dpc-5264	181	2	14	14	NUM
dpc-5264	181	3	.	.	PUNCT
dpc-5264	182	1	leo	leo	PROPN
dpc-5264	182	2	ms	ms	PROPN
dpc-5264	182	3	,	,	PUNCT
dpc-5264	182	4	sivamani	sivamani	ADJ
dpc-5264	182	5	rk	rk	PROPN
dpc-5264	182	6	.	.	PUNCT
dpc-5264	182	7	phytochemical	phytochemical	ADJ
dpc-5264	182	8	modulation	modulation	NOUN
dpc-5264	182	9	of	of	ADP
dpc-5264	182	10	the	the	DET
dpc-5264	182	11	akt/	akt/	PROPN
dpc-5264	182	12	mtor	mtor	PROPN
dpc-5264	182	13	pathway	pathway	NOUN
dpc-5264	182	14	and	and	CCONJ
dpc-5264	182	15	its	its	PRON
dpc-5264	182	16	potential	potential	ADJ
dpc-5264	182	17	use	use	NOUN
dpc-5264	182	18	in	in	ADP
dpc-5264	182	19	cutaneous	cutaneous	ADJ
dpc-5264	182	20	disease	disease	NOUN
dpc-5264	182	21	.	.	PUNCT
dpc-5264	183	1	arch	arch	ADJ
dpc-5264	183	2	dermatol	dermatol	NOUN
dpc-5264	183	3	res	re	NOUN
dpc-5264	183	4	.	.	PUNCT
dpc-5264	183	5	2014;306:861	2014;306:861	NUM
dpc-5264	183	6	-	-	PUNCT
dpc-5264	183	7	871	871	NUM
dpc-5264	183	8	.	.	PUNCT
dpc-5264	184	1	doi	doi	NOUN
dpc-5264	184	2	:	:	PUNCT
dpc-5264	184	3	10.1007	10.1007	NUM
dpc-5264	184	4	/	/	SYM
dpc-5264	184	5	s00403	s00403	NOUN
dpc-5264	184	6	-	-	PUNCT
dpc-5264	184	7	0141480	0141480	NUM
dpc-5264	184	8	-	-	SYM
dpc-5264	184	9	8	8	NUM
dpc-5264	184	10	.	.	PUNCT
dpc-5264	185	1	pmid	pmid	NOUN
dpc-5264	185	2	:	:	PUNCT
dpc-5264	185	3	24972910	24972910	NUM
dpc-5264	185	4	15	15	NUM
dpc-5264	185	5	.	.	PUNCT
dpc-5264	186	1	chamcheu	chamcheu	PROPN
dpc-5264	186	2	jc	jc	PROPN
dpc-5264	186	3	,	,	PUNCT
dpc-5264	186	4	roy	roy	PROPN
dpc-5264	186	5	t	t	PROPN
dpc-5264	186	6	,	,	PUNCT
dpc-5264	186	7	uddin	uddin	PROPN
dpc-5264	186	8	mb	mb	ADP
dpc-5264	186	9	,	,	PUNCT
dpc-5264	186	10	et	et	PROPN
dpc-5264	186	11	al	al	PROPN
dpc-5264	186	12	.	.	PUNCT
dpc-5264	186	13	role	role	NOUN
dpc-5264	186	14	and	and	CCONJ
dpc-5264	186	15	therapeutic	therapeutic	ADJ
dpc-5264	186	16	targeting	targeting	NOUN
dpc-5264	186	17	of	of	ADP
dpc-5264	186	18	the	the	DET
dpc-5264	186	19	pi3k	pi3k	PROPN
dpc-5264	186	20	/	/	SYM
dpc-5264	186	21	akt	akt	PROPN
dpc-5264	186	22	/	/	SYM
dpc-5264	186	23	mtor	mtor	PROPN
dpc-5264	186	24	signaling	signal	VERB
dpc-5264	186	25	pathway	pathway	NOUN
dpc-5264	186	26	in	in	ADP
dpc-5264	186	27	skin	skin	NOUN
dpc-5264	186	28	cancer	cancer	NOUN
dpc-5264	186	29	:	:	PUNCT
dpc-5264	186	30	a	a	DET
dpc-5264	186	31	review	review	NOUN
dpc-5264	186	32	of	of	ADP
dpc-5264	186	33	current	current	ADJ
dpc-5264	186	34	status	status	NOUN
dpc-5264	186	35	and	and	CCONJ
dpc-5264	186	36	future	future	ADJ
dpc-5264	186	37	trends	trend	NOUN
dpc-5264	186	38	on	on	ADP
dpc-5264	186	39	natural	natural	ADJ
dpc-5264	186	40	and	and	CCONJ
dpc-5264	186	41	synthetic	synthetic	ADJ
dpc-5264	186	42	agents	agent	NOUN
dpc-5264	186	43	therapy	therapy	NOUN
dpc-5264	186	44	.	.	PUNCT
dpc-5264	187	1	cells	cell	NOUN
dpc-5264	187	2	.	.	PUNCT
dpc-5264	188	1	2019;8:803	2019;8:803	NUM
dpc-5264	188	2	.	.	PUNCT
dpc-5264	189	1	doi	doi	NOUN
dpc-5264	189	2	:	:	PUNCT
dpc-5264	189	3	10.3390	10.3390	NUM
dpc-5264	189	4	/cells8080803	/cells8080803	SYM
dpc-5264	189	5	.	.	PUNCT
dpc-5264	190	1	pmid	pmid	NOUN
dpc-5264	190	2	:	:	PUNCT
dpc-5264	190	3	31370278	31370278	NUM
dpc-5264	190	4	16	16	NUM
dpc-5264	190	5	.	.	PUNCT
dpc-5264	191	1	einspahr	einspahr	PROPN
dpc-5264	191	2	jg	jg	PROPN
dpc-5264	191	3	,	,	PUNCT
dpc-5264	191	4	calvert	calvert	PROPN
dpc-5264	191	5	v	v	PROPN
dpc-5264	191	6	,	,	PUNCT
dpc-5264	191	7	alberts	alberts	PROPN
dpc-5264	191	8	ds	ds	PROPN
dpc-5264	191	9	,	,	PUNCT
dpc-5264	191	10	et	et	PROPN
dpc-5264	191	11	al	al	PROPN
dpc-5264	191	12	.	.	PUNCT
dpc-5264	192	1	functional	functional	ADJ
dpc-5264	192	2	protein	protein	NOUN
dpc-5264	192	3	pathway	pathway	NOUN
dpc-5264	192	4	activation	activation	NOUN
dpc-5264	192	5	mapping	mapping	NOUN
dpc-5264	192	6	of	of	ADP
dpc-5264	192	7	the	the	DET
dpc-5264	192	8	progression	progression	NOUN
dpc-5264	192	9	of	of	ADP
dpc-5264	192	10	normal	normal	ADJ
dpc-5264	192	11	skin	skin	NOUN
dpc-5264	192	12	to	to	ADP
dpc-5264	192	13	squamous	squamous	ADJ
dpc-5264	192	14	cell	cell	NOUN
dpc-5264	192	15	carcinoma	carcinoma	NOUN
dpc-5264	192	16	.	.	PUNCT
dpc-5264	193	1	cancer	cancer	NOUN
dpc-5264	193	2	prev	prev	PROPN
dpc-5264	193	3	res	res	PROPN
dpc-5264	193	4	(	(	PUNCT
dpc-5264	193	5	phila	phila	PROPN
dpc-5264	193	6	)	)	PUNCT
dpc-5264	193	7	.	.	PUNCT
dpc-5264	194	1	2012;5(3):403	2012;5(3):403	X
dpc-5264	194	2	-	-	SYM
dpc-5264	194	3	413	413	NUM
dpc-5264	194	4	.	.	PUNCT
dpc-5264	195	1	doi	doi	NOUN
dpc-5264	195	2	:	:	PUNCT
dpc-5264	195	3	10.1158/1940	10.1158/1940	NUM
dpc-5264	195	4	-	-	PUNCT
dpc-5264	195	5	6207.capr-11	6207.capr-11	NUM
dpc-5264	195	6	-	-	PUNCT
dpc-5264	195	7	0427	0427	NUM
dpc-5264	195	8	.	.	PUNCT
dpc-5264	196	1	pmid	pmid	NOUN
dpc-5264	196	2	:	:	PUNCT
dpc-5264	196	3	22389437	22389437	NUM
dpc-5264	196	4	17	17	NUM
dpc-5264	196	5	.	.	PUNCT
dpc-5264	197	1	brinkhuizen	brinkhuizen	PROPN
dpc-5264	197	2	t	t	PROPN
dpc-5264	197	3	,	,	PUNCT
dpc-5264	197	4	weijzen	weijzen	NOUN
dpc-5264	197	5	cah	cah	PROPN
dpc-5264	197	6	,	,	PUNCT
dpc-5264	197	7	eben	eben	PROPN
dpc-5264	197	8	j	j	PROPN
dpc-5264	197	9	,	,	PUNCT
dpc-5264	197	10	et	et	PROPN
dpc-5264	197	11	al	al	PROPN
dpc-5264	197	12	.	.	PROPN
dpc-5264	198	1	immunohistochemical	immunohistochemical	ADJ
dpc-5264	198	2	analysis	analysis	NOUN
dpc-5264	198	3	of	of	ADP
dpc-5264	198	4	the	the	DET
dpc-5264	198	5	mechanistic	mechanistic	ADJ
dpc-5264	198	6	target	target	NOUN
dpc-5264	198	7	of	of	ADP
dpc-5264	198	8	rapamycin	rapamycin	NOUN
dpc-5264	198	9	and	and	CCONJ
dpc-5264	198	10	hypoxia	hypoxia	NOUN
dpc-5264	198	11	signalling	signal	VERB
dpc-5264	198	12	pathways	pathway	NOUN
dpc-5264	198	13	in	in	ADP
dpc-5264	198	14	basal	basal	ADJ
dpc-5264	198	15	cell	cell	NOUN
dpc-5264	198	16	carcinoma	carcinoma	NOUN
dpc-5264	198	17	and	and	CCONJ
dpc-5264	198	18	trichoepithelioma	trichoepithelioma	NOUN
dpc-5264	198	19	.	.	PUNCT
dpc-5264	199	1	plos	plos	PROPN
dpc-5264	199	2	one	one	NUM
dpc-5264	199	3	.	.	PUNCT
dpc-5264	200	1	2014;9(9):e106427	2014;9(9):e106427	NUM
dpc-5264	200	2	.	.	X
dpc-5264	201	1	doi	doi	NOUN
dpc-5264	201	2	:	:	PUNCT
dpc-5264	201	3	10.1371	10.1371	NUM
dpc-5264	201	4	/	/	SYM
dpc-5264	201	5	journal	journal	NOUN
dpc-5264	201	6	.	.	PUNCT
dpc-5264	202	1	pone.0106427	pone.0106427	PROPN
dpc-5264	202	2	.	.	NOUN
dpc-5264	202	3	pmid	pmid	NOUN
dpc-5264	202	4	:	:	PUNCT
dpc-5264	202	5	25181405	25181405	NUM
dpc-5264	202	6	18	18	NUM
dpc-5264	202	7	.	.	PUNCT
dpc-5264	203	1	feehan	feehan	PROPN
dpc-5264	203	2	rp	rp	PROPN
dpc-5264	203	3	,	,	PUNCT
dpc-5264	203	4	shantz	shantz	X
dpc-5264	203	5	lm	lm	INTJ
dpc-5264	203	6	.	.	PUNCT
dpc-5264	204	1	molecular	molecular	ADJ
dpc-5264	204	2	signaling	signal	VERB
dpc-5264	204	3	cascades	cascade	NOUN
dpc-5264	204	4	involved	involve	VERB
dpc-5264	204	5	in	in	ADP
dpc-5264	204	6	nonmelanoma	nonmelanoma	ADJ
dpc-5264	204	7	skin	skin	NOUN
dpc-5264	204	8	carcinogenesis	carcinogenesis	NOUN
dpc-5264	204	9	.	.	PUNCT
dpc-5264	205	1	biochem	biochem	PROPN
dpc-5264	205	2	j.2016;473(19	j.2016;473(19	NOUN
dpc-5264	205	3	):	):	PUNCT
dpc-5264	205	4	2973	2973	NUM
dpc-5264	205	5	-	-	SYM
dpc-5264	205	6	2994	2994	NUM
dpc-5264	205	7	.	.	PUNCT
dpc-5264	206	1	doi	doi	NOUN
dpc-5264	206	2	:	:	PUNCT
dpc-5264	206	3	10.1042	10.1042	NUM
dpc-5264	206	4	/	/	SYM
dpc-5264	206	5	bcj20160471	bcj20160471	NOUN
dpc-5264	206	6	.	.	PUNCT
dpc-5264	207	1	pmid	pmid	NOUN
dpc-5264	207	2	:	:	PUNCT
dpc-5264	207	3	27679857	27679857	NUM
dpc-5264	207	4	19	19	NUM
dpc-5264	207	5	.	.	PUNCT
dpc-5264	208	1	karaosmanoglu	karaosmanoglu	PROPN
dpc-5264	208	2	n	n	CCONJ
dpc-5264	208	3	,	,	PUNCT
dpc-5264	208	4	ozdemir	ozdemir	PROPN
dpc-5264	208	5	cetinkaya	cetinkaya	PROPN
dpc-5264	208	6	p	p	NOUN
dpc-5264	208	7	,	,	PUNCT
dpc-5264	208	8	orenay	orenay	NOUN
dpc-5264	208	9	om	om	NOUN
dpc-5264	208	10	.	.	PUNCT
dpc-5264	208	11	evaluation	evaluation	NOUN
dpc-5264	208	12	of	of	ADP
dpc-5264	208	13	inflammatory	inflammatory	ADJ
dpc-5264	208	14	status	status	NOUN
dpc-5264	208	15	in	in	ADP
dpc-5264	208	16	blood	blood	NOUN
dpc-5264	208	17	in	in	ADP
dpc-5264	208	18	patients	patient	NOUN
dpc-5264	208	19	with	with	ADP
dpc-5264	208	20	rosacea	rosacea	NOUN
dpc-5264	208	21	.	.	PUNCT
dpc-5264	209	1	sci	sci	PROPN
dpc-5264	209	2	rep	rep	PROPN
dpc-5264	209	3	.	.	PROPN
dpc-5264	210	1	2023;13(1):9068	2023;13(1):9068	NUM
dpc-5264	210	2	.	.	PUNCT
dpc-5264	210	3	doi	doi	NOUN
dpc-5264	210	4	:	:	PUNCT
dpc-5264	210	5	10.1038	10.1038	NUM
dpc-5264	210	6	/	/	SYM
dpc-5264	210	7	s41598	s41598	NOUN
dpc-5264	210	8	-	-	PUNCT
dpc-5264	210	9	023	023	NUM
dpc-5264	210	10	-	-	PUNCT
dpc-5264	210	11	36247	36247	NUM
dpc-5264	210	12	-	-	SYM
dpc-5264	210	13	5	5	NUM
dpc-5264	210	14	.	.	PUNCT
dpc-5264	211	1	pmid	pmid	NOUN
dpc-5264	211	2	:	:	PUNCT
dpc-5264	211	3	37277425	37277425	NUM
dpc-5264	211	4	20	20	NUM
dpc-5264	211	5	.	.	PUNCT
dpc-5264	212	1	haber	haber	PROPN
dpc-5264	212	2	r	r	PROPN
dpc-5264	212	3	,	,	PUNCT
dpc-5264	212	4	el	el	PROPN
dpc-5264	212	5	gemayel	gemayel	PROPN
dpc-5264	212	6	m.	m.	NOUN
dpc-5264	212	7	comorbidities	comorbiditie	NOUN
dpc-5264	212	8	in	in	ADP
dpc-5264	212	9	rosacea	rosacea	NOUN
dpc-5264	212	10	:	:	PUNCT
dpc-5264	212	11	a	a	DET
dpc-5264	212	12	systematic	systematic	ADJ
dpc-5264	212	13	review	review	NOUN
dpc-5264	212	14	and	and	CCONJ
dpc-5264	212	15	update	update	VERB
dpc-5264	212	16	.	.	PUNCT
dpc-5264	213	1	j	j	PROPN
dpc-5264	213	2	am	be	AUX
dpc-5264	213	3	acad	acad	ADJ
dpc-5264	213	4	dermatol	dermatol	NOUN
dpc-5264	213	5	.	.	PUNCT
dpc-5264	214	1	2018;78(4):786	2018;78(4):786	NUM
dpc-5264	214	2	-	-	SYM
dpc-5264	214	3	792	792	NUM
dpc-5264	214	4	.	.	PUNCT
dpc-5264	215	1	doi	doi	NOUN
dpc-5264	215	2	:	:	PUNCT
dpc-5264	215	3	10.1016	10.1016	NUM
dpc-5264	215	4	/	/	SYM
dpc-5264	215	5	j.jaad.2017.09.016	j.jaad.2017.09.016	PROPN
dpc-5264	215	6	.	.	PUNCT
dpc-5264	216	1	pmid	pmid	NOUN
dpc-5264	216	2	:	:	PUNCT
dpc-5264	216	3	29107339	29107339	NUM
dpc-5264	216	4	21	21	NUM
dpc-5264	216	5	.	.	PUNCT
dpc-5264	217	1	luo	luo	PROPN
dpc-5264	217	2	m	m	PROPN
dpc-5264	217	3	,	,	PUNCT
dpc-5264	217	4	wei	wei	PROPN
dpc-5264	217	5	b.	b.	PROPN
dpc-5264	217	6	novel	novel	PROPN
dpc-5264	217	7	insights	insight	NOUN
dpc-5264	217	8	into	into	ADP
dpc-5264	217	9	rosacea	rosacea	NOUN
dpc-5264	217	10	’s	’s	PART
dpc-5264	217	11	role	role	NOUN
dpc-5264	217	12	in	in	ADP
dpc-5264	217	13	cancer	cancer	NOUN
dpc-5264	217	14	risk	risk	NOUN
dpc-5264	217	15	:	:	PUNCT
dpc-5264	217	16	a	a	DET
dpc-5264	217	17	mendelian	mendelian	ADJ
dpc-5264	217	18	randomization	randomization	NOUN
dpc-5264	217	19	approach	approach	NOUN
dpc-5264	217	20	.	.	PUNCT
dpc-5264	218	1	skin	skin	NOUN
dpc-5264	218	2	res	re	NOUN
dpc-5264	218	3	technol	technol	NOUN
dpc-5264	218	4	.	.	PUNCT
dpc-5264	219	1	2024;30(5):e13737	2024;30(5):e13737	X
dpc-5264	219	2	.	.	PUNCT
dpc-5264	219	3	doi	doi	NOUN
dpc-5264	219	4	:	:	PUNCT
dpc-5264	219	5	10.1111	10.1111	NUM
dpc-5264	219	6	/	/	SYM
dpc-5264	219	7	srt.13737	srt.13737	NUM
dpc-5264	219	8	.	.	PUNCT
dpc-5264	220	1	pmid	pmid	NOUN
dpc-5264	220	2	:	:	PUNCT
dpc-5264	220	3	38769705	38769705	NUM
dpc-5264	220	4	22	22	NUM
dpc-5264	220	5	.	.	PUNCT
dpc-5264	221	1	cho	cho	PROPN
dpc-5264	222	1	si	si	PROPN
dpc-5264	222	2	,	,	PUNCT
dpc-5264	222	3	lee	lee	PROPN
dpc-5264	222	4	h	h	PROPN
dpc-5264	222	5	,	,	PUNCT
dpc-5264	222	6	cho	cho	PROPN
dpc-5264	222	7	s.	s.	PROPN
dpc-5264	222	8	risk	risk	NOUN
dpc-5264	222	9	of	of	ADP
dpc-5264	222	10	skin	skin	NOUN
dpc-5264	222	11	cancer	cancer	NOUN
dpc-5264	222	12	and	and	CCONJ
dpc-5264	222	13	actinic	actinic	ADJ
dpc-5264	222	14	keratosis	keratosis	NOUN
dpc-5264	222	15	in	in	ADP
dpc-5264	222	16	patients	patient	NOUN
dpc-5264	222	17	with	with	ADP
dpc-5264	222	18	rosacea	rosacea	NOUN
dpc-5264	222	19	:	:	PUNCT
dpc-5264	222	20	a	a	DET
dpc-5264	222	21	nationwide	nationwide	ADJ
dpc-5264	222	22	population	population	NOUN
dpc-5264	222	23	-	-	PUNCT
dpc-5264	222	24	based	base	VERB
dpc-5264	222	25	cohort	cohort	NOUN
dpc-5264	222	26	study	study	NOUN
dpc-5264	222	27	.	.	PUNCT
dpc-5264	223	1	acta	acta	PROPN
dpc-5264	223	2	derm	derm	PROPN
dpc-5264	223	3	venereol	venereol	NOUN
dpc-5264	223	4	.	.	PUNCT
dpc-5264	224	1	2022;102	2022;102	NUM
dpc-5264	224	2	:	:	PUNCT
dpc-5264	224	3	adv00803	adv00803	NOUN
dpc-5264	224	4	.	.	PUNCT
dpc-5264	225	1	doi	doi	NOUN
dpc-5264	225	2	:	:	PUNCT
dpc-5264	225	3	10.2340	10.2340	NUM
dpc-5264	225	4	/actadv.v102.2563	/actadv.v102.2563	NOUN
dpc-5264	225	5	.	.	PUNCT
dpc-5264	226	1	pmid	pmid	NOUN
dpc-5264	226	2	:	:	PUNCT
dpc-5264	226	3	36250731	36250731	NUM
dpc-5264	226	4	23	23	NUM
dpc-5264	226	5	.	.	PUNCT
dpc-5264	227	1	lazzeri	lazzeri	PROPN
dpc-5264	227	2	d	d	PROPN
dpc-5264	227	3	,	,	PUNCT
dpc-5264	227	4	colizzi	colizzi	ADJ
dpc-5264	227	5	l	l	NOUN
dpc-5264	227	6	,	,	PUNCT
dpc-5264	227	7	licata	licata	VERB
dpc-5264	227	8	g	g	NOUN
dpc-5264	227	9	,	,	PUNCT
dpc-5264	227	10	et	et	PROPN
dpc-5264	227	11	al	al	PROPN
dpc-5264	227	12	.	.	PUNCT
dpc-5264	228	1	malignancies	malignancy	NOUN
dpc-5264	228	2	within	within	ADP
dpc-5264	228	3	rhinophyma	rhinophyma	NOUN
dpc-5264	228	4	:	:	PUNCT
dpc-5264	228	5	report	report	NOUN
dpc-5264	228	6	of	of	ADP
dpc-5264	228	7	three	three	NUM
dpc-5264	228	8	new	new	ADJ
dpc-5264	228	9	cases	case	NOUN
dpc-5264	228	10	and	and	CCONJ
dpc-5264	228	11	review	review	NOUN
dpc-5264	228	12	of	of	ADP
dpc-5264	228	13	the	the	DET
dpc-5264	228	14	literature	literature	NOUN
dpc-5264	228	15	.	.	PUNCT
dpc-5264	229	1	aesthetic	aesthetic	ADJ
dpc-5264	229	2	plast	plast	NOUN
dpc-5264	229	3	surg	surg	NOUN
dpc-5264	229	4	.	.	PUNCT
dpc-5264	230	1	2012;36(2):396	2012;36(2):396	NUM
dpc-5264	230	2	-	-	SYM
dpc-5264	230	3	405	405	NUM
dpc-5264	230	4	.	.	PUNCT
dpc-5264	231	1	doi	doi	NOUN
dpc-5264	231	2	:	:	PUNCT
dpc-5264	231	3	10.1007	10.1007	NUM
dpc-5264	231	4	/s00266	/s00266	NOUN
dpc-5264	231	5	-	-	PUNCT
dpc-5264	231	6	011	011	NUM
dpc-5264	231	7	-	-	PUNCT
dpc-5264	231	8	9802	9802	NUM
dpc-5264	231	9	-	-	SYM
dpc-5264	231	10	0	0	NUM
dpc-5264	231	11	.	.	PUNCT
dpc-5264	232	1	pmid	pmid	NOUN
dpc-5264	232	2	:	:	PUNCT
dpc-5264	232	3	218585597	218585597	NUM
dpc-5264	232	4	24	24	NUM
dpc-5264	232	5	.	.	PUNCT
dpc-5264	233	1	lin	lin	PROPN
dpc-5264	233	2	em	em	PRON
dpc-5264	233	3	,	,	PUNCT
dpc-5264	233	4	rajadurai	rajadurai	VERB
dpc-5264	233	5	s	s	PROPN
dpc-5264	233	6	,	,	PUNCT
dpc-5264	233	7	qureshi	qureshi	PROPN
dpc-5264	233	8	aa	aa	PROPN
dpc-5264	233	9	,	,	PUNCT
dpc-5264	233	10	cho	cho	PROPN
dpc-5264	233	11	e.	e.	PROPN
dpc-5264	233	12	prospective	prospective	PROPN
dpc-5264	233	13	study	study	NOUN
dpc-5264	233	14	evaluating	evaluate	VERB
dpc-5264	233	15	the	the	DET
dpc-5264	233	16	personal	personal	ADJ
dpc-5264	233	17	history	history	NOUN
dpc-5264	233	18	of	of	ADP
dpc-5264	233	19	rosacea	rosacea	NOUN
dpc-5264	233	20	and	and	CCONJ
dpc-5264	233	21	risk	risk	NOUN
dpc-5264	233	22	of	of	ADP
dpc-5264	233	23	cutaneous	cutaneous	ADJ
dpc-5264	233	24	squamous	squamous	ADJ
dpc-5264	233	25	cell	cell	NOUN
dpc-5264	233	26	carcinoma	carcinoma	NOUN
dpc-5264	233	27	among	among	ADP
dpc-5264	233	28	women	woman	NOUN
dpc-5264	233	29	in	in	ADP
dpc-5264	233	30	the	the	DET
dpc-5264	233	31	united	united	PROPN
dpc-5264	233	32	states	states	PROPN
dpc-5264	233	33	.	.	PUNCT
dpc-5264	234	1	j	j	PROPN
dpc-5264	234	2	am	be	AUX
dpc-5264	234	3	acad	acad	ADJ
dpc-5264	234	4	dermatol	dermatol	NOUN
dpc-5264	234	5	.	.	PUNCT
dpc-5264	235	1	2022;87(6):1389	2022;87(6):1389	NUM
dpc-5264	235	2	-	-	PUNCT
dpc-5264	235	3	1391	1391	NUM
dpc-5264	235	4	.	.	PUNCT
dpc-5264	236	1	doi	doi	NOUN
dpc-5264	236	2	:	:	PUNCT
dpc-5264	236	3	10.1016	10.1016	NUM
dpc-5264	236	4	/j.jaad.2022.09.004	/j.jaad.2022.09.004	PUNCT
dpc-5264	236	5	.	.	PUNCT
dpc-5264	237	1	pmid	pmid	NOUN
dpc-5264	237	2	:	:	PUNCT
dpc-5264	237	3	36089188	36089188	NUM
dpc-5264	237	4	2	2	NUM
dpc-5264	237	5	.	.	PUNCT
dpc-5264	238	1	cakir	cakir	PROPN
dpc-5264	238	2	bo	bo	PROPN
dpc-5264	238	3	,	,	PUNCT
dpc-5264	238	4	adamson	adamson	PROPN
dpc-5264	238	5	p	p	PROPN
dpc-5264	238	6	,	,	PUNCT
dpc-5264	238	7	cingi	cingi	PROPN
dpc-5264	238	8	c.	c.	PROPN
dpc-5264	238	9	epidemiology	epidemiology	PROPN
dpc-5264	238	10	and	and	CCONJ
dpc-5264	238	11	economic	economic	ADJ
dpc-5264	238	12	burden	burden	NOUN
dpc-5264	238	13	of	of	ADP
dpc-5264	238	14	nonmelanoma	nonmelanoma	ADJ
dpc-5264	238	15	skin	skin	NOUN
dpc-5264	238	16	cancer	cancer	NOUN
dpc-5264	238	17	.	.	PUNCT
dpc-5264	239	1	facial	facial	ADJ
dpc-5264	239	2	plast	plast	PROPN
dpc-5264	239	3	surg	surg	PROPN
dpc-5264	239	4	clin	clin	PROPN
dpc-5264	239	5	north	north	PROPN
dpc-5264	239	6	am	am	PROPN
dpc-5264	239	7	.	.	PUNCT
dpc-5264	240	1	2012;20(4):419	2012;20(4):419	NUM
dpc-5264	240	2	-	-	SYM
dpc-5264	240	3	422	422	NUM
dpc-5264	240	4	.	.	PUNCT
dpc-5264	241	1	doi	doi	NOUN
dpc-5264	241	2	:	:	PUNCT
dpc-5264	241	3	10.1016	10.1016	NUM
dpc-5264	241	4	/	/	SYM
dpc-5264	241	5	j.fsc.2012.07.004	j.fsc.2012.07.004	PROPN
dpc-5264	241	6	.	.	PUNCT
dpc-5264	242	1	pmid	pmid	NOUN
dpc-5264	242	2	:	:	PUNCT
dpc-5264	242	3	23084294	23084294	NUM
dpc-5264	242	4	3	3	NUM
dpc-5264	242	5	.	.	PUNCT
dpc-5264	243	1	egeberg	egeberg	PROPN
dpc-5264	243	2	a	a	PROPN
dpc-5264	243	3	,	,	PUNCT
dpc-5264	243	4	fowler	fowler	PROPN
dpc-5264	243	5	jf	jf	PROPN
dpc-5264	243	6	jr	jr	PROPN
dpc-5264	243	7	,	,	PUNCT
dpc-5264	243	8	gislason	gislason	PROPN
dpc-5264	243	9	gh	gh	PROPN
dpc-5264	243	10	,	,	PUNCT
dpc-5264	243	11	thyssen	thyssen	PROPN
dpc-5264	243	12	jp	jp	PROPN
dpc-5264	243	13	.	.	PUNCT
dpc-5264	244	1	rosacea	rosacea	NOUN
dpc-5264	244	2	and	and	CCONJ
dpc-5264	244	3	risk	risk	NOUN
dpc-5264	244	4	of	of	ADP
dpc-5264	244	5	cancer	cancer	NOUN
dpc-5264	244	6	in	in	ADP
dpc-5264	244	7	denmark	denmark	NOUN
dpc-5264	244	8	.	.	PUNCT
dpc-5264	245	1	cancer	cancer	NOUN
dpc-5264	245	2	epidemiol	epidemiol	PROPN
dpc-5264	245	3	.	.	PUNCT
dpc-5264	246	1	2017;47:76	2017;47:76	NUM
dpc-5264	246	2	-	-	SYM
dpc-5264	246	3	80	80	NUM
dpc-5264	246	4	.	.	PUNCT
dpc-5264	247	1	doi	doi	NOUN
dpc-5264	247	2	:	:	PUNCT
dpc-5264	247	3	10.1016	10.1016	NUM
dpc-5264	247	4	/	/	SYM
dpc-5264	247	5	j.fsc.2012.07.004	j.fsc.2012.07.004	PROPN
dpc-5264	247	6	.	.	PUNCT
dpc-5264	248	1	pmid	pmid	NOUN
dpc-5264	248	2	:	:	PUNCT
dpc-5264	248	3	28131793	28131793	NUM
dpc-5264	248	4	4	4	NUM
dpc-5264	248	5	.	.	PUNCT
dpc-5264	248	6	li	li	PROPN
dpc-5264	248	7	wq	wq	PROPN
dpc-5264	248	8	,	,	PUNCT
dpc-5264	248	9	zhang	zhang	PROPN
dpc-5264	248	10	m	m	PROPN
dpc-5264	248	11	,	,	PUNCT
dpc-5264	248	12	danby	danby	PROPN
dpc-5264	248	13	fw	fw	PROPN
dpc-5264	248	14	,	,	PUNCT
dpc-5264	248	15	han	han	PROPN
dpc-5264	248	16	j	j	PROPN
dpc-5264	248	17	,	,	PUNCT
dpc-5264	248	18	qureshi	qureshi	PROPN
dpc-5264	248	19	aa	aa	PROPN
dpc-5264	248	20	.	.	PUNCT
dpc-5264	249	1	personal	personal	ADJ
dpc-5264	249	2	history	history	NOUN
dpc-5264	249	3	of	of	ADP
dpc-5264	249	4	rosacea	rosacea	NOUN
dpc-5264	249	5	and	and	CCONJ
dpc-5264	249	6	risk	risk	NOUN
dpc-5264	249	7	of	of	ADP
dpc-5264	249	8	incident	incident	NOUN
dpc-5264	249	9	cancer	cancer	NOUN
dpc-5264	249	10	among	among	ADP
dpc-5264	249	11	women	woman	NOUN
dpc-5264	249	12	in	in	ADP
dpc-5264	249	13	the	the	DET
dpc-5264	249	14	us	us	PROPN
dpc-5264	249	15	.	.	PUNCT
dpc-5264	250	1	br	br	PROPN
dpc-5264	250	2	j	j	PROPN
dpc-5264	250	3	cancer	cancer	NOUN
dpc-5264	250	4	.	.	PUNCT
dpc-5264	251	1	2015;113(3):520	2015;113(3):520	NUM
dpc-5264	251	2	-	-	SYM
dpc-5264	251	3	523	523	NUM
dpc-5264	251	4	.	.	PUNCT
dpc-5264	252	1	doi	doi	NOUN
dpc-5264	252	2	:	:	PUNCT
dpc-5264	252	3	10.1038	10.1038	NUM
dpc-5264	252	4	/bjc.2015.217	/bjc.2015.217	NOUN
dpc-5264	252	5	.	.	PUNCT
dpc-5264	253	1	pmid	pmid	NOUN
dpc-5264	253	2	:	:	PUNCT
dpc-5264	253	3	26103573	26103573	NUM
dpc-5264	253	4	5	5	NUM
dpc-5264	253	5	.	.	PUNCT
dpc-5264	253	6	dupont	dupont	PROPN
dpc-5264	253	7	c.	c.	PROPN
dpc-5264	253	8	rosacea	rosacea	PROPN
dpc-5264	253	9	is	be	AUX
dpc-5264	253	10	not	not	PART
dpc-5264	253	11	associated	associate	VERB
dpc-5264	253	12	with	with	ADP
dpc-5264	253	13	skin	skin	NOUN
dpc-5264	253	14	cancer	cancer	NOUN
dpc-5264	253	15	.	.	PUNCT
dpc-5264	254	1	arch	arch	ADJ
dpc-5264	254	2	dermatol	dermatol	NOUN
dpc-5264	254	3	.	.	PUNCT
dpc-5264	255	1	1986;122(10):1099	1986;122(10):1099	NUM
dpc-5264	255	2	.	.	PUNCT
dpc-5264	256	1	pmid	pmid	NOUN
dpc-5264	256	2	:	:	PUNCT
dpc-5264	256	3	2945515	2945515	NUM
dpc-5264	256	4	6	6	NUM
dpc-5264	256	5	.	.	PUNCT
dpc-5264	257	1	lin	lin	PROPN
dpc-5264	257	2	em	em	PRON
dpc-5264	257	3	,	,	PUNCT
dpc-5264	257	4	qureshi	qureshi	PROPN
dpc-5264	257	5	aa	aa	PROPN
dpc-5264	257	6	,	,	PUNCT
dpc-5264	257	7	wisco	wisco	PROPN
dpc-5264	257	8	o	o	PROPN
dpc-5264	257	9	,	,	PUNCT
dpc-5264	257	10	cho	cho	PROPN
dpc-5264	257	11	e.	e.	PROPN
dpc-5264	257	12	single	single	PROPN
dpc-5264	257	13	-	-	PUNCT
dpc-5264	257	14	institution	institution	NOUN
dpc-5264	257	15	retrospective	retrospective	ADJ
dpc-5264	257	16	study	study	NOUN
dpc-5264	257	17	evaluating	evaluate	VERB
dpc-5264	257	18	personal	personal	ADJ
dpc-5264	257	19	history	history	NOUN
dpc-5264	257	20	of	of	ADP
dpc-5264	257	21	rosacea	rosacea	NOUN
dpc-5264	257	22	and	and	CCONJ
dpc-5264	257	23	risk	risk	NOUN
dpc-5264	257	24	of	of	ADP
dpc-5264	257	25	basal	basal	ADJ
dpc-5264	257	26	cell	cell	NOUN
dpc-5264	257	27	carcinoma	carcinoma	NOUN
dpc-5264	257	28	.	.	PUNCT
dpc-5264	258	1	j	j	PROPN
dpc-5264	258	2	am	be	AUX
dpc-5264	258	3	acad	acad	ADJ
dpc-5264	258	4	dermatol	dermatol	NOUN
dpc-5264	258	5	.	.	PUNCT
dpc-5264	259	1	2023;89(2):399	2023;89(2):399	NUM
dpc-5264	259	2	-	-	SYM
dpc-5264	259	3	401	401	NUM
dpc-5264	259	4	.	.	PUNCT
dpc-5264	260	1	doi	doi	NOUN
dpc-5264	260	2	:	:	PUNCT
dpc-5264	260	3	10.1016	10.1016	NUM
dpc-5264	260	4	/	/	SYM
dpc-5264	260	5	j.jaad.2023.03.055	j.jaad.2023.03.055	PROPN
dpc-5264	260	6	.	.	PUNCT
dpc-5264	261	1	pmid	pmid	PROPN
dpc-5264	261	2	:	:	PUNCT
dpc-5264	261	3	37061134	37061134	NUM
dpc-5264	261	4	7	7	NUM
dpc-5264	261	5	.	.	PUNCT
dpc-5264	261	6	sanchez	sanchez	NOUN
dpc-5264	261	7	-	-	PUNCT
dpc-5264	261	8	pellicer	pellicer	NOUN
dpc-5264	261	9	p	p	X
dpc-5264	261	10	,	,	PUNCT
dpc-5264	261	11	eguren	eguren	NOUN
dpc-5264	261	12	-	-	PUNCT
dpc-5264	261	13	michelena	michelena	PROPN
dpc-5264	261	14	c	c	PROPN
dpc-5264	261	15	,	,	PUNCT
dpc-5264	261	16	garcia	garcia	PROPN
dpc-5264	261	17	-	-	PUNCT
dpc-5264	261	18	gavin	gavin	PROPN
dpc-5264	261	19	j	j	PROPN
dpc-5264	261	20	,	,	PUNCT
dpc-5264	261	21	et	et	PROPN
dpc-5264	261	22	al	al	PROPN
dpc-5264	261	23	.	.	PROPN
dpc-5264	261	24	rosacea	rosacea	PROPN
dpc-5264	261	25	,	,	PUNCT
dpc-5264	261	26	microbiome	microbiome	NOUN
dpc-5264	261	27	and	and	CCONJ
dpc-5264	261	28	probiotics	probiotic	NOUN
dpc-5264	261	29	:	:	PUNCT
dpc-5264	261	30	the	the	DET
dpc-5264	261	31	gut	gut	NOUN
dpc-5264	261	32	-	-	PUNCT
dpc-5264	261	33	skin	skin	NOUN
dpc-5264	261	34	axis	axis	NOUN
dpc-5264	261	35	.	.	PUNCT
dpc-5264	262	1	front	front	ADJ
dpc-5264	262	2	microbiol	microbiol	PROPN
dpc-5264	262	3	.	.	PUNCT
dpc-5264	263	1	2024;14:1323644	2024;14:1323644	NUM
dpc-5264	263	2	.	.	PUNCT
dpc-5264	263	3	doi	doi	NOUN
dpc-5264	263	4	:	:	PUNCT
dpc-5264	263	5	10.3389	10.3389	NUM
dpc-5264	263	6	/	/	SYM
dpc-5264	263	7	fmicb.2023.1323644	fmicb.2023.1323644	PROPN
dpc-5264	263	8	.	.	PUNCT
dpc-5264	264	1	pmid	pmid	NOUN
dpc-5264	264	2	:	:	PUNCT
dpc-5264	264	3	38260914	38260914	NUM
dpc-5264	264	4	8	8	NUM
dpc-5264	264	5	.	.	PUNCT
dpc-5264	265	1	salzer	salzer	PROPN
dpc-5264	265	2	s	s	PROPN
dpc-5264	265	3	,	,	PUNCT
dpc-5264	265	4	kresse	kresse	PROPN
dpc-5264	265	5	s	s	PROPN
dpc-5264	265	6	,	,	PUNCT
dpc-5264	265	7	hirai	hirai	PROPN
dpc-5264	265	8	y	y	PROPN
dpc-5264	265	9	,	,	PUNCT
dpc-5264	265	10	et	et	PROPN
dpc-5264	265	11	al	al	PROPN
dpc-5264	265	12	.	.	PUNCT
dpc-5264	266	1	cathelicidin	cathelicidin	VERB
dpc-5264	266	2	peptide	peptide	NOUN
dpc-5264	266	3	ll-37	ll-37	NOUN
dpc-5264	266	4	increases	increase	VERB
dpc-5264	266	5	uvb	uvb	ADJ
dpc-5264	266	6	-	-	PUNCT
dpc-5264	266	7	triggered	trigger	VERB
dpc-5264	266	8	inflammasome	inflammasome	NOUN
dpc-5264	266	9	activation	activation	NOUN
dpc-5264	266	10	:	:	PUNCT
dpc-5264	266	11	possible	possible	ADJ
dpc-5264	266	12	implications	implication	NOUN
dpc-5264	266	13	for	for	ADP
dpc-5264	266	14	rosacea	rosacea	NOUN
dpc-5264	266	15	.	.	PUNCT
dpc-5264	267	1	j	j	PROPN
dpc-5264	267	2	dermatol	dermatol	PROPN
dpc-5264	267	3	sci	sci	PROPN
dpc-5264	267	4	.	.	PUNCT
dpc-5264	268	1	2014;76(3):173	2014;76(3):173	PROPN
dpc-5264	268	2	-	-	PUNCT
dpc-5264	268	3	179	179	PROPN
dpc-5264	268	4	.	.	PUNCT
dpc-5264	269	1	doi	doi	NOUN
dpc-5264	269	2	:	:	PUNCT
dpc-5264	269	3	 	 	SPACE
dpc-5264	269	4	10.1016	10.1016	NUM
dpc-5264	269	5	/	/	SYM
dpc-5264	269	6	j.jdermsci.2014.09.002	j.jdermsci.2014.09.002	PROPN
dpc-5264	269	7	.	.	PUNCT
dpc-5264	270	1	pmid	pmid	NOUN
dpc-5264	270	2	:	:	PUNCT
dpc-5264	270	3	25306296	25306296	NUM
dpc-5264	270	4	9	9	NUM
dpc-5264	270	5	.	.	PUNCT
dpc-5264	271	1	thapa	thapa	PROPN
dpc-5264	271	2	l	l	PROPN
dpc-5264	271	3	,	,	PUNCT
dpc-5264	271	4	xia	xia	PROPN
dpc-5264	271	5	j	j	PROPN
dpc-5264	271	6	,	,	PUNCT
dpc-5264	271	7	guo	guo	PROPN
dpc-5264	271	8	w	w	PROPN
dpc-5264	271	9	,	,	PUNCT
dpc-5264	271	10	usmani	usmani	ADJ
dpc-5264	271	11	h	h	PROPN
dpc-5264	271	12	,	,	PUNCT
dpc-5264	271	13	miller	miller	PROPN
dpc-5264	271	14	d	d	PROPN
dpc-5264	271	15	,	,	PUNCT
dpc-5264	271	16	lozeau	lozeau	PROPN
dpc-5264	271	17	d.	d.	PROPN
dpc-5264	271	18	rosacea	rosacea	PROPN
dpc-5264	271	19	and	and	CCONJ
dpc-5264	271	20	its	its	PRON
dpc-5264	271	21	association	association	NOUN
dpc-5264	271	22	with	with	ADP
dpc-5264	271	23	malignancy	malignancy	NOUN
dpc-5264	271	24	:	:	PUNCT
dpc-5264	271	25	systematic	systematic	ADJ
dpc-5264	271	26	review	review	NOUN
dpc-5264	271	27	.	.	PUNCT
dpc-5264	272	1	jmir	jmir	PROPN
dpc-5264	272	2	dermatol	dermatol	PROPN
dpc-5264	272	3	.	.	PUNCT
dpc-5264	273	1	2023;6	2023;6	NOUN
dpc-5264	273	2	:	:	PUNCT
dpc-5264	273	3	e47821	e47821	PROPN
dpc-5264	273	4	.	.	PUNCT
dpc-5264	274	1	doi	doi	PROPN
dpc-5264	274	2	:	:	PUNCT
dpc-5264	274	3	10.2196/47821	10.2196/47821	NUM
dpc-5264	274	4	.	.	PUNCT
dpc-5264	275	1	pmid	pmid	NOUN
dpc-5264	275	2	:	:	PUNCT
dpc-5264	275	3	37938876	37938876	NUM
dpc-5264	275	4	10	10	NUM
dpc-5264	275	5	.	.	PUNCT
dpc-5264	276	1	chang	chang	PROPN
dpc-5264	276	2	ys	ys	PROPN
dpc-5264	276	3	,	,	PUNCT
dpc-5264	276	4	huang	huang	PROPN
dpc-5264	276	5	yc	yc	PROPN
dpc-5264	276	6	.	.	PUNCT
dpc-5264	276	7	role	role	NOUN
dpc-5264	276	8	of	of	ADP
dpc-5264	276	9	demodex	demodex	NOUN
dpc-5264	276	10	mite	mite	NOUN
dpc-5264	276	11	infestation	infestation	NOUN
dpc-5264	276	12	in	in	ADP
dpc-5264	276	13	rosacea	rosacea	NOUN
dpc-5264	276	14	:	:	PUNCT
dpc-5264	276	15	a	a	DET
dpc-5264	276	16	systematic	systematic	ADJ
dpc-5264	276	17	review	review	NOUN
dpc-5264	276	18	and	and	CCONJ
dpc-5264	276	19	meta	meta	ADJ
dpc-5264	276	20	-	-	PUNCT
dpc-5264	276	21	analysis	analysis	NOUN
dpc-5264	276	22	.	.	PUNCT
dpc-5264	277	1	j	j	PROPN
dpc-5264	277	2	am	be	AUX
dpc-5264	277	3	acad	acad	ADJ
dpc-5264	277	4	dermatol	dermatol	NOUN
dpc-5264	277	5	.	.	PUNCT
dpc-5264	278	1	2017;77(3):441	2017;77(3):441	PROPN
dpc-5264	278	2	-	-	PUNCT
dpc-5264	278	3	447	447	NUM
dpc-5264	278	4	.	.	PUNCT
dpc-5264	279	1	doi	doi	NOUN
dpc-5264	279	2	:	:	PUNCT
dpc-5264	279	3	10.1016	10.1016	NUM
dpc-5264	279	4	/	/	SYM
dpc-5264	279	5	j.jaad.2017.03.040	j.jaad.2017.03.040	PROPN
dpc-5264	279	6	.	.	PUNCT
dpc-5264	280	1	pmid	pmid	NOUN
dpc-5264	280	2	:	:	PUNCT
dpc-5264	280	3	28711190	28711190	NUM
dpc-5264	280	4	11	11	NUM
dpc-5264	280	5	.	.	PUNCT
dpc-5264	281	1	gerber	gerber	PROPN
dpc-5264	281	2	pa	pa	PROPN
dpc-5264	281	3	,	,	PUNCT
dpc-5264	281	4	buhren	buhren	PROPN
dpc-5264	281	5	ba	ba	PROPN
dpc-5264	281	6	,	,	PUNCT
dpc-5264	281	7	steinhoff	steinhoff	PROPN
dpc-5264	281	8	m	m	PROPN
dpc-5264	281	9	,	,	PUNCT
dpc-5264	281	10	homey	homey	PROPN
dpc-5264	281	11	b.	b.	PROPN
dpc-5264	281	12	rosacea	rosacea	PROPN
dpc-5264	281	13	:	:	PUNCT
dpc-5264	281	14	the	the	DET
dpc-5264	281	15	cytokine	cytokine	ADJ
dpc-5264	281	16	and	and	CCONJ
dpc-5264	281	17	chemokine	chemokine	ADJ
dpc-5264	281	18	network	network	NOUN
dpc-5264	281	19	.	.	PUNCT
dpc-5264	282	1	j	j	PROPN
dpc-5264	282	2	investig	investig	NOUN
dpc-5264	282	3	dermatol	dermatol	NOUN
dpc-5264	282	4	symp	symp	NOUN
dpc-5264	282	5	proc	proc	NOUN
dpc-5264	282	6	.	.	PUNCT
dpc-5264	283	1	2011;15(1):40	2011;15(1):40	NUM
dpc-5264	283	2	-	-	SYM
dpc-5264	283	3	47	47	NUM
dpc-5264	283	4	.	.	PUNCT
dpc-5264	284	1	doi	doi	NOUN
dpc-5264	284	2	:	:	PUNCT
dpc-5264	284	3	10.1038	10.1038	NUM
dpc-5264	284	4	/	/	SYM
dpc-5264	284	5	jidsymp.2011.9	jidsymp.2011.9	PROPN
dpc-5264	284	6	.	.	PUNCT
dpc-5264	285	1	pmid	pmid	PROPN
dpc-5264	285	2	:	:	PUNCT
dpc-5264	285	3	22076326	22076326	NUM
dpc-5264	285	4	12	12	NUM
dpc-5264	285	5	.	.	PUNCT
dpc-5264	286	1	wang	wang	PROPN
dpc-5264	286	2	y	y	PROPN
dpc-5264	286	3	,	,	PUNCT
dpc-5264	286	4	wang	wang	PROPN
dpc-5264	286	5	b	b	PROPN
dpc-5264	286	6	,	,	PUNCT
dpc-5264	286	7	huang	huang	PROPN
dpc-5264	286	8	yet	yet	PROPN
dpc-5264	286	9	al	al	PROPN
dpc-5264	286	10	.	.	PUNCT
dpc-5264	286	11	multi	multi	ADJ
dpc-5264	286	12	-	-	ADJ
dpc-5264	286	13	transcriptomic	transcriptomic	ADJ
dpc-5264	286	14	analysis	analysis	NOUN
dpc-5264	286	15	and	and	CCONJ
dpc-5264	286	16	experimental	experimental	ADJ
dpc-5264	286	17	validation	validation	NOUN
dpc-5264	286	18	implicate	implicate	VERB
dpc-5264	286	19	a	a	DET
dpc-5264	286	20	central	central	ADJ
dpc-5264	286	21	role	role	NOUN
dpc-5264	286	22	of	of	ADP
dpc-5264	286	23	stat3	stat3	NOUN
dpc-5264	286	24	in	in	ADP
dpc-5264	286	25	skin	skin	NOUN
dpc-5264	286	26	barrier	barrier	NOUN
dpc-5264	286	27	dysfunction	dysfunction	NOUN
dpc-5264	286	28	induced	induce	VERB
dpc-5264	286	29	aggravation	aggravation	NOUN
dpc-5264	286	30	of	of	ADP
dpc-5264	286	31	rosacea	rosacea	NOUN
dpc-5264	286	32	.	.	PUNCT
dpc-5264	287	1	j	j	PROPN
dpc-5264	287	2	inflamm	inflamm	PROPN
dpc-5264	287	3	res	re	NOUN
dpc-5264	287	4	.	.	PUNCT
dpc-5264	288	1	2022;15:2141	2022;15:2141	PROPN
dpc-5264	288	2	-	-	SYM
dpc-5264	288	3	2156	2156	NUM
dpc-5264	288	4	.	.	PUNCT
dpc-5264	289	1	doi	doi	NOUN
dpc-5264	289	2	:	:	PUNCT
dpc-5264	289	3	10.2147	10.2147	NUM
dpc-5264	289	4	/	/	SYM
dpc-5264	289	5	jir.s356551	jir.s356551	X
dpc-5264	289	6	.	.	PUNCT
dpc-5264	290	1	pmid	pmid	NOUN
dpc-5264	290	2	:	:	PUNCT
dpc-5264	290	3	35392024	35392024	NUM
dpc-5264	290	4	13	13	NUM
dpc-5264	290	5	.	.	PUNCT
dpc-5264	291	1	deng	deng	PROPN
dpc-5264	291	2	z	z	PROPN
dpc-5264	291	3	,	,	PUNCT
dpc-5264	291	4	chen	chen	PROPN
dpc-5264	291	5	m	m	PROPN
dpc-5264	291	6	,	,	PUNCT
dpc-5264	291	7	liu	liu	PROPN
dpc-5264	291	8	y	y	PROPN
dpc-5264	291	9	,	,	PUNCT
dpc-5264	291	10	et	et	PROPN
dpc-5264	291	11	al	al	PROPN
dpc-5264	291	12	.	.	PUNCT
dpc-5264	292	1	a	a	DET
dpc-5264	292	2	positive	positive	ADJ
dpc-5264	292	3	feedback	feedback	NOUN
dpc-5264	292	4	loop	loop	NOUN
dpc-5264	292	5	between	between	ADP
dpc-5264	292	6	mtorc1	mtorc1	NOUN
dpc-5264	292	7	and	and	CCONJ
dpc-5264	292	8	cathelicidin	cathelicidin	NOUN
dpc-5264	292	9	promotes	promote	VERB
dpc-5264	292	10	skin	skin	NOUN
dpc-5264	292	11	inflammation	inflammation	NOUN
dpc-5264	292	12	in	in	ADP
dpc-5264	292	13	rosacea	rosacea	PROPN
dpc-5264	292	14	.	.	PUNCT
dpc-5264	293	1	embo	embo	PROPN
dpc-5264	293	2	mol	mol	ADP
dpc-5264	293	3	med	med	PROPN
dpc-5264	293	4	.	.	PUNCT
dpc-5264	294	1	2021;13(5):e13560	2021;13(5):e13560	X
dpc-5264	294	2	.	.	PUNCT
dpc-5264	294	3	doi	doi	NOUN
dpc-5264	294	4	:	:	PUNCT
dpc-5264	294	5	10.15252	10.15252	NUM
dpc-5264	294	6	/emmm.202013560	/emmm.202013560	PUNCT
dpc-5264	294	7	.	.	PUNCT
dpc-5264	295	1	pmid	pmid	NOUN
dpc-5264	295	2	:	:	PUNCT
dpc-5264	295	3	33734592	33734592	NUM